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Abstract  
 
This study explored and described the experience of people with a diagnosis of 
cancer, as they transitioned from life as a chemotherapy patient to life after treatment as 
a cancer survivor. The purpose of this study was to ultimately improve the care of 
people as they transitioned into life after completion of chemotherapy treatment. There 
is minimal information related to this phase of the cancer trajectory, therefore this study 
was intentionally exploratory and descriptive.  
To achieve the proposed outcome a two-phased approach was undertaken. In 
Phase One a qualitative approach was followed using Grounded Theory to the 
descriptive level of data analysis. The study was undertaken in a large tertiary hospital 
in Western Australia. The sample comprised of 14 cancer survivors who had completed 
chemotherapy treatment in the previous four to twelve weeks. Data was collected via 
semi structured telephone interviews. Descriptors of issues and experiences that arose in 
the first six months following completion of chemotherapy were elicited. Data was 
subsequently transcribed, coded and organised into themes of congruent relevance.  
Cancer survivors were found to transition through two stages in the early weeks 
following completion of chemotherapy. When physical symptoms and emotional losses 
were all encompassing, the survivors displayed vulnerability due to the loss of the 
treatment environment and a range of challenging emotions. As the weeks passed and 
physical symptoms began to abate, the survivors began to display characteristics of 
resilience, self empowerment and information seeking strategies which both informed 
and protected the survivor. The domains that challenged the survivor throughout this 
transition period encompassed physical, social, psychological and spiritual issues. 
In Phase Two of the study, key findings from Phase One were utilised to inform 
the adaptation of an existing quality of life tool, Quality of life – Cancer Survivor, 
which was identified following an extensive literature review. The adapted tool, Quality 
of Life – Chemotherapy Cancer Survivor, was assessed for clarity, content validity and 
apparent internal consistency by an expert panel of six oncology nurses who were 
employed within the same tertiary hospital setting. Feedback from this process was used 
to further amend the original tool. The researcher intends to   pilot test the revised tool 
with cancer survivors in preparation for a larger scale population based study following 
this Masters study. 
ii 
This study has provided an insight into the survivorship issues as people 
transition to life after chemotherapy and findings begin to fill a gap in understanding 
which has not previously be addressed in the available literature. Implications for future 
research and clinical practice including, gaps in survivor’s knowledge and transition 
process issues, are provided. 
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Chapter One 
Introduction  
 
Cancer and survivorship were once considered contradictory terms. Advances in 
screening, diagnosing and treating cancers over the past 20 years have resulted in 
improved cancer survival rates. It has been estimated that more than 60% of all people 
diagnosed with cancer are alive five years after their initial diagnosis (Jefford et al., 
2008). With a rising incidence in cancer diagnosis due to an ageing population and a 
rising survival rate from the initial cancer diagnosis, there is increasing cancer 
prevalence within the Australian community. Australian survival rates for cancer are 
high by world standards, in 2004 survivors of cancer represented 3.2% of the population 
(Australian Institute of Health and Welfare [AIHW], 2008). 
The incidence of cancer continues to increase globally, and the prevalence of 
cancer in developed countries is increasing dramatically. Prevalence of cancer refers to 
the number of people who have previously received a cancer diagnosis and who are still 
alive at a given point in time, whereas incidence is the number of new cancers 
diagnosed in a specified period of time. Prevalence figures are therefore affected by 
both the incidence and survival. In Australia in 2010, cancer accounted for 19% of the 
total burden of disease (AIHW, 2010). Survival rates following a cancer diagnosis have 
improved to such an extent that cancer is now considered one of the top six chronic 
conditions in Australia (Australian Bureau of Statistics, 2011). Chronic diseases are 
illnesses that are prolonged in duration, do not often resolve spontaneously and are 
rarely cured completely (AIHW, 2002). This is a dramatic turn around for a condition 
that was once considered rapidly fatal; cancer remains one of the most feared illnesses 
within the general population despite increasingly successful outcomes, this fear sets it 
apart from other chronic conditions (Rassmussen & Elverdam, 2007; Tritter & Calnan, 
2002).  
The significant change in the cancer care trajectory has led to a new phase in the 
cancer care continuum widely known as “cancer survivorship”. The most commonly 
accepted definition is the one advocated by the National Coalition of Cancer 
Survivorship which is “the experience of living with, through and beyond a diagnosis of 
cancer” (Hewitt, Greenfield, & Stovall, 2006, p. 27). The continuum of cancer was once 
mostly linear beginning with diagnosis, moving on to treatment and then a limited   
remission, followed by recurrence and death within a short time frame or for the few 
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fortunate individuals the pathway became follow up monitoring and a confirmation of 
cure at the five year post diagnosis mark. 
The current continuum of cancer is much more cyclical once the primary 
treatment is complete, for those who are considered cured there is now a long pathway 
of monitoring and managing long term side effects of treatment. There are now several 
episodes of recurrence of cancer for the individual which is managed by subsequent 
treatment and ongoing monitoring before eventual death. The timeline in this cycle may 
amount to many years. 
 
Background 
A diagnosis of cancer is one of the most feared health conditions within Western 
societies; the diagnosis brings with it stress, physical and psychological consequences, 
the stigma of cancer and segregation from significant others and the general population 
(Skillbeck & Payne, 2003; Stringer, 2008; Towers, 2007). Whilst coming to terms with 
the diagnosis, the person diagnosed with cancer also faces a multitude of decisions and 
challenges across a spectrum of physical, psychological and social domains. The 
challenges whilst undergoing acute cancer treatment are well researched and 
documented with the focus of effort concentrating on completing treatment and aiming 
for cure.  
Despite ongoing fear and misunderstanding of cancer as a disease with a fatal 
outcome, substantial investments in cancer research have resulted in better outcomes for 
individuals diagnosed with cancer, with significant success in terms of improved 
survival rates (Hewitt, et al., 2006). There are a number of factors attributed to the trend 
of increased relative survival from cancer across the continuum of care. First the 
increased education of the population as a whole about the signs and symptoms of 
cancer; second the benefits of screening; and finally the importance of self examination 
have increased the awareness of prompt action in seeking advice. Primary care has 
made considerable improvements in the diagnosis of cancer and the follow up methods 
related to suspicious signs and symptoms of cancer. Further, service redesign has 
improved referral pathways and a led to more widespread availability of treatment. 
Advances in scientific knowledge and technology have led to more effective 
investigations and staging of disease and the addition of subspecialisation in cancer 
treatments have further increased the effectiveness of treatments (AIHW, 2008). 
Surviving cancer has consequences that can change an individual’s way of life 
considerably. The impact of cancer does not end after treatment; the  2008 “Health and 
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Wellbeing Survey” in the United Kingdom  found that cancer survivors reported poorer 
health and well being than the general population (Department of Health, Macmillan 
Cancer Support, & NHS Improvement, 2010). As this is a relatively new phenomenon 
to health, research in this area continues to identify new issues which need addressing. 
Survivors of cancer have been strong advocates for the development of survivorship 
care, led largely by the National Coalition of Cancer Survivorship in the United States 
of America (USA). 
There is now a growing body of published research addressing long-term 
survivorship issues. “Living beyond Cancer” (2004) reported there were 10 million 
cancer survivors in the USA, many of who were at the end of treatment and found 
themselves “in a world that is intimately familiar, yet forever changed” (Reuben, 2004, 
p. 5). There are as many research domains in cancer survivorship as there are in cancer 
treatments and symptom management. However, there is a great imbalance in the 
amount of research undertaken in these domains as shown in Figure 1. PubMed 
citations between 1992-2004 have almost doubled for adult cancer treatment research 
from 11,928 to 23,736, whilst citations for adult cancer survivorship research has almost 
trebled they are still relatively small numbers 132 to 374 during the same period (Aziz 
& Rowland, 2003). Since 2005 there has been an exponential rise in the research 
approaches to the domain of cancer survivorship with 57,041 citations available on the 
PubMed database in 2011. 
 
 
 
Figure 1. Illustration of the imbalance between adult cancer treatment and adult cancer 
survivorship PubMEd citations available on an annual basis between 1992 and 2011. 
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Of significance, times of transition during the cancer trajectory have been 
identified as being particularly stressful. It has been stated that many newly diagnosed 
cancer sufferers who have completed treatment, found the period of time to the first 
follow up visit to be an anxious period (Hewitt, et al., 2006; Morgan, 2009; O'Neill, 
1975). During this time the individual and their family are confronted with a fear of 
recurrence and the prospect of having to deal with the physical and emotional pain 
(O'Neill, 1975). Mullen (1985), a clinician and a cancer survivor himself, postulated 
that: 
Survival, in fact, begins at the point of diagnosis, because that is the time when 
patients are forced to confront their own mortality and begin to make 
adjustments that will be part of their immediate, and to some extent, long term 
future (p. 270). 
 
 Mullen (1985) also described the survivorship journey according to three seasons: 
acute survival (beginning at diagnosis, dominated by interventions, fear and anxiety are 
constant elements); extended survival (begins when the patient goes into remission and 
undergoes periodic follow-up, psychologically dominated by fear of recurrence and a 
period of treatment-related physical limitations); permanent survival (commonly known 
as the time when a person is deemed to be “cured”, although person is indelibly affected 
by longer-term effects on mental and physical health from the secondary effects of 
cancer treatment). This study focused on the under researched early extended survival 
season, specifically, the time from when a patient completes primary treatment. 
 
 Research Problem 
The time following the completion of treatment has been acknowledged to be as 
challenging as the time spent undergoing treatment (Hewitt, et al., 2006; Leigh, 1992). 
Very little is known about the issues and challenges that individuals face as they 
transition from acute cancer treatment into the post treatment extended survival phase 
particularly in relation to chemotherapy. As more people survive cancer there is an 
identified need to increase evidence-based knowledge about the survivors’ lived 
experiences (Carter, 1993; Ganz, Schag, Lee, Polinsky, & Tran, 1992). Specialist 
oncology nurses contribute significantly to information and education during treatment 
based on evidence, however preparing the individual for post treatment life is 
predominantly based on anecdotal evidence and previous patient feedback. There is a  
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lack of evidence based studies in this area and very little is known about the actual 
patient experiences as they transition into life after chemotherapy. 
On completion of chemotherapy, patients are discharged home and experience a 
gap of four to eight weeks before their next hospital visit to begin the follow up or the 
surveillance part of their cancer journey. This time in particular has been identified as a 
time when cancer survivors may be left feeling abandoned and uncertain about their 
future care. Several authors consider the transition time from active treatment to post 
treatment care as a critical time for the survivors’ long-term health (Cardy, 2006; 
Taylor, 2008). 
 
Study Purpose 
The purpose of this two-phase study was to further understand the specific needs 
of cancer survivors as they transition from chemotherapy into life after cancer, and, to 
develop a method by which these needs could be measured. This study was undertaken 
in two sequential phases.  
 
Phase One: Qualitative. 
The aim of this phase was to identify the key experiences of cancer patients on 
completion of chemotherapy as they transition to life after cancer treatment.  
 
Objectives. 
1. To explore and describe from the patient’s perspective, the experience following 
the completion of chemotherapy. 
2. To identify factors which improved or exacerbated this experience. 
3. To identify the main themes relating to patient experiences of this transition 
from chemotherapy. 
 
Phase Two: Quantitative. 
The aim of this phase was to either develop a new research instrument or to modify 
an existing instrument which could be used to explore the needs of a large population of 
cancer survivors. Rather than develop a new instrument, the researcher modified an  
existing instrument for the Australian context: Quality of Life – Cancer Survivors(QOL-
CS). This instrument was originally developed and validated by (Ferrell, Hassey Dow, 
& Grant, 1995). This tool was primarily chosen because the items were consistent with 
the majority of key themes identified in Phase One. The revised instrument Quality of 
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Life – Chemotherapy Cancer Survivors (QOL-CCS) was then reviewed by an expert 
panel to assess clarity, apparent internal consistent and content validity. 
 
Questions. 
1. To what extent are the items in the QOL-CCS clear? 
2. To what extent do the domains in the QOL-CCS confirm internal consistency? 
3. To what extent do the domains in the QOL-CCS confirm content validity? 
 
Significance of the Study 
In order to meet the needs of this growing population it is important to first 
recognise and understand  those needs. This study  provides an understanding of the 
needs of the 5000 cancer survivors who transition from chemotherapy to life after 
cancer in Western Australia each year. The number of survivors within this cohort is set 
to rise exponentially in the next 20 years as the successes of current treatment 
improvements and earlier diagnosis continue to be delivered in cancer care to a rising 
number of cancer patients. The increased number of cancer patients projected in 
Western Australia is connected to both an increasingly aging population and a rising 
population due to migration projections. The results of this study will contribute to 
improving the quality of education and information that is provided to patients as they 
complete chemotherapy. This study will highlight the physical, emotional, social and 
spiritual experiences that patient encounter during the immediate post treatment time 
period. No Australian studies were identified that focussed specifically on this transition 
of care in cancer patients following the completion of chemotherapy. 
 
Definition of Terms 
  There is a great deal of international debate about when survivorship begins. 
This will be discussed in greater depth in the literature review chapter. The following 
terms surrounding survivorship are used throughout this thesis.  
 
 Cancer Survivor: An individual is considered a cancer survivor from the time of 
diagnosis through the balance of his or her life (Hewitt, et al., 2006; Morgan, 2009)  
 
Cancer Survivorship: The experience of living with, through and beyond a diagnosis of 
cancer (Clark et al., 1996) 
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Oncology Nurses: Nurses who have undertaken specialist training to work specifically 
with cancer patients throughout their patient journey. 
 
Prevalence: Prevalence of cancer refers to the number of people who have previously 
received a cancer diagnosis and who are still alive at a given point in time. 
 
Quality of Life: “an individual’s perception of their position in life in the context of 
culture and the value system in which they live and in relation to their goals, standards 
and concerns” (World Health Organisation, 2007).  
 
 Summary of the Chapter and Organisation of the Thesis 
        This initial chapter has provided the introduction, purpose, objectives, 
questions, background significance and definition of terms for the study. The relevant 
literature is discussed in Chapter Two, where the context of survivorship and current 
levels of knowledge are discussed. Chapter Three describes Phase One of this study, 
which was the qualitative methodology approach, alongside the ethical considerations 
associated with this research. Chapter Four presents the findings from Phase One. For 
clarity, the method and findings for Phase Two, a quantitative approach, is found in 
Chapter Five. In Chapter Six the findings are discussed in relation to current knowledge. 
The conclusion and recommendations are also found in this chapter.  
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Chapter Two: Literature Review 
 
  Introduction 
This chapter presents an overview of the literature currently available, in relation 
to the survivorship experience for people with a diagnosis of cancer, as they transition 
from completion of active chemotherapy treatment to life after cancer. The topics 
addressed during this review are: development of a survivorship concept; current level 
of knowledge regarding survivorship experiences and research; context of survivorship 
following chemotherapy treatment for cancer; differences in survivorship experience 
related to tumour type; differences in individual experiences at different timelines; 
quality of life issues relating to survivorship and survivorship knowledge in the 
Australian context. Themes relating to the family experience have not been included in 
this literature review, except from the viewpoint of the person diagnosed with cancer. 
Further, given the differences in survivorship issues for children and adolescents, this 
literature review focused solely on adults diagnosed with cancer, as they comprised the 
target population for this study. 
The literature review commenced with a search of the following databases: 
CINHAL, MEDLINE, ProQuest Nursing & Allied Health Source and PsycINFO. All 
years were included as this research domain is in its infancy and it was considered 
important to understand the context within which this research was grounded. The 
search terms used were: 
• survivorship; 
• cancer survivor; 
• transitional survivorship; 
• treatment end; 
• end of chemotherapy treatment; 
• research;  
• quality of life.  
The last search term “quality of life” was added following the realisation that quality of 
life in cancer survivors was a recurring theme when searching with the other search 
terms. The words cancer and oncology were used interchangeably with all search terms 
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to ensure all relevant information was captured. All additional appropriate references 
cited in relevant studies were also reviewed. 
 
Development of Survivorship Concept 
The concept of survivorship as a new and distinct phase of the cancer care 
continuum has been increasingly developed over the past two decades.  Advances in 
technology and treatment have changed the trajectory of the illness to a chronic disease 
in many instances, and it is now estimated that 61% of those diagnosed with cancer will 
be alive in five years (Ferlay et al.  2010).  
Macmillan Cancer Support in the United Kingdom (UK) have represented this 
new cancer continuum in the diagram below, representing both the stages and the 
directions which are now evident in the cancer journey.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Survivorship Care Pathway -Illustration of the different phases of health or 
illness that a person with cancer may experience from diagnosis onwards. Reproduced 
from Vision and five key shifts by Department of Health, Macmillan Cancer Support, & 
NHS Improvement, 2010. The National Cancer Survivorship Initiative Vision, p. 23. 
Copyright 2010 by Crown. Reprinted with permission.  
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As the number of cancer survivors increased throughout the 1970s and 1980s, a 
cancer survivorship advocacy community emerged. As a result numerous physical, 
medical, psychosocial, economic and legal issues were identified as a legacy of having 
had a cancer diagnosis and treatment.  In the USA in 1986, representatives of 20 
organisations amalgamated to form the National Coalition of Cancer Survivorship 
(NCCS). This organisation evolved from a peer-support organization to what is now in 
2012 a formidable advocacy group, which sets public policy priorities on behalf of 
people with cancer. The first goal of the NCCS was to change the perception and use of 
the term “cancer victims” to that of “cancer survivors” (Morgan, 2009). In 1996 the 
National Cancer Institute (NCI) created the Office of Cancer Survivorship (OCS) in 
recognition of the increasingly large number of individuals surviving cancer and their 
unique and understudied needs (Hewitt, et al., 2006). 
The combined efforts of the NCCS have forged many new approaches to 
survivorship care and research. One of their leading policy documents “Lost in 
Transition” (2006) is used by health professionals internationally. The first 
recommendation of this policy is particularly pertinent to this study: “Health care 
providers, patient advocates and other stakeholders should work to raise awareness of 
the needs of cancer survivors, establish cancer survivorship as a distinct phase of cancer 
care, and act to ensure the delivery of appropriate survivorship care” (Hewitt, et al., 
2006 p. 3). Historically, the concept of survivorship generally held by society was often 
associated with living through extraordinary life situations such as earthquakes, 
volcanic eruptions, floods, or evil wrong doings such as victims of violence or war 
(Breaden, 1997; Dow, 1990). Being associated with cancer holds a heavy social stigma 
as does being a holocaust survivor; many people may not want to be labelled as a 
survivor or thought of as different to anyone else (Markus, 2004). Whilst the true 
meaning of the words is simple, the connotations associated can be complex. The word 
Survivor is derived from the middle French word survivre to outlive, and from the Latin 
word supervivere to live more (Merriam-Webster, 2012). 
 Sontag (1978) articulated societal perceptions that cancer = death and people 
with cancer were victims.  Other preferred terms for survivors include fighters, thrivers, 
champions, patients or simply individuals who have had a life threatening disease 
(Hewitt, et al., 2006; Reuben, 2004). It appears that society still holds Sontag’s (1978) 
view. Previous studies identified that public attitudes towards cancer appear to be 
pessimistic and that cancer is perceived as contagious, a death sentence, threatening, a 
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dreaded condition and painful (Rendle, 1997). Corner (1988) summarised several 
studies regarding health care professionals and attitudes to cancer and concluded that 
most attitudes were negative. Whilst researchers continued confirming negative 
attitudes to cancer the improvements in treatments were gradually increasing the 
numbers of people surviving cancer. 
A source of debate and consideration in this area of research has been the 
definitions that have been attached to the survivorship journey. This was particularly 
evident in earlier years when the starting point of survivorship was contentious. The 
range of views included: survivorship starting at the point of diagnosis; survivorship 
starting on completion of initial treatment; or survivorship starting when the person had 
lived five years beyond their diagnosis (Breaden, 1997; Reuben, 2004). In one of the 
seminal cancer survivorship papers Mullen (1985) suggested that  “survivorship begins 
at the point of diagnosis, because this is the time when patients are forced to confront 
their own mortality and begin to make adjustments that will be a part of their immediate 
and long- term future” (p. 270). 
The NCCS defined cancer survivorship as “the experience of living with, 
through and beyond a diagnosis of cancer” (Hewitt, et al., 2006)  and further stated that 
“an individual is considered a cancer survivor from the time of diagnosis, through the 
balance of his or her life” (p. 27). These latter definitions are by far the most accepted at 
present and are used throughout this thesis (Morgan, 2009; National Cancer 
Survivorship Initiative, 2010). 
The NCCS purposefully chose the term survivorship at its inception in 1986, 
believing that it promoted empowerment in those with a diagnosis of cancer (Twombly, 
2004). Since then it has been used extensively to promote the new stage in the cancer 
continuum, however, very little research has been undertaken to elicit the acceptability 
of the term survivor to those cancer patients to whom it refers. Hewitt et al. (2006) 
inferred the term survivorship was less palatable to the European community because of 
the holocaust associations; however in recent years the majority of publications from 
Europe widely use the survivorship terminology. Park, Zlateva and Blank (2009) 
undertook an interesting study in which they explored whether survivors in the first one 
to three years identified themselves as: a “survivor”, a “victim”, a “patient” or a “person 
with cancer”. The most popular self-identity in this study was “survivor” for 83% of the 
cohort, and  “person who has had cancer” for 81% of the cohort. Of note, the 
researchers concluded that each individual identity carried meaning for the individual 
that affected not only health behaviours, but also interactions with others. The 
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researchers postulated that survivors who self-identified with the  “patient” label may 
have experienced reduced feelings of control and hope. These patients may continue to 
relinquish responsibility for their health to their health care team, thus maintaining the 
passive role. There was an association between self-identifying as survivors and having 
a better psychological well being. The findings from this study were congruent with 
other studies of long-term cancer survivors (Deimling, Bowman, & Wagner, 2007; 
Deimling, Kahana, & Schumacher, 1997; Park, et al., 2009). 
Many researchers have identified the multi-dimensional nature of survivorship. 
It encompasses physical, psychosocial and economic sequelae of cancer diagnosis and 
its treatment, as well as issues related to health care delivery, access and follow up care 
among both paediatric and adult survivors of cancer ( Ferrell, Dow, Leigh, Ly, & 
Gulasekaram, 1995; National Cancer Survivorship Initiative, 2010). The complex 
nature of survivorship issues and needs impact upon many aspects of care ranging from 
prevention, screening and rehabilitation through to end of life care (Morgan, 2009). 
Survivorship as a health care concept is still a relatively new phenomenon, despite or 
perhaps due to this, there remains a struggle to deliver one accepted definition of who is 
a survivor and when survivorship begins. What is accepted, however, is that survivors 
have many unique needs, which are at present not well understood. 
 
Current Level of Knowledge Regarding Survivorship Experiences and Research 
The goal of survivorship research is to understand and thereby reduce the 
adverse effects of a cancer diagnosis and treatment in order to optimize outcomes for 
cancer survivors and their families (Aziz & Rowland, 2003; Ganz, 2003). The focus of 
cancer care has traditionally been confined to diagnosis and treatment. Consequently, 
there has been a plethora of research in these two areas compared with survivorship. For 
example, by 2004 the imbalance in research cited in PubMed related to active cancer 
treatment (n=23,736) was enormous compared with the research relating to cancer 
survivorship (n=374) (Aziz & Rowland, 2003). Since 2005 there has been an 
exponential rise in research related to cancer survivorship with 57,041 citations 
available on the PubMed database in 2011.  The inequity in research contributes to the 
survivorship conundrum. Whilst the concerted research effort into cancer treatments has 
resulted in great strides forward producing more cancer survivors, the lack of 
survivorship research has resulted in a widespread failure to recognise and address the 
psychosocial needs of cancer survivors because of a variety of barriers (Kaplan, 2008). 
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 The approach to survivorship research has been fragmented as the isolated 
approaches of survivorship research have made oversight of the process difficult 
(Breaden, 1997). It is now increasingly understood that there are as many research 
domains in cancer survivorship as there are in cancer treatments. While the physical and 
emotional impact of cancer treatment in the acute period are well known, there is less 
understanding about the fact these effects can continue well beyond treatment (Hewitt, 
et al., 2006). Survivorship research has demonstrated there are significant longer term 
implications for the survivor as a result of the cancer diagnosis and its subsequent 
treatments; this has been referred to in several texts as the “price of survival” (Davies, 
2009; Ganz,2002; Gotay & Muraoka, 1998; Hewitt, et al., 2006; Hewitt, Rowland, & 
Yancik, 2003). 
Recently there has been a considerable increase in the amount of research 
undertaken to develop and test interventions to improve the survivorship experience. 
This work has included studies on the use and delivery of follow up care plans (Ganz & 
Hahn, 2008; Morgan, 2009) and screening tools (Holland & Reznik, 2005; Pigott, 
Pollard, Thomson, & Aranda, 2008). However, what appears to be lacking in this 
approach is a determination of the individual’s unique lived experience of cancer 
treatment, that is, the follow up care needs as determined by patients’ own perceptions 
(Adewuyi-Dalton, Zieland, Grunfeld, & Hall, 1998; Mullen, 1985; Schlairet, Heddon, & 
Griffis, 2010). A handful of researchers have explored the individual’s experience of 
survivorship according to specific timeframes (Carter, 1993; Gotay & Muraoka, 1998), 
or following specific interventions  (Emery et al., 2008; Galvao & Newton, 2005), or by 
tumour  group (Baravelli et al., 2009; Brennan, Butow, & Spillane, 2008; Dizon, 2009). 
There is now growing  evidence of unmet needs in the first year after treatment, with a 
2009 study showing that one in four cancer survivors had at least five unmet physical or 
psychological needs (Hindle, 2010, Lobb, 2009).  
The NCCS has clearly set the agenda for cancer survivorship research by 
directing that it should address the physical, psychosocial and economic domains of a 
cancer diagnosis and its treatments, whilst retaining the focus on the health and the life 
of the person with the cancer history. Intervention studies are needed that develop or 
test strategies to promote optimal health status in survivors of cancer, information on 
survivors of cancer who have previously been understudied, and research on the impact 
of cancer on the family (Hewitt, et al., 2006; Rowland, Aziz, Tesauro, & Feuer, 2001). 
The importance of survivorship was demonstrated by the development of a 
committee by the Institute of Medicine of the National Academies in the USA. The role 
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of this committee was to investigate medical and psychosocial issues faced by cancer 
survivors and to make recommendations to improve their health care and quality of life. 
As previously discussed, the expert committee produced a pivotal report focusing on 
survivors of adult cancer during the phase of care that follows primary treatment, this 
report was entitled: “From Cancer Patient to Cancer Survivor: Lost in Transition” 
(Hewitt, et al., 2006). Findings were based on evidence from the research literature 
rather than indirectly from survivors. The report provides an excellent summation of 
what was known and understood in relation to survivorship in the USA until 2005 and 
concludes with ten recommendations, the first aiming to raise awareness of the needs of 
cancer survivors and establishing cancer survivorship as a distinct phase of cancer care.  
Understanding what cancer patients need to know and from whom they receive 
information during the course of their care is essential to ensuring quality care (Finney 
Rutten, Arora, Bakos, Aziz, & Rowland, 2005). The current study sought to contribute 
to this important body of knowledge by providing evidence to further raise the 
awareness of the unique needs of cancer survivors as they transition from completion of 
chemotherapy treatment into follow up care. 
 
 Context of Survivorship Following Chemotherapy Treatment for Cancer  
The period following primary cancer treatment is recognised as under researched 
and therefore lacking in evidence based guidance for health care providers (Breaden, 
1997; Hewitt, et al., 2006; Little & Sayers, 2004; Rassmussen & Elverdam, 2007). 
Cytotoxic chemotherapy is one of the main treatment modalities used to manage cancer; 
in Australia if optimal treatment rates are achieved 51% of those treated for cancer will 
receive chemotherapy (Blinman et al., 2012). Despite the significant number of people 
who receive chemotherapy there is a considerable lack of chemotherapy survivorship 
related research available, although there is a plethora of research related to 
chemotherapy delivery and treatment of side effects. 
Several researchers have identified the mixed emotions of completing treatment. 
Elation on completing treatment is often coupled with anxiety of losing contact with the 
treatment team and fellow patients. Conversely, a desire never to see the treatment team 
again may exist. This suggests an association between somatic anxiety and substantial 
psychological distress (Allen, Savadatti, & Levy, 2009; Doyle, 2008). Survivors 
frequently and with intense language described feeling abandoned, pushed out or cast 
adrift by the health care system at the time of treatment completion (Allen, et al., 2009; 
Jefford, et al., 2008; Rancour, 2008). 
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Qualitative and quantitative studies have attempted to establish the issues faced 
by patients completing treatment for cancer; the following themes have emerged from 
the literature: 
• Thoughts and fears about cancer including: fear of recurrence; anxiety about the 
future; isolation, fear of death and intrusive or avoidance thoughts about cancer. 
• Physical and psychological consequences of treatment including: the possibility 
of early menopause; late or longer term effects such as fatigue. 
• Returning to normal including: dealing with changes to identity; body image; 
returning to work; and uncertainty about health and effects of treatment. 
• Sexuality and fertility including: decreased libido; erection and ejaculatory 
difficulties; reduced frequency of sexual intercourse; anxiety about future 
infertility; and decreased interest in having a child. 
• Follow up including: ambivalence about discontinuing treatment; fear of future; 
follow up appointments; and longer term effects of treatment. 
• Impact of cancer on family and friends.  
• Financial implications including: a loss of income and assets during treatment 
and ongoing challenges obtaining insurances and mortgages.  
(Department of Health, 2010; Hewitt, et al., 2006; Jefford, et al., 2008; Karahalios et 
al., 2007). 
The physical impact of chemotherapy in the short term has been acknowledged 
in several papers that discuss the longevity of some side effects such as fatigue (Jefford 
et al., 2011; Speigel & Kato, 1996; Spiegel, Kraemer, & Bloom, 1989). It has also been 
identified the likelihood of post cancer disabilities were more than three times as likely 
if chemotherapy was a part of the treatment (Taylor  et al., 2004). Available papers 
suggest there is a new balance to be found as a return to good health may not 
necessarily be a return to the normality of life before cancer (Dow, 1990). It would 
appear that survivorship has at least two stages: surviving the initial diagnosis and 
subsequently the aftermath of treatment (Leigh, 1992). The NCCS identified that many 
patients completed their primary treatment unaware of their heightened health risks, and 
lack of preparation to manage their future health care needs (Hewitt, et al., 2006). 
 
Differences in Survivorship Experience Related to Tumour Type 
The cancer sites with the highest frequency of survivors were recently described 
as: breast (22%), prostate (19%) colorectal (10%) and gynaecologic (9%) (Kaplan, 
2008; Ries et al., 2004;   Rowland, 2008). When contemplating the survivorship 
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experience in relation to the actual cancer diagnosis each tumour group will be unique 
in terms of needs, even those with the same cancer type and treatment regime will 
identify very different needs (Hewitt, et al., 2006; Hodgkinson, Butow, & Hunt, 2007; 
Jefford, Karahalios, Angle, Baravelli, & Akkerman, 2007; Jefford, et al., 2011). For 
example, Fox and Lyon (2006) argued that lung cancer patients may have a unique view 
of transition from completion of chemotherapy, as treatment related symptoms may 
exacerbate disease related symptoms and further contribute to poorer quality of life 
outcomes, as well as survivorship. For this reason the authors believe that specialized 
care must extend beyond the treatment phase. Hewitt et al. (2006) discussed long-term 
needs unique to specific tumours, showing  there are wide ranges of physical and 
psychological side effects which are evident in the long term profile of cancer survivors. 
There is however no evidence to indicate when these side effects become evident or if 
they are burdensome during the immediate post treatment episodes.  
Fox and Lyon (2006) found that survivors of lung cancer experienced distressing 
symptoms; specifically depression and fatigue, well into cancer survivorship and these 
clustered symptoms significantly influence quality of life. There are some distinctions 
to be found in the survivorship experience according to the initial cancer diagnosis. 
Taylor & Odey (2011) reported that colorectal cancer patients identified fewer physical 
symptoms or concerns than other cancer survivors. Jefford et al. (2011) however, 
identified a range of distressing, embarrassing and potentially life threatening 
complications to which colorectal cancer patients are susceptible. Breast cancer patients 
often experience physical side effects unique to their cancer treatment, which cause an 
early menopause. The post treatment effects of menopause can affect fatigue, quality of 
life and sleep. Success in treatment for ovarian cancer, once an almost fatal form of 
cancer, has now caused a psychological shift from preparing for death at diagnosis to 
preparing for life after cancer. Cochrane (2003) compared this to the phrase “health 
within illness” a concept commonly used in HIV/AIDS literature. Rassmussen & 
Elverdam (2007) claimed that regardless of the type or location of the cancer and the 
treatment received, cancer survivors have similar experiences in the process of 
surviving cancer. Jefford et al., (2008) identified common themes in their research with 
survivors across a range of tumour types, which appears to support Rassmussen & 
Elverdam’s (2007) claims. It would seem that survivors encounter a range of common 
experiences such as fatigue and a range of disease / treatment-specific experiences such 
as early menopause. 
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 Differences in Individual’s Experiences at Different Timelines. 
For many of the 114,000 people diagnosed with cancer each year in Australia 
(AIHW, 2010), resuming the routines of work and family life after completing active 
treatment may be especially difficult. Anxiety over cancer recurrence may dominate at 
this time, and questions also arise about the next steps in the care continuum (Alfano & 
Rowland, 2006; Breaden, 1997; Jefford, et al., 2008). The transition from diagnosis and 
active treatment to survivorship is an understudied phase in the cancer trajectory 
(Hewitt, et al., 2006; Stanton et al., 2005). Research to date has shown the longer term 
picture of the journey many experience, the needs at time of transition onto this journey 
remain as yet only marginally explored. 
           The period prior to the first follow up visit is likely to be an anxious time when 
the individual and their family are confronted with the fear of recurrence and having to 
deal again with the physical and emotional pain (O’Neill, 1975). This highlights the 
importance of understanding patients’ issues and concerns on completion of 
chemotherapy, to ensure that health care practitioners are aware of potential information 
needs. Personal accounts of having cancer by Armstrong (2001) and Carr (2004), have 
added to the literature by expressing their feelings of being powerless after completion 
of treatment and being unsure about what they were supposed to do to help themselves. 
Earlier studies have also identified these feelings (Breaden, 1997; Pelusi, 1997).  
Transition at the end of treatment can be a traumatic time for patients; whilst 
they are finally leaving treatment behind they are also leaving what has become a safety 
net of health professional connection, no longer being required to attend clinic visits, 
hospital stays and even emergency attendances. Patients who look forward to the day 
they would complete the arduous demands of treatment are often surprised by the void 
(Hewitt, Barmundo, Day, & Harvey, 2007; Rancour, 2008). Well planned and 
coordinated care to facilitate transition from acute cancer treatment to life after cancer 
has been identified as critical; a deficit in this knowledge will increase risks for the 
survivor (Hewitt, et al., 2006). 
Mullen (1985) developed a framework for the survivorship process, which 
entailed distinct phases that an individual moves through; he described this as the three 
“seasons” of survival in the survivorship journey: 
• Acute Survival – beginning at diagnosis and dominated by diagnostics and 
therapeutic interventions – fear and anxiety are constant and important elements 
of this stage. 
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• Extended survival – this period is entered as the patient goes into watchful 
waiting with periodic examination. Psychologically this period is dominated 
with fear of recurrence and contains a period of physical limitations following 
the therapeutic interventions. 
• Permanent survival – “cure”, although the person that has got to this stage of the 
cancer experience is indelibly affected by it. Longer-term effects on health from 
secondary effects of cancer treatment may represent another area of risk 
(Mullen, 1985).  
No specific timeframes exist for the stages described by Mullen and it has been 
suggested that not all patients experience all stages (Decker, Haase, & Bell, 2007; 
Morgan, 2009; Mullen, 1985).  
A transition implies moving from one relatively stable state, with an experience 
of disorganization and upheaval during the process, toward another stable state (Boyle, 
2006; Clarke-Steffen, 1993). Any transition implies the letting go of old relationships, 
forms, methods and roles, even if the nature of the transition is perceived as positive one 
(e.g. promotion, marriage or completing treatment for cancer); all transitions imply 
leaving the familiar and suggest a sense of loss or grief. Survivors can feel lost and 
confused by the sudden cessation of treatment. They may be pronounced “cancer free” 
or have “no evidence of disease” but rarely are they told they are cured (Rancour, 
2008). Studies have revealed that periods of highest distress for women with breast 
cancer are associated with transition points in treatment (Kaplan, 2008). Comprehensive 
reviews of available literature report the period after completion of treatment brings its 
own unique, and in some cases, still poorly understood challenges. Whilst survivors are 
relieved to be ending treatment, many survivors report being unprepared to manage the 
long-term effects of cancer and its treatment. Survivors are articulating that being 
labelled disease free does not mean being free from disease (Alfano & Rowland, 2006; 
Hewitt, et al., 2006; Reuben, 2004). 
As they transition to recovery survivors want to know: who will follow them; 
which symptoms to monitor; when to be alert to changes in health; what their “new 
normal” will be and how they can reduce their risk of recurrence and remain healthy 
(Alfano & Rowland, 2006; Hewitt, et al., 2007). Similarly, it has been demonstrated that 
survivors also want to know and understand their follow up plan; who will monitor their 
health and risks; and what they can do for themselves to adapt and prevent further 
recurrences (Rancour, 2008). Getting the balance of information correct is important; 
many survivors claimed to have been overwhelmed at the end of active treatment and 
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were given so much information about follow up care verbally they couldn’t take it all 
in (Hewitt, et al., 2007). 
It is evident the cancer experience changes the psyche of individuals as they 
move between roles of patient and survivor. When a person is diagnosed with cancer 
they become a patient, they also become a part of the community of practice that 
consists of specialist doctors, nurses and technicians who are mobilized to have an 
impact on the patient. As the person completes treatment they must change roles yet 
again, from being a patient to being a survivor, adjusting to limited contact with the 
health professional team and a requirement to assume the responsibility of self 
monitoring and to find a new equilibrium (Allen, 2009). 
 
Quality of Life Issues Relating to Survivorship 
The World Health Organisation (2007) defined quality of life as “an individual’s 
perception of their position in life in the context of culture and the value system in 
which they live and in relation to their goals, standards and concerns” (p.1). Ferrans 
(2005) explains that quality of life has been conceptualized as normal functioning, 
social usefulness, general well being, ability to fulfil life’s goals, and happiness and life 
satisfaction, this description is supported by several authors (Albaugh & Hacker, 2008; 
Wochna Loerzel, McNees, Powel, Su, & Meneses, 2008). The meaning of health and 
life itself can be altered following a diagnosis of cancer (Vachon, 2001). Cancer 
survivors report struggling to achieve a balance in their life’s and a sense of wholeness 
and life purpose after a life altering experience (Ferrell, 2004). It is therefore evident 
that one’s own perception of quality of life is determined in accordance with one’s own 
values of normal, being culturally acceptable and usefulness. It includes the ability to 
set goals and have a purpose in life. Quality of life measures are now commonly found 
in many research papers and are widely used to determine how individuals assess their 
own general well being. However, there is a lack of consensus on a health related 
quality of life definition. Ganz (2000) labels the health effects of cancer and its 
treatments on perceived quality of life as “the price of survival” (p. 324).  
Fatigue is a commonly described symptom considered to greatly impact on 
quality of life. Broeckel, Jacobsen, Balducci, Horton, & Lyman (2000) found that  
breast cancer survivors 3-36 months following adjuvant chemotherapy reported more 
fatigue than a comparison group with no history of cancer. Adjuvant chemotherapy 
indicates that the survivors have had chemotherapy in addition to another treatment to 
assist in amelioration or cure of the breast cancer. This USA quantitative study 
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compared results to two surveys between cancer survivors post chemotherapy and 
women who had never been diagnosed with cancer. Overall the cancer cohort scored 
lower in both surveys, and physical aspects were much more poorly scored than 
psychological aspects. Women who were older and married scored higher in 
psychological well being than the remainder of the group (Broeckel, Jacobsen, 
Balducci, Horton, & Lyman, 2000).  
A third of breast cancer survivors have reported severe fatigue associated with 
higher levels of depression, pain and sleep disturbances (Bower et al., 2000). Bennett, 
Winter-Stone & Nail (2006) undertook a review of available literature relating to 
exercise intervention in cancer survivors and concluded that many cancer survivors 
reported a decline in their physical functioning, including basic body mobility and 
engagement in work and leisure activities, during cancer treatment and immediately 
afterwards related to fatigue. Their paper presented a conceptual model, which provides 
opportunities for further studies to increase an understanding of how exercise 
interventions may work for survivors. 
A comprehensive conceptual model of quality of life in cancer survivors was 
developed by Ferrell, Hassey Dow, et al. (1995). This team recognised that whilst on 
active treatment the main focus of care had been physical and psychological well-being. 
Several months later the focus shifted to social and spiritual well-being, often with a 
change in direction around managing physical and psychological well-being, for 
example the late effects of fatigue or cognitive impairment whilst not life threatening 
are certainly life altering. There is a lack of agreement about what constitutes the 
dimensions of quality of life, however the domains in this model are consistent with the 
predominant view ( Ferrell, Hassey Dow, et al., 1995; Spiker, 1990) 
Based on this quality of life model, Ferrell, Dow et al., (1995) also developed 
and tested a quality of life instrument for longer term cancer survivors; the aim of this 
instrument was to measure the specific concerns of this group of survivors. The Quality 
of Life – Cancer Survivors tool (QOL-CS) is based upon a previous quality of life 
instrument developed by researchers at the City of Hope National Medical Centre 
(Ferrell, Dow, et al., 1995).  The instrument has been widely used in cancer care and has 
been adapted for several different cancer populations across a range of ages, tumour 
types and languages, for example: Hispanic patients with cancer, (Juraz, Ferrell, & 
Borneman, 1998); breast cancer survivors (Ferrell et al., 1996) and ovarian cancer 
survivors (Ferrell, Smith, Juarez, & Melancon, 2003). 
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        Short, Vasey, Joseph & Tunceli (2005) showed that 20% of cancer survivors have 
cancer related disabilities one to five years after diagnosis. Re-establishing oneself back 
into pre-cancer lifestyle norms may occur gradually during the course of active cancer 
therapy or abruptly following completion of treatment depending upon individual’s 
requirements of hospitalization and recovery (Boyle, 2006). The positive aspects of 
cancer survivors’ quality of life perception include a greater appreciation of life (Bush, 
Haberman, Donaldson, & Sullivan, 1995; Mellon, 2002), and a healthier lifestyle 
(Alfano & Rowland, 2006; Allen, et al., 2009; Mellon, 2002). Hoffman & Stoval  
(2006) showed that survivors who were informed about their options believe they have 
some personal control over decision-making generally have higher quality of life. 
Reported negative aspects of quality of life perception have included longer term side 
effects of cancer (Dow, Ferrell, Leigh, Ly, & Gulasekaram, 1996), altered sexuality and 
self-image (Ganz et al., 1996) and economic problems (Ferrans, 2005). Control, aches 
and pains, uncertainty, satisfaction, future appearance and fatigue were the most 
consistent domains shown to affect perception of quality of life.  Quality of life was also 
reported to be higher in those who had survived for longer than five years past diagnosis 
(Morgan, 2009).  
Spirituality has been described as an important aspect of quality of life for 
patients with cancer; it encompasses not only religiosity but also other dimensions such 
as hopefulness, transcendence and purpose. Spirituality is linked to life meaning; 
previous literature has described the importance of spirituality as a component of 
deriving meaning from cancer (Ferrell et al., 2003). Roos & Powell (2005), both cancer 
survivors from Australia, eloquently discussed the journey from a person confronted 
with cancer to a patient and then back to an individual but changed. These changes 
occur along a continuum of meaning based on negotiation with information the person 
receives along the journey. In negotiating this process the person is dealing with issues 
of self, issues of meaning and issues of identity all of which link to the original quality 
of life definition from the World Health Organisation at the beginning of this section. It 
would appear that maintaining or restoring quality of life is vital to all cancer survivors. 
 
Survivorship Knowledge in the Australian Context. 
One of the few Australian studies in this domain and timeline is a qualitative 
study undertaken by Jefford et al. (2008), which looked at survivorship issues following 
treatment completion from the viewpoint of 22 survivors and 20 health care 
professionals. Through a process of focus groups, this study found that dealing with 
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fatigue, anxiety about cancer recurrence, others expecting you to be back to normal, 
having to create new expectations about physical ability, and anxiety about leaving the 
hospital system, were the most commonly reported. The participants ranged in length of 
survivorship from less than 12 months to over 10 years with over 75% of participants 
being over a year post treatment. The strength of the current study is that it focused 
solely on patients who had completed chemotherapy within three months.  
There is a great deal of congruence between Jefford et al.’s (2008) findings and 
the quality of life research discussed previously in this section. This work has been 
instrumental in highlighting the issues of survivorship in the Australian context and has 
led to the development of the Australian Survivorship Centre based at Peter MacCallum 
Cancer Institute in Melbourne, Victoria. Jefford et al.’s (2008) findings have provided a 
broad platform on which more specific research can now add to the understanding of 
survivorship challenges in Australia. Jefford and his team continue to build upon this 
research with a series of interventions designed to address the unmet needs identified in 
the 2008 study. For example, developing and testing written information booklets 
(Jefford et al., 2007) and more recently, piloting nurse-led follow up support for patients 
with bowel cancer (Jefford et al., 2011). 
Lobb et al. (2009) recently added to the Australian context with findings from a 
study undertaken in Western Australia with 66 survivors of haematological 
malignancies. Participants were surveyed using a structured quantitative instrument in 
order to establish their unmet needs on the completion of treatment. Findings were 
consistent with those identified earlier in this chapter as well as the work of the Jefford 
team (2008) as discussed above. Lobb et al.’s (2009) research began to explore the 
perception of strategies which may help to meet the unmet needs, for example, use of 
case managers. It was also reported that 59% (n=39) patients perceived it would have 
been helpful to speak to a professional at treatment completion about the experience of 
diagnosis and treatment, and making the transition from active treatment.  
The current study builds upon the work by Jefford et al. (2008) and Lobb et al.’s 
(2009) work by specifically targeting individual survivors within the early transition 
phase, who had completed chemotherapy and providing them with the opportunity to 
openly discuss their needs through a semi structured interview process. An 
understanding of the concerns from the survivors’ perspective allowed the researcher to 
develop items for an instrument that could be used clinically to determine specific needs 
at completion of chemotherapy treatment. It is anticipated that development of such an 
instrument would assist health professionals to provide care that is: tailored to an 
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individual’s care needs; facilitates the delivery of appropriate information in a timely 
manner; and supports a smoother transition for patients as they leave the acute care 
setting. 
 
Summary of Chapter Two 
        The increasing prevalence of cancer survivors in developed countries is a clear 
challenge to both clinicians and researchers alike. Whilst it is important to continue 
looking for cures and improvements in treatment experiences, it is now evident that 
research and care of cancer survivors is equally important. The literature review 
confirmed that cancer is an extreme experience that disrupts people’s lives and sense of 
identity. For the previous months whilst undergoing treatment patients are forced to 
relinquish normal life, social roles and often work, in order to cope with the complex 
treatment requirements and physical side effects that cancer treatments are known to 
cause. Once treatment is completed, this is often the first time the individual has an 
opportunity to reflect on the impact of being diagnosed with a cancer and what that 
means to them as an individual, as a family member, and as a member of the wider 
community. At this stage survivors often begin to articulate their search for the 
understanding of their new ”normal” and acceptance of their new self after the treatment 
journey. Health care professionals can provide timely and appropriate support into the 
transition period once the key issues and concerns of survivors at this time are 
understood.  
The findings from this literature review were used to shape the development of 
the interview guide for this study in order to clarify the key issues and concerns of 
survivors.  It is known that improved and timely education facilitates better 
psychological health in cancer patients and survivors, however this needs to be based on 
actual requirements; currently we do not understand the full range of gaps in knowledge 
relating to this cohort of survivors. The number of cancer survivors continues to rise, 
the increasing number of cancer survivors is occurring alongside an increasing 
incidence in cancer diagnosis due in part to an ageing population. Health services will 
not be able to continue managing the increasing demand of new patients and survivors 
in the current model of care delivery, unless new models of care are developed to more 
efficiently meet individual patient needs.  Research is vital to identify the issues for 
survivors in the transition period and to test new methods of survivorship care delivery 
across a continuum of care ranging from self management strategies due to nurse-led 
clinics and shared care models.  
24 
This study will contribute and build upon the current knowledge available in the 
survivorship continuum, by concentrating on an area of need that has not been wholly 
addressed in the research to date. That being, the specific timeline immediately after the 
completion of chemotherapy treatment, given than over half of all cancer patients will 
receive chemotherapy this study presents an opportunity to understand the needs of a 
sizable proportion of the survivorship community.  
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  Chapter Three: Methodology 
 
Introduction to the Chapter 
This chapter describes the qualitative approach used for Phase One and the 
ethical considerations for this study. It illustrates the processes employed to collect and 
analyse the data and also discusses ethical considerations that occurred before and 
during the study. The purpose of this study was to ultimately improve the care of people 
as they transitioned into life after completion of chemotherapy treatment. There is 
minimal information related to this phase of the cancer trajectory, therefore this study 
was intentionally exploratory and descriptive.  
In order to achieve the proposed outcome a two-phase approach was 
undertaken. In Phase One a Grounded Theory qualitative approach was followed to the 
descriptive level of data analysis. Data was collected via semi structured telephone 
interviews which elicited the descriptors of issues and experiences that arose for patients 
in the first six months following completion of chemotherapy. In Phase Two, findings 
from Phase One were used to embark on a quantitative approach in which an existing 
cancer survivorship instrument was amended with the intention of using the revised tool 
to explore survivorship issues that occur during the first three months following the 
completion of chemotherapy. The revised questionnaire was then tested for clarity, 
content validity and apparent internal consistency with an expert panel of senior 
chemotherapy nurses from a large tertiary cancer service in Western Australia.  
To assist with clarity in reading this thesis, the methodology for Phase Two is 
presented in Chapter Five where it is described in conjunction with the results for Phase 
Two. 
Phase One: Qualitative 
The intention of this study was to contribute to a very limited body of 
knowledge regarding the early survivorship period of persons diagnosed with cancer. A 
qualitative research approach was chosen to facilitate the exploration of the 
phenomenon and to gain a richer understanding of the experiences of individuals. 
Qualitative research provides systematic processes to enable the researcher to explore 
behaviour, feelings and experiences of individuals and how they make sense of these 
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perceptions. This approach is particularly useful in areas where little is known or 
understood (Burns & Grove, 2009;  Holloway & Wheeler, 2010; Liamputtong, 2009). 
 
Grounded Theory 
As previously described, this phase of the study was exploratory and employed 
the Grounded Theory approach to the descriptive level of analysis. Grounded Theory is 
an approach whereby theory is generated based on the data, which has been collected 
and analysed. The constant comparative method is utilised to analyse the data, and this 
necessitates comparing and contrasting the concepts identified in the data. Grounded 
Theory enables a problem to be studied from the perspective of the individuals affected. 
It captures social process within the social context and is a particularly useful approach 
when little is known about a particular area. Grounded Theory of health-related 
phenomena has implications for nursing practice; it identifies how individuals make 
sense of their experiences (Birks, Chapman, & Francis, 2006; Burns & Grove, 2009; 
Holloway & Tordes, 2010; Portney & Watkins, 2000; Walker & Myrick, 2006; Wuest, 
1995). For people with a cancer diagnosis completing chemotherapy treatment, the use 
of Grounded Theory facilitated a greater understanding of their physical and 
psychological experiences. This perspective can lead to improvements in nursing care 
provision.  
Grounded Theory was first described by Glaser & Strauss (1967) in their 
seminal work “The Discovery of Grounded Theory”. Since this time the method has 
been both adopted and adapted by many other researchers in the social sciences and 
health care fields, especially in nursing (Carpenter, 1995; Charmaz, 2007; Corbin, 1986; 
Corbin & Strauss, 2008; Morse, 2001). Notably, Strauss & Corbin (1990) in their book 
“Basics of Qualitative Research: Techniques & Procedures for Developing Grounded 
Theory” detailed a significant refinement to the 1967 procedures. Grounded Theory is 
still a relatively new approach compared with other methods and therefore continues to 
be developed, transformed and critiqued. It is interesting to note that in later years 
Glaser and Strauss disagreed about the fundamental procedural issues of the 
methodology. These approaches subsequently became known as the Glaserian & 
Straussian approaches; the main differences surrounded data analysis and how theory 
was induced from the data (Birks, et al., 2006; Heath & Cowley, 2004; Walker & 
Myrick, 2006; Woods, 2003). 
 According to the literature, Grounded Theory originates from sociology, 
although Glaser (2005) has refuted this claim. The sociological roots are specifically 
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connected with symbolic interactionism, which theorises that meaning is negotiated and 
understood through interactions with others in social process (Blummer, 1986; Dey, 
1999; Jeon, 2004; Polit & Beck, 2006; Starks & Brown, 2007). The epistemological 
basis of Grounded Theory in symbolic interactionism provides a great deal of 
congruence for the field of nursing and the strong links between Grounded Theory, 
symbolic interactionism and nursing are evident in the nursing literature (Milliken & 
Schreiber, 2001; Morse, 1994; Stern, 1994). Symbolic Interactionism was first noted in 
1937 by Herbert Blummer and was constructed from the basis of many intellectuals. 
This perspective in partnership with Grounded Theory provides patterns of human 
behaviour, experiences, common perceptions, and how people make sense of their 
world in common circumstances.  
As discussed, the purpose of this study to qualitatively identify, explore and 
describe the experience of cancer survivorship transition from chemotherapy to life a 
cancer survivor. Hence, Grounded Theory was used to the level of data analysis to 
identify the meaning described by cancer survivors and provide an insight into their 
own reality and perception of the interactions they had experienced during this period.   
 
Research Setting 
This study took place in one of three public tertiary hospitals in Western 
Australia, within the medical oncology and haematology departments. The departments 
provide care to over 2000 public and private patients per year from both metropolitan 
and rural Western Australia.  All types of solid cancer tumours and haematological 
malignancies with the exception of allogeneic transplants are treated at this centre; there 
is also a strong culture of clinical trials. Care is provided using a multidisciplinary 
approach lead by haematologists, medical oncologists, a nurse practitioner and other 
senior cancer nurses. Patients cared for in this setting have complex treatment 
requirements and visit the hospital on multiple occasions during the course of their 
chemotherapy treatment. Oncology care is now primarily an out patient managed 
system of care delivery with inpatient episodes reserved for the exceptionally unwell 
person. As a state wide treatment centre the research setting provided the opportunity to 
draw from a wide range of candidates. 
 
Sample Selection 
The accessible population for this study were those patients treated at the cancer 
centre described in the research setting above. Participants were recruited from the 
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medical oncology and haematology departments and had a cancer diagnosis. As the 
hospital is a state-wide treatment centre for cancer it provided the opportunity to draw 
from a wide range of potential participants. The research sample for this study was 
drawn from a target population of all individuals who received chemotherapy in 
Western Australia.  
A purposive sampling method was used. This approach enabled the researcher to 
select certain participants to ensure that a wide range of patient characteristics were 
represented in the data. In adopting this approach it was important to clearly indicate the 
characteristics and rationale for inclusion or exclusion when participants were selected 
(Burns & Grove, 2009; Gerrish & Lacey, 2010; Holloway & Wheeler, 2010). In 
keeping with the purposive sampling approach, a set of pre determined criteria were 
used to select chemotherapy patients for interview. Participants were selected to reflect 
varying experiences of the transition period between four and 24 weeks following 
completion of chemotherapy. This period of time was considered long enough for 
individuals to have recovered from the immediate physical effects of the final 
chemotherapy treatment, but not too long for participants to have forgotten the details of 
the experience. Participants had a minimum of four to six months of chemotherapy 
treatments; this was considered a long enough time period to have settled into a pattern 
of care and also reflected the average timeline for the most commonly delivered 
chemotherapy regimens. No exceptions to cancer type were made as the area of research 
interest related to the treatment rather than the disease. For this reason there were no 
specific requirements set for gender, geographical location, or family setting. 
Participants under the age of 25 years have been identified as a unique population with 
unique needs, which are being addressed at the national arena and were therefore 
excluded. Likewise, those participants already recruited into a clinical trial were 
intentionally excluded as they were already subject to intense data collection which 
usually includes mandated follow up visits within the trial period during which patients 
receive additional support. This was  considered to potentially conflict with the current 
study. Further, participation would have placed these patients at risk of  research 
burden.. 
Participants were recruited using the approaches of self-selection or active 
invitation. Posters and leaflets were posted in both departments with contact details 
made available; patients who were interested often spoke with the chemotherapy nurses 
requesting more information and then either phoned the researcher directly or asked the 
nurses to express interest on their behalf. This approach yielded only a small number of 
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participants (n=4). The second approach was to write to all eligible individual 
participants who were identified as meeting the inclusion sampling criteria by the 
chemotherapy nurses. Those who were invited were provided with a letter of 
introduction, a study information sheet, a tick box form to opt out, and an addressed 
reply paid envelope (Appendix A).  This method was more successful. Of the 20 
patients who were invited, 10 patients agreed to participate  in the study and 10 patients 
chose to opt out by returning the opt out letter. Nine patients did not specify a reason for 
their decision to opt out and one patient chose not to participate as he felt too unwell.. 
The researcher made frequent visits to both departments providing education about the 
research and opportunities for discussion with the nursing team, in order to maintain the 
profile of the research and also the individual nurses understanding of the process to 
support discussion with potential participants. If an opt-out letter was not received by 
the date indicated in the letter then the potential participant was telephoned to ascertain 
their willingness to be a part of the process, if they agreed then the date and time for the 
interview was confirmed during this call. On the day of the interview a text message 
was sent confirming the interview time, telephone number and the contact details of the 
researcher if they wished to change the arrangement. At the agreed time the researcher 
telephoned the participant, confirmed the convenience for the individual, ascertained 
permission to record the interview once again and repeated the explanation about the 
study before the interview commenced. 
Recruitment continued until theoretical saturation became evident. Theoretical 
saturation occurs when no new relevant codes or concepts are identified in comparison 
with the data already collected, only redundancy of previously collected data (Burns & 
Grove, 2009; Gerrish & Lacey, 2010; Munhall, 2007). A total of 14 participants were 
interviewed; ten were female and four were male. Ages ranged from 35 years to 78 
years with a mean of 58 years. The length of time since completion of chemotherapy 
ranged from four weeks to 14 weeks, with an average time since completion of 
chemotherapy being ten weeks. The diagnosis of cancer included, gynaecological, 
colorectal, breast and haematological with six having a haematological malignancy and 
therefore being treated in the haematology department. The participants lived 
throughout Western Australia, with eight based in Perth and four living in the far north 
and south west regions of Western Australia (see Table 1). 
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Table 1  
  Demographic characteristics of cancer survivors who participated in the interviews 
Demographic domains Variables n  
Gender Male 
Female 
 4 
10 
Age 30-60 
>60 
 8 
 6 
Time since completing 
treatment 
4 weeks 
6 weeks 
8 weeks 
9 weeks 
10 weeks 
11 weeks 
12 weeks 
 1 
 1 
 2 
 1 
 4 
 3 
 2 
Cancer Types Breast 
Colon 
Lymphoma 
Multiple Myeloma 
Ovary 
 1 
 1 
 3 
 5 
 4 
Place of residence Perth Metropolitan  10 
 South West Region  3 
 Pilbara Region  1 
 
 
Theoretical Sensitivity 
Theoretical sensitivity has been described as a key characteristic of Grounded 
Theory.  Glaser (1967) highlighted the importance of a researcher’s awareness of the 
subtleties of the data. Theoretical sensitivity provides the researcher with the ability to 
have insight, thus providing understanding and meaning to the data. This sensitivity 
may be gained from literature or from professional experience. The researcher of this 
study was a cancer nurse with over 25 years of cancer nursing experience; many of 
these years having been spent delivering chemotherapy and leading teams of nurses who 
care for these patients. Hence theoretical sensitivity was demonstrated as a key 
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component of this research process. As a new researcher, this was managed by honest 
reflection, memos and regular clarifying discussions with research supervisors. 
 
Interviews 
Interviews were chosen as the approach for data collection in this study. 
Interviews were semi-structured and undertaken by telephone at a time and in a place 
convenient to the participants.  The flexibility of interviews enabled the researcher to 
explore the subject matter in greater detail than other available approaches such as the 
written survey. The support for interviews is robust in the qualitative academic 
environment as a means of data collection. Interviews are considered to provide a prime 
opportunity to capture an individual’s feelings, experiences, perceptions, thoughts and 
social context; knowledge is produced as a result of interaction between the interviewer 
and the interviewee (Kvale, 1996; Liamputtong, 2009; Marshall & Rossman, 2006). An 
in-depth interview is considered the best approach for accessing the lived experience of 
health and illness from individuals who are disempowered by their illness, not only is 
this approach flexible but it allows statements to be followed up with additional 
prompting and questions to clarify meanings immediately ( Holloway & Wheeler, 2010; 
Low, 2007). An exploratory approach was used with a semi-structured interview 
technique and the use of probes were used when opportunities arose to obtain further 
information in a specific area. The questions were intentionally broad e.g. “ how long is 
it since you completed chemotherapy and how have you felt since then?”. This enabled 
the interview to be directed by the participant rather than the researcher. The questions 
were contained within an interview guide (Appendix B). This was used to focus the 
interview on the main domains being explored. The sequencing of questions varied 
between individual participants. The guide ensured that the researcher had collected 
similar types of data from all the informants (Holloway & Wheeler, 2010). 
Traditionally interviews take place in a face-to-face situation, however due to 
the tyranny of distance for many participants who lived rurally or in outer metropolitan 
regions, interviews in this study were conducted by telephone. Holloway & Wheeler 
(2010) supported the use of telephone interviews particularly relating to the benefits of 
convenience, cost savings, immediacy of responses and spontaneity between the 
researcher and the participant. A stated disadvantage of telephone interviews has been 
identified as a lack of deep interaction as the interviewer and participant know each 
other from a distance. The telephone interview approach required the researcher to rely 
on well-developed communication skills as non-verbal cues were not available to 
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establish how comfortable the participant was with the process. Equally the participant 
can be  unclear how much they were being listened to. Therefore, in order to facilitate 
this discussion the researcher gave very clear instructions at the beginning of the 
interview so that the participant could decline answering any questions they were not 
comfortable to answer. The ability to use silence as a strategy to give the participant an 
opportunity to reflect is very limited in a telephone interview. The researcher frequently 
made small noises such as “um” or “yes” to indicate she was listening and encouraged 
the participant to continue talking. She also clarified participants’ understanding of what 
had been said by reflecting the key statements back to the participant for confirmation. 
Occasionally participants checked the researcher was being attentive by asking 
questions such as “Do you know what I mean?” or “Does that make sense?”  
As an approach, telephone interviews versus face to face interviews have been 
tested with no difference found between the number and quality of responses (Garbett & 
McCormack, 2001; Gerrish & Lacey, 2010; Midanik & Greenfield, 2003). The 
telephone interview requires a similar sequenced approach as in face-to-face interviews; 
greeting the person on the telephone, confirming the purpose of the call and clarifying 
that the time was convenient. Asking if the participant was comfortable and did they 
have a drink was also deemed important. The introduction offered the chance to build a 
rapport, explain what the study was aiming to address and clarifying any questions 
about the process, including confidentiality. At this stage, permission to digitally record 
the interview was obtained and consent to partake in the study was captured on the 
verbal recording. The interview then commenced with an open general question which 
set the scene by asking how long it had been since the participant had  completed 
chemotherapy and how they had been in general since then.  
The duration of the interviews was determined by the participant and ranged 
from 18-42 minutes. Interviews were recorded onto compact discs that were labelled 
with the date and a pseudonym. Pseudonyms were also used in the transcription process 
to ensure confidentiality. Demographic information was collected at the beginning of 
the interview including the participant’s gender, age, treatment length, diagnosis (see 
Table 1). The interviews were transcribed verbatim by an experienced individual to 
ensure the participants’ words were preserved as accurately as possible. The researcher 
who listened to the recordings many times in order to become immersed in the data 
checked the accuracy of the transcripts. The transcriber signed a confidentiality 
agreement (Appendix C) prior to commencement of this process.  
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Data Analysis  
 The analysis of data followed the Grounded Theory approach of the constant 
comparative method of data analysis first described by Glaser and Strauss (1967). The 
Grounded Theory approach was followed to the descriptive level only; this included the 
identification of codes, and the grouping of codes into themes. This method of analysis 
on the data provided during interviews by the survivors and provided a descriptive 
framework of their experiences at this time. The analysis did not follow Grounded 
Theory to the theoretical level which would have analysed and processed the data with 
the intent of generating theory and concepts which would have explained the survivors’ 
actions. In the descriptive method of analysis the researcher moves through the analysis 
comparing each incident in the data with other incidents for similarities and differences; 
those found to be similar are grouped together with a higher level descriptor. In this 
process the researcher is able to differentiate one theme from another and identify 
specific issues related to each theme (Corbin & Strauss, 2008;  Holloway & Wheeler, 
2010). 
Once transcription of each interview was complete, the document was formatted 
with page numbers and line numbers, as well as half sheet columns to leave space for 
theme identification. Open coding was used first where transcripts were read line by line 
and descriptive coding was applied identifying information, which was considered 
important; the codes labelled common themes or categories. Holloway & Wheeler 
(2010) suggested this type of coding prevents researchers from imposing their own 
framework and ideas on the data. Initially 82 codes were identified (Appendix D). The 
codes were then grouped together with codes of similar meaning that were linked to the 
same phenomenon. This phase is identified as axial coding and is the step which allows 
the researcher to connect different codes, identified in the initial coding. This 
organisation of the data enabled connections to be made between a major category and 
sub categories (Minicheiello, Aroni, & Hays, 2008). This new group of codes was then 
further condensed to a smaller number of common themes. To reduce the risk of 
inferential leaps by a novice researcher, constant discussion and exploration occurred 
with research supervisors. External research supervisors assessed the credibility and 
consistency of the thematic developments performing independent coding and analysis.  
Appendix E provides an overview of the development from initial codes to a major 
theme; this information may be used to establish the existence of an audit trail for this 
research study. 
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Trustworthiness and Rigour 
There remains both confusion and disagreement within the qualitative research 
field of nursing in relation to ensuring and validating the quality of a research approach. 
There are numerous attempts to define what constitutes a good, trustworthy qualitative 
study  (Rolfe, 2006; Sandelowski, 1986; Sandelowski & Barroso, 2002). However 
despite over 25 years of debate the one thing for which there does appear to be 
agreement  is that reaching a consensus on quality criteria is unlikely in the immediate 
future (Morse, Barrett, Mayan, Olson, & Spiers, 2002). A solution to providing 
trustworthiness (rigour) of a study may be possible if the reader is able to appraise the 
events, influences and actions of the researcher (Koch, 2006) 
Several approaches to demonstrate rigour have been demonstrated in the 
literature. Guba & Lincoln (1989) framed the domains which need to be addressed as 
credibility, transferability and dependability. Sandelowski (1986) and Beck (1993) both 
determine dependability to be auditability, meaning that another researcher can follow 
the decision trail employed by the investigator in the study. For the purpose of this piece 
of research the Beck (1993) criteria to demonstrate trustworthiness in order to facilitate 
the critique of qualitative research was applied to highlight the steps taken by the 
researcher to illustrate credibility, auditability and fittingness as detailed below. 
Credibility 
Demonstrating credibility requires the researcher to describe the phenomenon 
they are exploring in accurate detail. This description needs to be instantly recognisable 
to people who have had that experience, or have professional expertise in that area 
(Beck, 1993; Cooney, 2011; Glaser & Strauss, 1967; Guba & Lincoln, 1989). This 
study utilised the Grounded Theory approach to the descriptive level of data analysis 
which should enable the findings to accurately reflect the participant’s experience. In 
order to demonstrate the credibility of the study the researcher opted to engage experts 
in the field. This approach is supported by Cooney (2011) and Cutcliffe (2005) who 
claimed that there is more resonance in the findings if credibility is agreed upon by an 
expert panel rather than those who provided the raw data in the first instance. 
Auditibility 
By developing a comprehensive record of all methodological decisions, the 
researcher creates an audit trail which provides sufficient detail to enable other 
researchers to repeat the study in the same setting (Beck, 1993; Guba & Lincoln, 1989; 
Jenks, 1995).  In keeping with the Grounded Theory approach the researcher used 
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memos in sufficient detail to provide detail of the approach taken, whilst recognising 
that an audit trail is not a concept commonly described in Grounded Theory. The 
memos provided enough detail to demonstrate how the initial 82 codes developed into 
the themes (Appendix F) discussed in the findings chapter and supported by quotes 
from the participants. 
Researcher reflexivity is considered an important component of the Grounded 
Theory approach (Cooney, 2011; Strauss & Corbin, 1998). An awareness and a 
demonstration of the researcher’s personal assumptions, values and biases is an 
important part of the discussion process. As the researcher has considerable experience 
and expertise it was important to hold regular and frank discussions with the research 
supervisors particularly during the thematic development stage of the study, to ensure 
that bias was not determining the direction of the findings. 
Fittingness 
Otherwise described as transferability, fittingness determines that the findings 
should be meaningful to others in similar situations (Beck, 1993; Koch, 1994; 
Sandelowski, 1986). In order to demonstrate this criterion, the researcher has detailed in 
this methodology chapter, the study context, survivor participant demographic profile 
and characteristics of the study setting to enable future researchers to determine the 
transferability of the study. 
In conclusion Beck’s (1993) criteria of credibility, auditability and fittingness 
have been utilised to demonstrate the rigour of this study undertaking the Grounded 
Theory approach to the descriptive level of data analysis.  
 
Ethical Considerations 
Ethical approval to conduct this study was obtained from the Committees for 
Conduct of Ethical Research at Sir Charles Gairdner Hospital (HREC 2008-070) and 
Edith Cowan University (HREC 3706).  
For Phase One, each patient participant received a letter of introduction and 
study information sheet describing the study (Appendix A) and inviting his/her 
involvement. The letter of invitation provided details regarding the purpose of the study, 
use of information and an assurance of anonymity. Verbal consent to take part in the 
study and have the interviews recorded was recorded at the beginning of each interview. 
The letter of introduction clarified that individuals were under no obligation to be 
involved in the study.  
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For Phase Two, potential participants were sent a letter of introduction to the 
study that provided details about the study and the requirements for participating in this 
phase. A copy of the QOL-CCS and survey tools used for the testing of clarity, content 
and apparent internal consistency was also included. Return of the completed survey 
tools was accepted as implied consent.  
Sources of raw data, questionnaires and computer diskettes were secured in a 
locked filing cabinet in the office of the researcher at the Department of Health Western 
Australia. Shredding of written data and deletion of electronic files will occur five years 
following publication of findings in accordance with item 2.1 in the Australian Code for 
the Responsible Conduct of Research (2007). No name related information will be used 
in written reports or presentations, as only group data will be presented. Any data 
collected has been used exclusively for this study and will be destroyed at the 
individual’s request at any stage. It was also made clear to participants they could 
withdraw from the study at any stage without repercussions to their treatment (patient 
participants) or employment (chemotherapy nurses). As previously stated the transcriber 
was required to sign a confidentiality contract and all recordings. Pseudonyms replaced 
the participants’ names on the transcripts. A second researcher analysed the data to 
provide an unbiased view and ensure a validity check. 
 
Conclusion 
 In summary, this chapter has described the qualitative methodology used for 
Phase One of the study as well as the ethical considerations for both phases. It has 
illustrated the processes employed to collect and analyse the data and finally discussed 
the ethical considerations that occurred before and during the study. The findings of this 
study are outlined in Chapter Four. Direct quotes from the interview transcripts have 
been used to highlight emerging themes. The participants are coded Survivor 1 (S01) 
onwards for identification and attribution throughout the chapter  A discussion of the 
Phase Two quantitative methodological approach and findings for the study will be 
presented in Chapter Five.  
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Chapter Four 
Phase One Findings 
Introduction 
This chapter presents the qualitative findings from Phase One of the study. Code 
numbers rather than names of the cancer survivors who were interviewed have been 
used. Analysis of the interview transcripts exposed cancer survivors’ perceptions of 
completing chemotherapy treatment and the period immediately following this time. 
Findings have been configured into two major categories according to a timeline on the 
treatment journey. The first being experiences as chemotherapy completes, and the 
second being experiences as the cancer survivor transitions onto the next stage of the 
journey.  
 
 
Figure 3.  Illustration of findings displaying the relationships between timelines, 
categories and subcategories of cancer survivors’ experiences. 
 
Experiences on Completion of Chemotherapy 
In this phase of the survivors’ journey, experiences related to the loss of the 
treatment experience, emotional changes, and dealing with the physical effects of 
chemotherapy (NB Chemotherapy was usually referred to as “Chemo” by the 
participants in this study). Due to the complexity and interlinks between these 
categories further sub categories were generated for clarity. Loss of the treatment 
experience contains the following domains:  loss of identity, loss of the treatment 
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community and loss of perceived planned future. The emotional changes category has 
been divided into the domains of: feelings of isolation, feelings of low mood and 
unexpected emotional changes. 
 
Loss of the Treatment Experience. 
Survivors who were interviewed described going through a time of change. 
Chemotherapy units, health care professionals, appointments for chemotherapy and 
blood tests had been their reality for at least six months previously. This experience 
occurred alongside other patients, family and friends and a community who supported 
and shared the treatment experience. As this episode of the treatment journey drew to a 
close, many adjustments were said to be required. This category was further divided to 
include the domains of: loss of identity, loss of the treatment community and loss of 
planned future; although they remain inextricably interlinked from the perspective of 
cancer survivors. 
 
Loss of identity. 
Loss of identity related to patients no longer understanding or feeling like they 
belonged and was a concept they struggled to express clearly, “It was a little bit, oh how 
would you explain, like it was, like it was all over and sort of a little bit lost.” (S05);  
and “In general [I am] feeling a bit lost in terms of where to go from here” (S04). The 
readjustment appeared to be in making sense of their new situation and feeling as 
though they no longer belonged, “I think I felt like I had landed back on Earth but in a 
foreign country” (S04). There was an awareness that changes had occurred either within 
themselves or their perceived place within society, “Just that sense of I can’t just re-join 
the flock again and carry on as before” (S04). The fundamental question at this time 
appeared to relate to finding their new place of belonging, “I am not who I was and I’m 
not receiving treatment, so who am I?” (S04). 
These feelings appeared to be heightened by the lack of preparation at the end of 
treatment:  
 Because when you’re sick you just deal with the sickness and you’ve got a task at 
hand but when all that’s over it’s just a different experience to that which I didn’t 
expect … I was cut completely free and that was it. (S07) 
 
The end of treatment was perceived as a sudden event, despite most patients knowing 
their proposed treatment plan for months prior to completion: 
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Suddenly you’re an outpatient, ready or not the systems finished with you … 
You need an initiation back out from being a patient. It’s almost like being 
homeless really. You’re not in the cycle any more. You are not really being 
cared for in that sense (S04); 
 
 Suddenly it was right you no longer need us any more so that’s the end of that 
…because I was going through it for so long that when it came to an abrupt halt 
…you were a little bit lost (S11). 
 
Loss of the treatment community. 
Analysis of the interviews demonstrated that it wasn’t solely the loss of structure 
and the task of being a patient that was being experienced, patients were also aware that 
they lost connections with the treatment community in the form of health care 
professionals and other patients: “There are a lot of nurses around that you can talk to 
and people who are feeling sick as well” (S07): 
 
There is such a sense of community I think when you are having chemo, the 
support you get from the staff, from other patients and from other patient’s family 
and friends I found really quite inspiring. After the treatment, it’s quite isolated. 
(S04) 
 
When treatment ended, there was an awareness among participants that they didn’t 
belong to this community any longer and a sense that they didn’t know where to go 
next, “You can’t really ring up the nurses because they are busy dealing with all the 
new people … the support stops and you are not sure where to go” (S03); “It’s almost 
like being homeless really” (S04). 
 Another participant said: 
Well I know the girls there are really busy and they are really great and it was like 
"oh! Excuse me, remember me, remember you were treating me, now I'm here 
you don't need me anymore, I was special last week! How come I'm not special 
this week?"  and I was probably being a bit silly but I think they just haven't got 
the time to fuss over, I mean I was being fussed over obviously I was having the 
needles and I was having the chemo and I was having all this and people were 
being sweet and kind and it was just lovely in that sense but suddenly it was right 
you are no longer need us any more so that’s the end of it. (S11) 
 
In summary, survivors valued the sense of community they experienced from 
fellow patients and health care professionals, they experienced an acute sense of loss in 
relation to the easy access to support that they received during their treatment episode. 
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Loss of perceived planned future. 
At the end of treatment whilst all of the above mentioned losses were creating 
the turmoil as described, the opportunity to plan for the future appeared to be stifled by 
the fear of what the future might hold, “That feeling of ambivalence I think, about what 
I want to do in the future. What’s the point if it is going to come back?” (S04). 
The challenge for the survivor to deal with the depth of these feelings was indicated to 
be enormous:  
It [having cancer] knocks around your sense of stress and security and the 
confidence in the future and you just start feeling really vulnerable. And that was 
probably the biggest thing for me, the biggest hurdle for me to get over. (S07) 
 
Another survivor explained: 
I really wasn’t that happy for a long time afterwards to be honest – it sets you 
back and you sit around and you think you’re going to live forever and then you 
realise you’re going to kick the bucket and then you haven’t got a chance anyway. 
(S08) 
 
Some of the survivors realised this episode of chemotherapy was not automatically the 
end of their treatment journey, therefore the original plan they had focused on during 
treatment was lost and readjustment to a new plan was needed already, “It would be 
quite devastating to have done what I have done and then have a scan say that you 
didn’t get a remission” (S07).Survivors also had an understanding that for them 
chemotherapy may not necessarily be the end of their treatment journey, this was 
especially problematic if the final chemotherapy date was in a state of flux: 
I think not having an end date and being up in the air deciding that I had radiation 
and also I had a mastectomy. So for me, chemo was sort of the end of treatment. I 
still had decisions to make. So there were still emotional personal things going on. 
So I guess what I’m saying is, I can’t just say “I’ve finished chemo and there’s no 
other stuff happening”. Like still things in life to look at, and deal with. (S01)  
 
The vulnerability experienced appeared to be strongly linked to the uncertainty of their 
prognosis, “I suppose afterwards I found that was the time I needed emotional support 
because that is the time I felt the most vulnerable” (S04); “ I’d get quite weepy … So 
that I suppose knocks around your sense of stress and security and the confidence in the 
future and you just start feeling really vulnerable” (S07); “I think it is still in the back of 
my mind all the time, just worried that it is going to reappear” (S03). 
 One survivor recognised the fear caused her to have ‘bad days’: 
There are days when you wake up and think you’ve got through all this treatment 
and especially after I thought it was over and you didn’t feel well on a particular 
day and you were thinking, God I’ve gone through all these months of this to no 
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avail and I’m still feeling like this and you feel sorry for yourself … and you 
know that you have gone through all of this and are all the tests going to come 
back and say we’re not much further ahead. (S10) 
 
Survivors whilst not overtly discussing this fear on a regular and open basis were aware 
that it was an underpinning feature of their current emotional state. One survivor 
discussed how she prepared for the worst whilst going through treatment: 
When you are going for treatment you have a lot of time sitting in those waiting 
rooms and there are a lot of people who get to know each other and they talk 
across each other and you can’t help but listen to what they have to say and your 
taking it all on board, I suppose how there treatments are going and all the time I 
was listening to things that they are doing and how much time they have off 
before being back again and I was actually preparing myself for all of that I was 
thinking oh well this is not curable or this is something that you are going to have 
to get on with. (S11) 
 
In conclusion, the loss of the treatment episode of care in the survivors’ journey 
encompassed experiences of loss of belonging and disconnect, loss of the patient role 
and its accompanying tasks, loss of the treatment community including ready access to 
support and finally a fear for their future knowing that treatment offered no guarantees.  
 
Emotional Changes. 
This category, whilst still concentrating on the end of treatment timeline, has 
been further divided into the sub-categories: feelings of isolation, fear for the future, 
feeling low in mood, and unexpected emotional changes. For all the survivors end of 
treatment was expressed as a time of great emotional turmoil. Survivors expressed the 
shock, vulnerability, isolation and fear that they experienced at this time. With a few 
powerful words they were able to express their complete disarray at this time, “It’s 
really frightening. Like it’s really frightening” (S01); “I’m a bit numb still” (S05). 
The sudden loss appeared to be such a shock to individuals, “I was cut free and that was 
it” (S07); “I think I found the first time I had chemo because you were used to going 
(for chemotherapy) when it was cut off, it was a major shock” (S03). 
 
Feelings of isolation. 
Even when expecting the feeling of isolation, the emotional turmoil was evident. 
This emotional turmoil encompassed a sense of isolation which strongly linked to the 
emotions felt to the losses or disconnects that survivors perceive experiencing, “I feel 
quite isolated that at the end you go ‘Oh my God!’ I’ve now got to navigate my own 
ship” (S04). 
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A survivor who had been through the journey before was prepared for this stage: 
The second time I was more prepared for it … I mean the second time my 
husband stopped work so I had someone here but I still felt, I don’t know how to 
explain it because you are used to having that support and when it stops it is a lot 
different. (S03) 
 
Another survivor explained how this isolation affected her, “Some days I would have a 
little bit of a cry to myself and feel a bit down … I would be home all alone … it was 
tedious sometimes” (S13). 
These feelings were not solely limited to the treatment community, but also to 
the wider social circle of the survivor, “When you are sick and going through the 
treatment you’ve got people ringing and enquiring about you and that sort of thing and 
now that doesn’t sort of happen.” (S05). Conversely, another survivor described how 
her cancer diagnosis caused friends to avoid her:  
Some friends don’t know how to react, so there are some friends who I haven’t 
seen in ages … it’s almost like they wait for you to be well again so they can cope 
and so you just have to understand that it where people are at. (S10) 
 
Survivors felt that others did not understand what they were going through which 
enhanced their feelings of isolation and vulnerability, “Sometimes I’d feel as though 
nobody cared what I was going through” (S09); the lack of understanding is further 
compounded by the feeling of isolation: 
 I would have thought that someone popping in to see how you were going 
probably would have unleashed an avalanche of tears if they had known what I 
had been through … I was too sick to be out and about. And you get a bit house 
bound as well so that didn’t help. (S07) 
 
In summary, survivors were experiencing an array of emotions whilst feeling generally 
isolated, this was compounded by a perceived lack of acknowledgment from others 
about their tumultuous experience.  
 
Feelings of low mood. 
Survivors expressed a range of negative emotions to demonstrate the low mood 
they experienced at the end of treatment, some felt too ill to feel any emotion at all, 
“You don’t feel anything …You are just too sick to complain, you just want it to end. 
Just get through the next thing you had to get through, the next day or the next hour” 
(S07). 
 One survivor expressed feeling extremely low and suicidal on occasions 
towards the end of chemotherapy (S01), others expressed not only the depth of feeling 
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but also the duration of this emotional state, feeling frightened (S01); “On the inside I 
didn’t feel particularly great at all. I felt quite deflated” (S04). Another said, “It was 
what made me depressed or I would bounce around …  generally sort of get down and 
sort of like a lot of people get depressed … it certainly affected all that year … I really 
wasn’t that happy for a long time afterwards to be honest” (S08). 
 
One survivor described the unpredictable nature of recovery after treatment as 
particularly detrimental to her emotional health: 
 
I think it was the unpredictability of it that made it difficult, you know it’s not like 
anything you had before, when you have the flu and you start to get better and 
you think ok I’m on a roll, but with this you felt like it was one step forward and 
one step back. (S10) 
 
Even when survivors were excited and positive about the prospect of finishing 
chemotherapy, emotional swings occurred: 
Initially I was quite excited to finish chemo and really sort of looking forward to 
that wishful thinking, you know all the things that you are going to do … And I 
was actually really surprised at how depressed I got and how emotional I became, 
probably about a month after treatment. (S04) 
 
Survivors had clearly encountered many emotional changes along the journey to this 
point; they often appeared to have unanticipated emotions. 
 
Unexpected emotional changes.  
Survivors described events or people who upset them which appeared to take 
them by surprise:  
Psychologically, some unforeseen difficult and upsetting moments, which I didn’t 
anticipate. You know, emotionally fragile sometimes. A bit like post-traumatic 
stress, you know … I would start talking about my experience to somebody or I 
would see something on T.V which was about cancer or needles or something and 
I would get a bit upset and then I would need to have a real bawl and that took me 
by surprise … I was quick to get upset a few times with things and just beautiful 
things as well you know, gifts and people doing nice things for you. I’d cry a lot. 
Kindness made me cry a lot. (S07) 
 
Survivors own expectations also contributed to the emotional turmoil experienced: 
 I sort of expected myself to feel full of life and feel absolutely fabulous. But I 
didn’t … And the pressure to be, something new or, yeah there is a bit of pressure. 
Just got to be really happy. And every day is fabulous. (S04) 
 
The desire to protect loved ones placed an additional burden on survivors: 
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My sisters would ring each day but there’s a need to protect the people that you 
love as well you know, but I didn’t want to discuss what I was going through with 
them because they had gone through the journey with me already. So the more 
together you are the more they can relax and let go, I just wanted them to relax a 
bit. So I felt like I wore the emotional thing pretty deep. (S07) 
 
External pressures such as financial responsibilities also contributed to the emotional 
burden:  
Well, I couldn’t get sick leave … Because I don’t own a house or anything like 
that but I’ve been saving pretty hard to try to get something like that. So because I 
had liquid assets they didn’t find me eligible … So that, that’s really stressful 
when you’re a single woman who has been diagnosed, yeah, it’s really stressful. 
(S01) 
 
In conclusion, the completion of chemotherapy treatment is an emotionally 
tumultuous time; survivors expressed a myriad of mostly negative emotions including 
fears, isolation, low moods and unpredictable emotional behaviour. Coupled with the 
feeling of being disconnected and loss of structure from the treatment experience, this 
was clearly a very difficult all encompassing experience to navigate through. 
 
Physical Changes. 
On completion of chemotherapy physical changes are common, some transient, 
and some permanent. This section explores the physical effects experienced at the end 
of treatment. All of the survivors were dealing with physical changes, which were 
impacting on their day to day lives and emotions at the end of treatment. The range 
included unique complaints such as: 
The muscle wasting, fatigue, my stomach was sensitive to certain foods so I had 
aversions to certain foods, so I under ate for a while because I did have a 
perforated duodenum so I’m not sure if it was because of that or the drugs or both. 
I felt a slight passing nausea which made me not want to eat certain things. (S07) 
 
Another survivor said:  
Okay except I’m having a lot of trouble when my body gets warm. I get these 
terrible itching all over me like ants crawling all over me . . . From the top of my 
head … its not like an ordinary itch, its like something crawling all over your 
body, you know, like ants. (S09)  
 
Some physical changes were described by several survivors and included: - 
constipation, nausea, weight loss, swollen legs, hallucinations caused by drugs, joint 
stiffness, sore mouth, taste changes and memory impairment. 
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Hair loss was another common physical change experienced by several of the survivors. 
In addition, when hair had regrown the change in body image had a significant impact 
on one survivor: 
I have had a little cry, I look so different … I used to have long hair right the way 
down my back and it got all knotted with the chemotherapy and I had to shave it 
all off, I have white hair now … I look so different, it’s a different ball game…I 
was a pretty little girl before now I look like a business tycoon. (S13) 
 
The overwhelming physical change discussed was fatigue which was expressed 
as physical weakness and lack of energy, “Fatigue was the big one … physically I felt 
quite tired” (S04); “I think I just had a physical depression. I don’t think I was mentally 
depressed, I think my body was depressed” (S07); “Tiredness, definitely … when I 
finished I was tired for quite a while” (S09). The awareness of fatigue was related to 
how much they were able to do: 
I’ve still been tired. It’s better now though that the chemo has stopped. When I 
was going through the chemo, I was extremely tired but it is getting better, slowly 
… I was in bed at 7:30 or 8 o’clock every night. So that’s not normal no. (S03) 
 
Mentally, I want to do things but physically I can do some small things but it gets 
very tiring because I have lost so much muscle and condition and God knows 
what else. (S14) 
 
No energy, not being able to get out of bed and each day was the same as the last, 
that’s the awful thing, you think tomorrow you’ll feel a bit better… I thought I 
was getting better and then I would have a day where I was completely without 
energy and completely exhausted. (S10) 
 
The fatigue prevented survivors from working, “I was just obliterated so I 
stopped and I haven’t done any work since then” (S01). Or the fatigue caused them to 
modify their work hours in a staged way, “I was working full time and then I went part 
time because I had to have a hysterectomy. So I had the six weeks off, I went back part 
time and then when my chemo changed I was too tired” (S04); “I can’t work, I’m not 
physically strong enough to work yet, but luckily I have income protection” (S11). 
Survivors identified that doing simple things, such as walking short distances was 
challenging, “Well I started off just trying to walk to the corner because I had lost all 
my muscle strength. I was all floppy. Then I started walking around the block slowly, 
holding on to somebody” (S07). 
 
Especially in comparison to pre treatment energy levels:  
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I just have to pace myself, so it’s like being old, you know, when you are 
continually pacing yourself and thinking no I can’t do too much … I was working 
10 hour days going out at night and I was pretty much doing what I wanted. (S10) 
 
“I’m simply not as strong as I would like to be … I still have to work on doing a bit of 
exercise and more walking”. (S12) 
 
The frustration of having time to do things but not the energy was another challenge to 
survivors at the end of treatment: 
What I’ve noticed is that when people are getting treatment often they don’t have 
the energy or time or resources to participate in anything else but after treatment 
you suddenly have all this time and you are not well enough to go back into your 
old life or your new life. (S04) 
 
Fatigue was identified as a significant contributing factor to the challenge of 
remembering:  
I had a notebook and I would take that with me. ‘Cause it’s really hard when 
you’re emotionally in there and you’re so tired, to remember it all, so I didn’t 
need to get myself to remember it off the top of my head. I always and I still do it, 
still mentally list stuff. (S01) 
 
Survivors were aware that they weren’t remembering important information that they 
wanted to retain: “I often felt like I knew that I couldn’t get my brain to the places 
where it needed to go. It was just like my head was murky” (S10) 
 
Because you can’t remember. If you are sick, then your memory is shot to pieces 
and if you are tired you are not absorbing information. So you know you have got 
to go see a doctor in four weeks but you can get easily confused … It hasn’t been 
that great and I haven’t really recovered that well and since the chemo has stopped 
there. (S07) 
 
Fatigue had a strong negative effect on emotions and feelings: 
You are really weak and you want to look like you’ve got things together but I 
just drifted around and cried a bit because I just got so fed up trying to haul my 
body out of bed and you feel so weak. You feel weak like a kitten … when you 
get up you collapse … And that makes you feel so pathetic but then you feel 
pathetic emotionally….I was so low on energy that I just didn’t feel anything to 
intensely it was just like a depression so I didn’t feel anything that intensely but 
once I started to get better and my energy went up my emotions were more 
intense so it upsets you more. (S07) 
 
However a positive effect was noted as fatigue improved, survivors were aware of even 
slight improvements in fatigue levels, “Physically, you know where you are physically 
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weak in the first few weeks. And then you get your energy back which is such a boost 
to your mood to get some energy back” (S07). Another said, “I have a reasonable level 
of energy, I can walk a little bit faster. Like last week I was aware I went to the garbage 
bin, and I did it without feeling like I needed to collapse was great” (S01). 
The relationship between fatigue and level of mood is so intertwined it was said 
to be impossible to consider one without the other, a change in one has a corresponding 
effect on the other, “There’s no way to disconnect the impact that physical exhaustion 
has on your spirit and emotion” (S01). Only one survivor (S11) did not have any issues 
with fatigue and described herself as having “absolutely bounds of energy” since 
completing treatment in comparison to feeling continually tired whilst having 
chemotherapy. Interestingly this survivor displayed positive self talk from diagnosis 
onwards: 
My conclusion was at the very beginning that my life would not be worth living if 
I let this get to me, that’s how it would be, if I couldn't live my life as best I could 
and let this get to me then life would just be unbearable as far as I'm concerned. 
So I just incorporated it. (S11) 
 
Survivors recognised that some changes were going to be long term; one survivor 
whose cancer had affected his back discussed the emotional toll of the physical change: 
I would like to have been how I was before …well that may happen but not to the 
same extent, I find it pretty boring just sitting at home, because I’m limited in the 
fact that I can’t do a lot of exercise, I can’t do any gardening or tinkering in the 
shed … I know myself that certain things won’t happen that way again, you know 
the body’s damaged it’s never going to repair itself to the full extent … I may or 
may not have to wear a back brace for the rest of my life. (S14) 
 
Over half the survivors experienced an unplanned/unexpected hospital 
admission, because they were so physically unwell at the end of chemotherapy 
generally due to infections. Survivors described being extremely unwell due to 
infections, adverse treatment events and allergic reactions, which for the individual 
were all encompassing and for some resulted in several weeks in hospital after the 
completion of treatment. Whilst the survivors were still connected with the treatment 
community they were not well enough to begin their transition onwards, physically they 
remained dependant on their hospital teams and psychologically they had not begun to 
experience the losses related to treatment end. 
In summary, the time immediately after completion of chemotherapy was filled 
with experiences of loss in social, spiritual, psychological and physical domains. Social 
domains include the loss of relationships with the treating teams and fellow patients, 
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spiritually, self perception has often altered with a loss of self identity and an increased 
awareness that they have changed as a result of their journey; with a resulting need to 
revaluate their future. Psychologically survivors displayed a range of altered emotions 
including shock, vulnerability, isolation and fear. Physical changes were evident and 
common across all survivors, although there was variation across the range of physical 
changes; fatigue was common and compounding. 
 
Experiences in Transition 
For the purpose of this study, transition is defined as the process or period in 
which a person with a cancer diagnosis undergoes a change and passes from one stage 
or state to another. Cancer survivors often refer to their coping skills or ability to cope. 
In this study to cope is considered to represent the ability to deal successfully with a 
difficult problem or situation. 
From the evidence provided thus far, it was clear that at the end of treatment 
survivors faced a series of personal challenges they felt physically unwell, emotionally 
in turmoil, socially disconnected with a lack of recognition of their suffering from 
others, and were questioning their future. Analysis of the interviews demonstrated that 
as survivors began to improve physically particularly from symptoms of fatigue, they 
also began the process of transition towards their new future. The process of transition 
involved dealing with the highlighted personal challenges whilst finding new balance, 
working towards their future goals and achieving a normal life. 
As the all-encompassing effects of physical fatigue begin to recede, the intrinsic 
characteristics of human nature took over. This section has been divided into two 
categories resilience and empowerment; in the interests of clarity the empowerment 
section has been further sub categorised into self-awareness, self-protecting, self 
informing and self-management. 
 
 Resilience 
As physical strength of the survivors began to return, their personal resolve also 
began to return. During the interviews survivors articulated a range of personal values 
and beliefs which helped them to cope with the process of transition, “I just live life as 
normal” (S02); “I mean my attitude is that I not going lie down and die” (S08). 
Another survivor explained: 
I’m quite a positive person I suppose and that seems to make a difference …Yeah, 
I suppose I am quite blessed as a person my observation is that everyone in life 
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gets an opportunity to go through a crisis and that it is how you handle things 
rather than what is happening to you. Attitude is everything. (S04) 
 
Another said,  “I think . . . I know, I promised myself that no matter what happens . . . if 
I’m to die from this or if it came back or anything like that I would be okay if I make 
sure I’m true to myself” (S01). This survivor describes what the impact would be for 
her if she was not positive: 
 
I can’t let this affect me … I can’t let this get to me … I didn’t even voice it, I just 
thought I’m going to do this and get through this as a part of my day or week and 
incorporate it into that … I can’t imagine not being positive, that’s me, it would 
be just awful to live negatively, I couldn’t love that way, it’s not how I live, life 
would not be worth living, If I had to live that way , it would be too miserable, far 
too miserable. (S11) 
 
Survivors appeared to accept that this was their personal challenge: 
 
 I think just accept what’s what. You can’t choose what is sent to you, can you? … 
You can choose the way you accept it. And I think most people can with a bit of a 
push, looking at it in the right light rather than the ‘woe is me’ attitude which I 
know a lot do have. There is nothing you can do about it. (S06) 
 
 Another survivor highlighted her personal balance: 
Where I am emotionally and mentally, that has been the biggest thing that I’ve 
protected. That doesn’t mean that I haven’t physically tried to take care of myself 
… a couple of months ago I pushed a little bit more than the average person 
would. I wasn’t meaning to. I’ve always been like that as a person though, so 
there’s some things you just can’t straight away turn an off switch on … I’m not 
going to blame myself around that. I do things; I’m a do things person. (S01) 
 
One survivor described how she was surprised to find the inner strength she had, “I 
don’t know where that strength came from, it must have been the Lord, I don’t know 
where I got the strength, I was really strong … it changed my whole life … I think I feel 
more confident now than when I started (S13). 
 
Survivors displayed acceptance as they worked through the transition phase, that this is 
a long term journey from which they may not fully recover: 
Be prepared for the long haul, be prepared to be inconvenienced, it’s your life, if           
you want it you’ve got to put up with it and follow what is told to you and don’t 
expect miracles overnight … it’s about five years before you know how things 
are going but at the moment you are in for the long haul … it’s a long road to go 
before I get back to somewhere that I was before, if not totally back to where I 
was. (S14) 
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 However being accepting did not mean giving in, “Well I’m not about to sit at home 
and think ‘I wish I had done this because a week down the track and my feet aren’t any 
better’” (S06). Survivors drew on their own personal resolve and coping skills during 
this period, “Something, just within myself has come up at a time when I needed it” 
(S01); “I just dealt with it by myself” (S03); “I’ll get through it like I normally do and 
that’s it” (S04); “I worked my way through it … I was down in the doldrums for a 
while so I worked my way through it” (S08). 
Survivors displayed differing views on emotional resilience from firm views about 
anxiety and depression:  
No I don’t believe in that [Depression] sorry … Well the whole thing is if you let 
things get you down, and they do at times, like when your husband passes away. 
You don’t spend 42 years with someone and it doesn’t get to you and that took 
quite a few years to get over, I’ll admit. But when I think health is concerned, how 
can I put it? We were brought up to always look after our health so we were a 
healthy family … we are all of a similar outlook on life. Get on with it. (S06) 
 
To actively managing potential emotional issues: 
 
I’ve been pretty proud of myself mentally; I wasn’t pushing myself to be positive, 
feeling what I was feeling. Ever since I was diagnosed I’ve been going to see a 
breast cancer counsellor and getting help regularly, it just helps me to process and 
get through it … I don’t want to be pushing down anything, stuff that I haven’t 
resolved. (S01) 
 
There was also an awareness of the need to be kind to themselves: 
 
Be kind to yourself and take it slowly, don’t expect too much, you know it is 
going to go up and down and you are going to have bad days and sad days …you 
just have to pace yourself and the people around you have to understand that and 
be good to you too. (S10) 
 
From the analysis it was clear that resilience is a complex web of personal 
values, attitudes and attributes that each person brings to their personal cancer journey. 
The importance of acceptance, understanding this is their challenge and maintaining a 
positive attitude appeared highly important to survivors. The resilient streak displayed 
here was not evident at the end of treatment when physical fatigue dominated the 
person’s outlook. It could therefore be concluded that human resilience changed a 
person’s focus as the process towards transition began. 
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Empowerment 
Once survivors began to articulate and display their resilient spirit, the next step 
in the transition process was becoming self-empowered. This was displayed in a series 
of complex strategies which contributed to their self-empowerment and ability to take 
control of their destiny towards achieving their personal goal. The action of 
empowerment was further divided into four categories of actions: self-awareness, 
seeking support, self-protection, self informing and self-management were all found to 
be  important aspects related to empowerment of the survivor.  
 
Self-awareness. 
Survivors were aware they had maintained a mostly passive role during 
treatment and that transition required a different behaviour from them: 
 You kind of sit around and take what you need to take during the treatment but 
when you get better you don’t want to do that anymore. You want to be a bit more 
pro-active and less passive. When you are sick you are happy just to lie there and 
let anyone jab anything in you, you know? But that is not suitable for when you 
are well. You need to be a bit more self-determining about your life. I could have 
gone six months without any follow up treatment if I hadn’t followed it up. (S07) 
 
Whilst survivors were able to take control of limited aspects of their treatment plan, the 
following survivor’s emphasis has shifted from her need for treatment to her need for 
rest, … “and then I said, actually I’m due to start radiation in a couple of weeks … look, 
no, I need to go and have this holiday rather than change the dates again” (S01). This 
same survivor identified that she had personally changed and learnt the skill of assertion 
in order to meet her own needs: 
I did get through this, and I’ve learnt so much about myself, and I’ve learnt so 
much about, my ability to be assertive, my ability to sit in a doctor’s office for 
once and know what I want and actually say to him “no, look what you’ve just 
said to me has made me feel incredibly anxious. (S01) 
 
Survivors’ ability to self manage their future included testing this control by rebelling 
against normal expected care, “Ironically, I started smoking, heavier than I have done 
for years and years and years in January. There was that bit of me that wanted to be 
really rebellious and you know I can and will and who is going stop me? … Almost a 
bit defiant” (S04). 
 
However this individual soon reverted back to self-management processes that would 
support her goal of good physical health: 
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I’ve just given up this week so I am feeling very virtuous and it is kind of that 
sense of I suppose that smoking for me is a coping mechanism. It’s one of those 
things that I go to. Not healthily, I know that but old behaviour that dictates how I 
do feel about myself. I’m making some choices out of caring for myself rather 
than being rebellious. And I am sure it is part of this coming back out, actually 
being able to function for more than an hour at a time. (S04) 
 
The ability to foster their personal resilience and take control of their destiny was not 
developed in isolation, for some recognition and support from others was an important 
enabler: 
I’m a bit angry now and I’ve identified that I have become a bit crabby and angry 
and my boss has said that ‘I think you have spent so long being passive and 
accepting of everything that has been happening to you that now you’ve got your 
strength back you have become intolerant of things you don’t want to put up with’ 
making me a bit crabby. And I’ve got a lot of complaints about life at the moment! 
I don’t like being like that so I have some issues … I’m always having to 
apologise to people for being so grumpy. (S07) 
 
Another survivor identified:  
And also, he said to me “Ask lots of questions, ask lots of questions. You don’t 
have to be a bitch about it, ask lots of questions. Because as soon as you start 
asking lots of questions they’re going to give you more information, and they’ve 
realised you’re interested.”… he gave me this great pep talk, and it was really 
great. And he also gave me someone who is not your traditional Western 
medicine…. I think, it’s not that I don’t trust Western medicine but I just didn’t 
want to hand myself over and go “what did you think?” (S01) 
 
Seeking support. 
Survivors were adept at finding emotional support that suited their needs, they 
displayed self awareness of whom they chose to reveal their inner emotions too, often 
rationally protecting their family and therefore indirectly themselves: 
 
I could talk to them [breast care nurses] in a way about stuff that maybe my 
family couldn’t quite hear, because they might freak out a little bit. But I could 
just say life’s really crap, I’m feeling a bit suicidal, or whatever was going on, you 
know? (S01) 
 
Survivors protected themselves from the consequences of sharing their emotions, they 
were acutely aware of the impact of others and their need to create distance in order to 
reduce their own anxieties and emotional needs, one survivor chose to stay in the WA 
for treatment even though her family was on the east coast: 
But they’re very stressful, emotionally (my family). So it was kind of good to have 
the distance, even though physically it was something your family could do, 
emotionally it was easier … I didn’t need to protect them, this has been a big 
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exercise for me learning to put myself first, emotionally and part of my family 
issue is that emotionally it would have been all about other people first … So 
when I’m saying protect I’m really meaning that I disclosed or didn’t disclose 
things to protect myself, my emotions. (S01) 
 
Survivors often sought professional emotional support to enable self control of their 
emotional health, their relationships and their personal goals: 
 Ever since I got diagnosed I’ve been going to the breast cancer counsellor, and 
getting help quite regularly, it just helps me process and get through it …I don’t 
want to be pushing down anything, stuff that I haven’t resolved (S01);  
 
“I went to see a psychologist at the same time to kind of pre-empt that transition 
back into non-treatment” (S04); “I think it really helps to have someone else to 
listen to what you say and weigh it up a little bit and have some ideas to help” 
(S13). 
 
Self-protecting. 
Self-protecting proved to be another important empowerment strategy, once 
survivors had started to gather their resilience and take control of their destiny, there 
was a need to maintain a focus on a positive future even if there was a continual 
background fear for their future. Survivors were particularly focused on maintaining a 
positive outlook and approach in order to do this they avoided negative environments, 
situations and people as much as possible: 
Because I joined the cancer support group and that was good but it was also 
with people that were sort of the cancer has recurred the second, third and fourth 
time and I feel like I am in a really different place from them (S04).  
 
Survivors were aware of the impact of others emotions on themselves and could focus 
clearly on self protecting distancing strategies:  
There is a lady who is from down this way as well and she is a few months behind 
me and she was a little bit negative and she was struggling mentally coping with 
the diagnosis and that type of thing and talking about death and that sort of stuff 
and I found that a bit hard to handle. It brought me down talking to her. But I’d 
always try to be positive about it. (S05) 
 
Survivors were able to set boundaries around their information needs whilst managing 
their self-protection tactics: 
 
It really rattled my cage that flyer because I had been so motivated and I had been 
so positive about getting back and getting on top of things and feeling so great and 
I just felt that was a real crushing blow and I couldn’t let that go without saying 
something … So if I could continue to receive information that wasn’t anything to 
do with death and funerals I’d be happy to receive it. (S07) 
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Survivors used humour to hide their true feelings, either to protect family and friends: 
I’d get quite weepy but then I just laughed and told them not to take any notice, I 
do this a lot … there’s a need to protect the people that you love as well … the 
more together you are the more they can relax and let go and I just wanted them to 
relax a bit. (S07) 
Survivors also felt the need to appear in control, “you want to look like you’ve got 
things together” (S07); “I would crack jokes about it but I wasn’t that happy about 
things” (S08). Survivors were aware of their self image to others and engaged close 
acquaintances to help manage these connections:  
 Protect yourself from well wishers because you’ll have to say your story over and 
over again and you are tired and exhausted so you don’t want to have to repeat the 
same thing over and over again and upset them more because you sound so tired 
and weak they can hear it in your voice … Have someone to protect you. My mum 
stood between me and phone calls a bit, which was good. (S07) 
 
In order to maintain her positive energy one survivor described her avoidance of 
dwelling on the past: 
… I try not to look back on it either, why don't I look back? I don't look back 
because that’s past and I very rarely look back in the past anyway you know so I 
again it is a part of me and a part of the way I think so I guess it is forward always 
with me. (S11) 
 
Another participant avoided the present issues in both her actions and how she thought 
about herself:  
 
I haven’t even marked it on the calendar, I suppose a bit of an avoidance thing, I 
don’t dwell on it, I hedge around it all the time, I don’t let it get me down, I don’t 
think I’m a cancer patient, I never think that … but I suppose I am though. (S13) 
 
Distraction was also found to be a useful self-protection  strategy; by keeping busy so 
there wasn’t time to think about the particular areas of concern, “My thing would be to 
keep busy and you know I guess, don’t let it get you down and find something to do that 
you can do without thinking about it” (S08). 
 
Self-management strategies. 
Survivors’ personal beliefs were indicated as having a strong impact on how 
they developed strategies to manage the physical and psychological impacts of cancer 
and the chemotherapy treatment during this transition period. Physically survivors were 
able to monitor and modify their activity to support their recovery from fatigue and 
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their gradual physical improvement, by setting goals and targets and testing their 
abilities, their choices included who they wished to get support from and what help they 
wanted to aid recovery: 
Obviously not one hundred per cent, but relative to chemo I’m …waking up 
feeling reasonably awesome, and everything …I have a reasonable level of 
energy, I can walk a little bit faster. Like last week I was aware I went to the 
garbage bin, and I did it without feeling like I needed to collapse was great.  So 
it’s just really simple things, like, I’ve got more energy, I wouldn’t say I’ve even 
maybe seventy per cent. But relative to how crap I was in chemo it feels like a 
hundred and fifty per cent. (S01) 
 
Survivors were aware of different interactions in public, alongside the smallest 
physical improvements, “I really noticed that physically I was getting stronger. I started 
Pilates and making a commitment and now my hair has come back people don’t 
automatically look at you and assume”(S04); “if its physical I get quite stiff, but I’m 
getting stronger and stronger in terms of fitness” (S08).  
 
Survivors were adept at managing their lifestyle to their slowly improving fatigue 
levels; this appeared to be an intuitive approach rather than a strategically planned 
action, “You can’t force anything, if your body doesn’t want to do it, there is not much 
you can do” (S12). 
 
Survivors discussed how they slowly adapted but constantly reassessed their ability and 
progress: 
I used to potter a little bit … Then I’d sit down and have a rest and then get up and 
do something else and sit down and have a rest …When I go food shopping, my 
husband always used to, we always used to go together . . . But I am starting to go 
a little bit on my own now. (S05) 
 
Well I started … just trying to walk to the corner because I had lost all my muscle 
strength. I was all floppy. Then I started walking around the block slowly, holding 
on to somebody and then I got a treadmill and so when I started back at work I 
started getting on the treadmill and then I started to do 30 minutes on 6 kilometres 
per hour … I was full time and exercising 5 mornings as week, on the bike once a 
week. Now I do it on the weekends as well. I just found the contrast between bad 
and good and did it when I felt good. (S07) 
 
 
For other physical side effects of chemotherapy, some of which started during 
treatment and continued into the transition phase, survivors used a range of approaches, 
often dependent upon previous coping skills and strategies. Self-management of side 
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effects was demonstrated for many physical symptoms such as dealing with the problem 
of constipation, this survivor had a goal which they monitored, if they didn’t achieve 
this, then they used prior knowledge to rectify the situation:   
 If I don’t go to the toilet one day then I’ll take some prunes or have some oats 
or something the next day and if that doesn’t work then I’ll take the pill. I’ve 
never had to in my life before but when they say this can happen well I look 
after it so it doesn’t happen. (S06) 
 
Another survivor talked about how he self-managed insomnia, again he had a goal, 
monitoring and a solution in process to deal with this based on his own knowledge: 
 
I found the solution to my lack of sleep, the easiest way was listening to tapes if 
you watch TV or read a book you fall asleep then I’d wake up and I was worse. 
This way I fall asleep with the ear phones, they drop out and I don’t hear 
anything anymore. (S08) 
 
 
All of the above actions are based on previous knowledge and expectations, 
individuals have their own acceptable goals which they monitor and take action to 
rectify as needed. Survivors throughout the interviews described a range of areas where 
knowledge deficit hindered their ability to self-manage and cope with their physical and 
emotional recovery from chemotherapy and their transition onwards. This tended to be 
in domains that were previously unchartered by the patient, in other words they had no 
prior experience and knowledge on which to draw to rectify the situation. For example 
at the end of treatment one survivor said: 
 
I just felt like a malingerer, laying around, not doing anything and if someone had 
of said then “Most people take this long and you’ve had this happen and you are 
still doing really well. You don’t need to rush.” That sort of reassurance that I am 
doing normally or am I really sick or am I doing great? That would be good 
feedback. (S07)  
 
As the survivor above couldn’t reconcile prior knowledge and physical ability, she 
experienced a negative impact and perception of herself, she recognised that had she 
had the knowledge this would not have been the case. Whereas another  survivor (from 
the quote below) felt more positively because she had a ‘cause’ or knowledge of why 
they were encountering this experience. She was able to accept and self-manage the 
period of fatigue. It is therefore evident that knowledge helped survivors to find 
personally acceptable causes for negative experiences: 
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… just in part of my brain, from the conversation I’d had with people, there was 
just a seed that was planted that said, you might feel a bit down and know that it’s 
just the drugs … It’s just enough there to help me go, okay, to separate me and 
the process … It’s really, really important, because otherwise it’s like self-
identifying as always down or always feeling fatigue. And just going, now hang 
on, there’s a separation between who I am and what I’m capable of and the fact 
that I’m just going through this really debilitating, depressing phase (S01) 
 
Survivors indicated that hearing about the physical experiences of other survivors 
helped them to understand, the information or ‘lived experience’ of other survivors 
helped them to understand and fill in a prior knowledge gap: 
 
One of the things that I understand now from talking to other cancer survivors that 
I didn’t know is like body stiffness. Like getting pains in my hands in the middle 
of the night. It shifts around my body like in my hips which talking to other 
people post treatment they’ve all said “Oh yes. That’s normal”. (S04) 
 
And that might sound funny but if she’s gone through it and you hear someone 
else say that it makes you go, “oh, okay I’ve finished chemo but it’s going to take 
a while for my body to get over this”. (S01) 
 
Survivors who felt unable to self manage their experiences identified limitations in the 
new information they were given which limited their ability to prepare and instead 
encountered negative experiences and undue anxieties:  
 
Right from the word go I had been very annoyed that they give you an overview 
of what is going to happen … you read the documents on it and that gives you 
some of the side effects, had they have been clearer I would have been much 
more prepared … I know the effects are different for different people but if 
you’ve got that little bit of information you know what to expect … instead of 
thinking something has gone wrong. (S14) 
 
This survivor felt that the limited explanations compromised his ability to self-care, 
“They don’t explain the blood test very well … I had to ask for the blood test results … 
nobody told me whether this should or should not be a worry. If I had the blood count 
or the cell count then I would have responded properly” (S02). 
Survivors were able to identify areas of knowledge deficit that would benefit 
from information and enhance their ability to understand and self manage situations. 
Survivors wanted to understand the impact that chemotherapy had on their body 
particularly the long term impacts of the drugs in their system: 
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I would find it really useful to have some guidance around after chemo has done 
its job; I suppose I have this image of wanting to be able to clean my body out. 
And whether it does make any difference like a detox or a cleanse or that kind of 
thing. Maybe it’s psychological but it’s like I feel I have got residual chemicals in 
me that maybe are creating problems now. (S04) 
 
Survivors were aware of their limited knowledge in regards to both treatment planning 
and how little they understood from their actual treatment. They sensed the 
fragmentation of health information relating to their care. This enhanced their anxiety 
about future care and the need to gain knowledge and take control, “I just sort of went 
with the flow and half the time I didn’t even know what was going on” (S05); “They 
don’t explain … They look at the results and they don’t tell the patient very much … I 
need to know but the chemo guys don’t tell you anything” (S02). 
It’s hard because you get confused about everything and then the medical system 
and the doctors are using computers and whatever and the medical records and 
you go in there and you go to see the doctor/specialist and it is totally 
discontinuous and no one has got it … so it’s very hard I think for them to know 
your allergies and how you are with chemo. (S08) 
 
In the transition phase survivors expressed significant information gaps about 
plans for their future care and not knowing if the treatment had been beneficial, this 
prevented their ability to take control and self manage:  “I got a CAT scan, I did it a 
month ago … they haven’t told me what they are going to do yet” (S02). 
 
Survivors continued to feel lost and had information gaps relating to support they could 
access: “… the support stops and you are not sure where to go” (S03), “ in general 
feeling I’m a bit lost in terms of where to go from here” (S04). Knowledge was clearly 
an important commodity for survivors, with appropriate knowledge and their prior 
learnt behaviour survivors could take control by being assertive. If the survivor 
encounters an experience they have dealt with before they can draw on prior learning to 
forge a way through the issue no matter how arduous, even whilst still experiencing 
significant fatigue one survivor recounts how she managed to achieve antibiotic therapy 
at home: 
They sent me home with some antibiotics … and I had an allergic reaction to the 
oral antibiotics and they wanted me to get back in the car and go back up to Perth 
and I knew what the problem was so I chucked them (the antibiotics) in the bin 
and I said I am not going back up to Perth … I said it’s ridiculous, we’ve got 
trained staff here in Bunbury, I need a new script, I need a different antibiotic and 
so I rang up my doctor and I rang up the haematology centre and I made them talk 
to each other and I can get a blood test down here and I can get a doctor to 
prescribe an appropriate drug down here. I don’t need to travel 200km back to 
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Perth and neither of them were happy. My GP wasn’t too happy but the 
haematologist was quite co-operative in the end. (S07) 
 
And how she managed her planned follow up care: 
 In December I had to remind him (the doctor) about that (missed PET scan) and 
then by the time we had booked another one that was six months. The doctors plan 
was that I was to have Mabthera (a monoclonal antibody given IV after acute 
treatment for a period of several months) and that hadn’t been initiated either I had 
to tell the girls that I needed that at the next appointment as well. I felt like I was 
managing myself completely without even a written plan from the doctor and then 
I had to double check and ask “Can you double check that I have done the right 
thing?” In my March appointment I booked myself to have Mabthera. (S07) 
 
And how she clarified information about her treatment in order to manage future care 
episodes, realising that this may be important knowledge to have: 
I mean I didn’t know what drug I’d had, I don’t know if I’ve had the swine flu 
injection or not because I got treated as a swine flu patient at one point. I don’t 
know what went on; it was all a bit of a blur. I just had to cross my fingers and 
hope they know what they are doing. I really should have some idea of what I 
have had. And I had to ring up and find out what the drug was that was making 
me sick four weeks ago because I thought ‘I need to know what that antibiotic is 
that is making me sick. I’ve got no idea. (S07) 
 
One survivor attempted to control the process so that she did not have to endure the 
period of awaiting results, this sadly did not come to fruition, “I asked if it was possible 
to get results by email rather than wait six weeks for an appointment, that was arranged 
and teed up and I never got it. And I didn’t get onto it, I waited for the appointment, 
you know the resignation thing” (S07).  
Knowledge also enabled the survivors to set realistic expectations, a central 
action to all the survivors’ behaviour in coping throughout their journey whether it was 
immediately post treatment or in the transition phase as they started to recover from the 
impacts of chemotherapy was that of planning.  Whilst on chemotherapy planning 
appeared wishful: 
Initially I was quite excited to finish chemo and really sort of looking forward to 
that wishful thinking, you know all the things that you are going to do. So I 
suppose having had chemo I spent a lot of time thinking of the resolutions if you 
like of the things I was going to do. (S04) 
 
As survivors moved into the transition phase their planning became more hopeful and 
they started to set new goals which were solely focused on their physical abilities such 
as, actively thinking about employment:  
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So now I am kind of looking at what am I going to do for a living now? … At one 
level I would have loved to have gone ‘okay, I’ll pack myself off to uni’ or travel 
but at the moment I just want to work or see if some of this art therapy takes off. 
(S04)   
 
For others the desire was to return to normality, “It’s best to certainly struggle on 
and that’s it.  People say ah well, it’s all free go and live, run around see the 
world, for me it’s just go back and live the way you always did” (S08). For some 
having things to look forward to in the short term was important, “I had a holiday 
at my sisters for nine days” (S13). 
 
For those who had returned to work planning centered on maintaining normality and 
honoring work commitments: 
 
I’ve been very protective of my job and I haven’t wanted to take any time off that 
I don’t have to take off. CAT scans and doctors appointments I haven’t been able 
to avoid but other than that I’ve been very reluctant to take time off … I did offer 
to be the co-coordinator of an after hours support group which was never taken up 
from my local leukaemia foundation support service co-coordinator … I cant take 
three hours off in the middle of the day, there must be other people like me who 
are back at work and integrating back into their life who might want to meet in the 
evening. (S07) 
 
Finding work life balance was also important to survivors in the planning stage: 
 
So I’ve come to the conclusion that I’ll at least get some part time work doing 
something to pay the bills and then the opportunities for me to do what I think is 
really important in my community … and I’ve also got to look at my own stress 
and energy levels and find a balance. (S04) 
 
I can’t go back to fulltime work yet, I’m not up to that. But I’m wanting to go 
back two days, then three days, then maybe up to four days, I’ll see how I go. 
(S01) 
 
Survivors had obviously gone through the treatment and transition journey hoping that 
their cancer was cured; their initial plans would always centre on this premise even if 
the fear of recurrence was in the back of their mind. For those survivors who hadn’t 
achieved the desired outcome from this round of treatment, the planning needed to start 
again and information was said to be vital in helping to reset realistic expectations: 
 
When the cancer came back the second time I found it more difficult to deal with 
than the first time. Because you think that with the first one because you beat it 
you aren’t going to get it again. So when it comes back I think that it creates more 
anxiety for people. (S03) 
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I didn’t get remission out of my treatment. I found that out in March …  So I’m 
feeling a little bit tired and emotionally I feel I need to spend more time thinking 
about things. And I just feel a bit rushed working full time and I want to 
contemplate my navel a little bit. So I’m feeling a little bit crabby now … it would 
be good if somebody had followed up that by saying if the result wasn’t good then 
where to now instead of waiting three months for the next scan to see if it has 
grown. (S07) 
 
Or in the longer term: 
 
It’s given me a new lease in life, I want to train to be an enrolled nurse, I want to 
go travelling and I want to go to India and see the leprosy mission and see how 
they work with lepers, I want to go into nursing or OT (Occupational Therapist), 
It’s always something I wanted to do. (S13) 
 
Self-informing. 
Where knowledge wasn’t easily available survivors were incredibly adept at self 
informing. A range of skills throughout the interviews were displayed, survivors were 
acutely aware when they did not receive enough or timely information, analysis of the 
interviews displayed a range of information gathering strategies including non-
government organisations such as breast cancer foundation (S01) and Cancer Council 
(S03) to other health care professionals not directly related to the chemotherapy 
experience i.e.  chiropractor (S01), liver surgeon (S02). One survivor actively avoided 
written information believing that it planted ideas, she chose to gain her information by 
observing friends and family who had also been treated with chemotherapy: 
I’m not a great one for reading all that sort of stuff. I’m more inclined to … You 
know how we just discussed how many people were sick, I think if you know that 
more than half of the people that go in and have chemo are crook with the 
medication. To me that would make you think that you are expecting it so you 
would be down anyway so that may help that happen … my husband had bowel 
cancer. He didn’t get sick with any of his chemo’s. I’ve got another friend and 
he’s got a multiple myeloma and he hasn’t had any sickness with the actual 
treatment but he has had added side effects of other cancers come up so they don’t 
know which is his first and which is his second so he is a different thing all 
together but he is bright and happy as well and looking forward to the rest of his 
life. I’ve never personally met anybody that I know that has let it get them down. 
So how it affects certain sections of the community I don’t know. (S06) 
 
Whilst others actively sought information and validation of the information they 
received: 
I have always supplemented the information I got from the hospital from people 
who’ve gone through chemo and friends who have, who’ve done it … I’ve just 
62 
supplemented the information that I was given, and I’ve read through the booklets 
and all that stuff so that helps me, to get a realistic idea that as soon as chemo 
finished I’m not going to feel well. Like my friend was saying no, it was six or 
twelve months afterwards she was starting to feel back to herself, you know … if 
she’s gone through it and you hear someone else say that it makes you go, “oh, 
okay I’ve finished chemo but it’s going to take a while for my body to get over 
this. (S01) 
 
Another survivor discussed the challenge in receiving, retaining and the timing of 
information: 
 
I realise people can try and give you all the information but there are questions 
you cant ask because you don’t know and I would be much wiser knowing what I 
am asking or what the journey was going to be next time … I don’t remember her 
telling me that information but it was probably that when she told me it wasn’t 
relevant and I just flipped it out of my mind. (S10) 
 
The gathering of information and planning for follow up appointments with the doctors 
helped survivors to take control and gain the information that they needed to plan for 
their future: 
 
Just information gathering that helped me, independent information gathering has 
helped me to have that ability to go “hang on, hang on”. Making lots of lists 
before I went in to the doctors and taking that with me … the night before 
appointments I would review the literature again …I would ask myself the 
question …what do I want out of tomorrow’s appointment? … it is a very good 
question because it’s taking back charge as well and not being passive. (S01) 
 
 
In summary, during the transition phase, analysis of the interviews has 
demonstrated the personal resolve the survivors drew from to begin to take control. This 
included resilience and empowerment through self-awareness, self-protection and self-
management, all based upon their own individual beliefs, values and attitudes which 
one survivor summed up as “ I dare to hope” (S11). In order to self-manage survivors 
needed new knowledge and life experience (acquired knowledge) to apply to the range 
of challenges that they may encounter during this transition period. Knowledge enabled 
the survivor to take control, set realistic expectations and find further information they 
required. Obviously to self manage one needed the ability to be self-aware, which was 
required for self-protection an important skill used by all the survivors in various forms. 
Self informing provided the necessary information to support self management. 
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Summary of Chapter Four 
In conclusion, completing chemotherapy treatment for the survivors’ 
encompassed experiences of loss of belonging and disconnect, loss of identity, loss of 
the treatment community including ready access to support and finally a fear for their 
future knowing that treatment offers no guarantees. The completion of chemotherapy 
treatment was an emotionally tumultuous time; survivors expressed a myriad of mostly 
negative emotions including fears, isolation, low moods and unpredictable emotional 
behaviour. This was clearly a very difficult all encompassing experience to navigate 
through. From the descriptions provided by survivors it is clear that in the weeks 
immediately post chemotherapy treatment, the survivors are clearly physically unwell 
and whilst they still have connections with the treatment community they are not well 
enough to begin their transition onwards. 
Analysis of the interviews relating to the transition phase has demonstrated that 
personal resilience, knowledge and the ability to plan are all vital coping components 
for survivors during this part of their journey. Personal resilience detailed the personal 
resolve the survivors drew from to begin to take control. This included emotional 
resilience, empowerment, maintenance of a positive outlook through self-protection and 
a range of self-management strategies all based upon their own individual beliefs and 
values. 
The information gaps identified by survivors related to understanding the 
physical changes, treatment side effects, and future plans. Survivors found themselves 
completing treatment and intending to move forwards without all the necessary detail to 
make informed decisions or begin to achieve an appropriate plan, whether that be back 
to work, back to social engagements or onto the next step in their treatment plan. 
Following the qualitative analysis the literature was reviewed and gaps were 
identified in terms of information needs that survivors had identified. These will be 
discussed in greater detail in the Chapter Five. 
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Chapter Five  
Phase Two: Instrument Development and Testing 
 
Introduction and Background 
This chapter describes the quantitative methodology used in Phase Two of this 
study; it illustrates the processes employed to collect and analyse the data and also the 
ethical considerations that occurred before and during the study.  The process followed 
to modify an existing tool in this research was deliberately similar to the process 
followed when developing a new tool. Following Phase One of this study in which key 
qualitative findings were established, a comprehensive literature review was undertaken 
to identify whether a suitable tool existed for use with this population. It became evident 
that no valid and reliable instrument was currently available to assess the transition 
needs of cancer survivors on the completion of chemotherapy treatment. However, an 
instrument titled Quality of Life- Cancer Survivor (QOL-CS) was identified that was 
designed to explore longer-term survivorship (Ferrell, Dow et al., 1995) in cancer 
patients. The findings from the qualitative phase were used to adapt this existing cancer 
survivorship instrument with the permission of the original authors Ferrell, Dow et al. 
(1995) (Appendix G). The instrument was modified to allow the exploration of 
survivorship issues that occur during the first three months following the completion of 
chemotherapy as identified in this study. The revised questionnaire was then tested for 
clarity, content validity and apparent internal consistency with an expert panel of senior 
oncology nurses from a large tertiary cancer service in Western Australia.  
Ferrell, Dow et al., (1995)  developed and tested a quality of life instrument for 
long term cancer survivors that was based on the City of Hope quality of life model. 
The purpose of this instrument was to measure the specific concerns of this group of 
survivors. The instrument has been widely used in cancer care and adapted for several 
different cancer populations across a range of ages, tumour types and languages, for 
example: Hispanic patients with cancer (Juraz, et al., 1998), breast cancer survivors 
(Ferrell, et al., 1996), and ovarian cancer survivors (Ferrell, et al., 2003).  
The Quality of Life-Cancer Survivor (QOL-CS) tool contains numerous items 
that were consistent with the key descriptors identified from the interviews conducted in 
this study. Given the universal acceptance and use of this tool, as well as the relevance 
of many of the items to the population of interest in this study, the researcher opted to 
make a minor adaptation to this instrument by adding seven additional items designed to 
capture the full scope of key descriptors (needs) identified from the qualitative phase of 
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this study. This adapted version of The QOL-CS was titled the QOL-CCS (Quality of 
Life- Chemotherapy Cancer Survivor). Following refinement of this new instrument, 
preliminary validity testing was undertaken to determine clarity, content validity and 
apparent internal consistency. This preliminary testing was conducted using six 
experienced oncology nurses from a major cancer treatment centre in Western Australia.  
The QOL-CS tool initially described by Ferrell, Dow et al., (1995), recognised 
that most quality of life tools focused on measuring acute cancer and treatment side 
effects rather than a longer term view of cancer survivorship which results in a diverse 
and different range of side effects. Not surprisingly, the origin of quality of life 
assessment in the cancer population was initially linked to clinical trials (Gill & 
Feinstein, 1994). At this stage most tools used measures that had been determined by 
the clinicians based on their clinical experiences, rather than the experiences and 
perceptions of patient themselves. The QOL-CS tool was revised over a one year period 
following a series of interviews and focus groups with cancer survivors and for the first 
time, explored the construct of positive adjustment, following the City of Hope 
researchers recognition that most of the tools focused on the downside of having cancer.  
Given the identified gap in the cancer literature related to the immediate 
transition needs of patients who complete chemotherapy, and the lack of a valid tool 
that could be used to plan individualised follow-up care, the need for a more 
contemporary survivorship instrument was identified by the researcher. It was 
considered appropriate that in order to ensure suitability of the new tool for 
chemotherapy transition survivorship, and in keeping with Ferrell’s (1995) approach to 
item generation, new items generated for inclusion the revised QOL-CCS should be 
shaped by patients’ own perceptions rather than those of health professionals. 
Therefore, the themes identified in the findings of the qualitative interviews were the 
source of the additional items for this revised tool. 
The World Health Organisation (1997) defined quality of life as “an individual’s 
perception of their position in life in the context of culture and value system in which 
they live and in relation to their goals, standards and concerns” (p. 1). Within the field 
of healthcare, quality of life is often regarded in terms of how it is negatively affected. It 
is well recognised that the meaning of health and life itself can be altered following a 
diagnosis of cancer, cancer survivors have reported struggles to achieve a balance in 
their lives and a sense of wholeness and life purpose after a life altering experience 
(Ferrell, 2004; Vachon, 2001). 
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Quality of life measures are now commonly used and reported in the literature 
and this widely used measure determines how individuals assess their own general well 
being. However, there is a lack of consensus on a health related quality of life 
definition. Ganz (2000) labelled the health effects of cancer and its treatments on 
perceived quality of life as “the price of survival”. (p. 324). Quality of life is generally 
accepted as a multidimensional construct for which many definitions exist. Ferrell’s 
body of work was focused on describing quality of life in cancer patients with early 
work leading to development of a model of quality of life (Ferrell, Grant, & Padilla, 
1991;  Ferrell, Wisdom, & Wenzl, 1989). This model was based on the following four 
domains of quality of life for cancer patients: physical well being; psychological well-
being; spiritual well-being; and social well being. The QOL-CS (Ferrell, Dow, et al., 
1995) was based on these core domains and specifically adapted for longer-term cancer 
survivors. 
The QOL-CS instrument is considered simple and practical for use with it’s 
intended population of long term cancer survivors. It comprises 41 items representing 
the four domains of quality of life incorporating physical, psychological, social, and 
spiritual well being as the previously described. Psychometric testing was performed on 
a population of 686 respondents, and included measures of reliability and validity. 
Ferrell et al. (1995) reported two measures of reliability. The range of test-retest 
reliability scores were: physical (r = 0.88), psychological (r = 0.88), social (r = 0.81), 
and spiritual (r = 0.90), with an overall score of r=0.89. High internal consistency 
estimates were reported; Cronbach’s alpha subscale alphas ranged from r=0.93 overall; 
and r = 0.71 for spiritual well being, r = 0.77 for physical, r = 0.81 for social, and r = 
0.89 for psychological subscales/domains (Ferrell, Hassey Dow, et al., 1995). Content 
validity was established by a panel of quality of life researchers and nurses with 
expertise in oncology, stepwise multiple regression was used to determine factors most 
predictive of overall quality of life in cancer survivors. Seventeen variables were found 
to be statistically significant accounting for 91% of the variance in overall quality of 
life. Pearson's correlations were used to estimate relationships between the subscales of 
QOL-CS and the subscales of the established FACT-G tool. The FACT-G tool is used 
the functional status of patients with specific cancer diagnosis. There was moderate to 
strong correlation between associated subscales including QOL-CS physical to FACT 
physical (r = 0.74), QOL-CS Psych to FACT Emotional (r = 0.65), quality of life Social 
to FACT Social (r = 0.44). Further measures of validity were used including 
correlations of individual items of the QOL-CS tool, factor analysis, and construct 
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validity discriminating known groups of cancer survivors. Findings showed the QOL-
CS and its subscales adequately measured quality of life in the population of cancer 
survivors (Ferrell, Hassey Dow, et al., 1995) 
Findings from the previous qualitative interviews undertaken with 14 cancer 
survivors who were in the transition phase following completion of chemotherapy were 
used to inform the generation of new items in the QOL-CCS (Quality of Life- 
Chemotherapy Cancer Survivor) tool developed in this study. As previously stated, this 
48-item tool is a modified version of the 41-item QOL-CS. Table 2 demonstrates how 
the new questions generated linked specifically to themes identified in the analysis 
discussed in Chapter Four. Appendix E provides an overview of the development from 
initial codes to a major theme  The other themes identified were considered to be 
covered by the original QOL-CS tool questions either directly or indirectly. 
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Table 2 
Links between new questions and identified themes 
 
New questions added  Related themes identified in qualitative 
analysis 
 
q. 45 Did you receive enough information 
about physical changes at the end of 
chemotherapy treatment? 
 
 
Physical 
 
q. 46 Do you understand everything that 
happened during treatment? 
 
 
Self management 
 
q. 47 Do you understand your plan of 
care from now on, including timeframes? 
 
 
Loss of identity 
Loss of community 
Isolation 
Self management 
 
 
q. 48 Have you tried to find information 
from other places? 
 
 
Self management 
Self informing 
Self awareness 
 
 
q. 49 Were you provided with any written 
information about life after 
chemotherapy? 
 
 
Self informing 
 
q. 50 If you were provided with 
information, was it useful? 
 
 
Self informing 
 
q. 51 Have you been able to make any 
plans for your future? 
 
 
Self management 
 
 
Instrument Testing: Clarity, Content Validity and Apparent Internal Consistency  
Given the time constraints of this Master’s study, only preliminary psychometric 
assessment of the QOL-CCS was possible. This was undertaken between August and 
September 2011 at a large tertiary cancer centre in Western Australia. This centre cares 
for approximately 2000 cancer patients. The testing process used the method described 
by (Imle & Atwood, 1988) for assessing the validity and apparent internal consistency 
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of inductively generated domains. Apparent internal consistency is used to describe the 
non-quantitative assessment of homogeneity of content (Imle & Atwood, 1988). Three 
questions were addressed: 
1. To what extent are the items in the QOL-CCS clear? 
2. To what extent do the domains in the QOL-CCS confirm internal consistency? 
3. To what extent do the domains in the QOL-CCS confirm content validity? 
 
Target Population, Sample Size and Recruitment 
In keeping with Aamodt’s (1983) recommendations, raters should be drawn 
from the context within which the original data were generated. Six senior nurses with 
significant experience in chemotherapy delivery were recruited from the cancer division 
to form an expert panel. Each panel member met the following eligibility criteria: 
• working as a senior cancer nurse in either a specialist or managerial role 
• five years of experience with cancer patients who are receiving chemotherapy 
• experience in caring for patients post chemotherapy in a variety of settings 
These nurses all had many years experience of working with cancer patients, and 
use of this expert panel was in keeping with item generation for the original Ferrell’s 
QOL-CS instrument first tested in 1995. This sample size was based on Lynn’s (1986) 
method for determining the number of panel members needed to determine content 
validity. This estimate is obtained by calculating the proportion of the number of panel 
members who might agree out of the total number planned for use, and then setting the 
standard error of the proportion to identify the cut-off for chance versus real agreement. 
Using this formula, a minimum of five panel members is required to provide a sufficient 
level of control for chance agreement. The six expert nurses were asked to complete 
three tools determining the following domains of clarity, internal consistency and 
content validity (Appendix H). Prior to the testing process, panel members were 
informed there were seven new items in the instrument which were based on the 
information needs identified from the interviews.  With six selected panel members, a 
minimum of five of whom should agree to attain a percentage agreement of at least 
83%. Agreement of 83% (i.e. five of six experts rating each item acceptable) was pre-
set as the minimum. This criterion is based on calculating the proportion of experts who 
might agree, out of the total number planned for use, and then setting the standard error 
of the proportion to identify cut-off for chance versus real agreement. According to 
Lynn (1986), this computation allows the researcher to establish a necessary level of 
percentage agreement at a 0.05 level of significance. For this phase of the study, nine 
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eligible nurses were invited to participate by letter (Appendix I). Six nurses returned the 
completed forms within the required timeline. Consent was therefore implied by return 
rather than in writing.  
 
Data Analysis 
Clarity rating. 
Participants were asked to indicate whether the language used in the 
questionnaire was appropriate and whether items in the instrument were: a) clearly 
worded, b) belonged together, c) were relevant and d) were complete. Item clarity is 
desired to convey a single message or portion of the inductively generated concept 
(Imle & Atwood, 1988). Once it was established that survey instructions were clear, 
participants were asked to score each of the 48 items as clear or unclear. Space was 
provided for comments and opportunities to discuss the comments were provided. 
Information ascertained in relation to clarity was incorporated in the new instrument 
(Figure 4). To aid the reader, Ferrell’s original QOL-CS is included in Appendix J 
There was 100% agreement amongst the participants that the instructions on 
clarity rating were clear. The participants rated 46 of the 48 items at 83% or 100% 
agreement. Item 20 “time since chemotherapy was completed” was rated as being clear 
by only one participant.  The five participants who rated this item as unclear all 
commented they did not understand the meaning or intention of this item. After 
consideration by the researcher, it was realised the QOL-CCS related solely to patients’ 
experiences since completion of chemotherapy, hence the item was considered 
redundant and so the original statement was reinserted. Item 21 “how much anxiety do 
you have?” achieved agreement of 67% (i.e.  four out of six participants). Comments 
regarding this question included the potential for patients to confuse anxiety with 
depression, depression was also considered to be a clinical term, the term “distress” is 
considered to be a  less stigmatising term which reflects the mix of unpleasant emotions 
that cancer patients experience. This has been extensively validated in work undertaken 
in the development of the distress thermometer (Holland & Reznik, 2005). Item 21 was 
changed to reflect the term distress. Advocates of screening of cancer patients for 
emotional distress consider that a systematic approach will promote equitable access to 
psychological services rather than depending on clinician or patient initiated referrals 
(Vodermaier, Linden, & Siu, 2009). The QOL-CCS tool has been developed as a part of 
a research approach to learn more about a specific population at a specific time rather 
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than for ongoing screening, therefore a more significant integration of distress screening 
tools has not been considered appropriate in the revision of the instrument. 
 
Apparent internal consistency. 
Measurement of apparent internal consistency questions the homogeneity of the 
content. There was 100% agreement that all 41 items belonged together and belonged 
within the questionnaire. Despite this unanimous agreement for all items, item 20 was 
reinstated to the original format as discussed above. 
 
Content validity. 
Content validity assessment involved the evaluation of the extent to which items 
in the QOL-CCS “fitted” the conceptual domain of interest, in this case, transition from 
chemotherapy (Nunnally & Bernstein, 1994). Not only is it important to assess the 
adequacy of items in order to understand the meaning of the conceptual domain, it is 
also necessary to also determine whether any redundancy exists among scale items 
(Imle & Atwood, 1988).  Assessment for content validity required the participants to 
confirm their agreement with the label and definition of the instrument. Agreement of 
100% was achieved.  Following this, each participant read each item and was asked to 
score “yes”or “no” in response to whether the item `fitted’ the QOL-CCS label and 
definition. There was 100% agreement for 44 of the 45 items. Item 20 (as previously 
discussed) achieved a rating of 83%, as did item 30 “is your sexuality impacted by your 
illness”. Items 21 and 22 related to anxiety and depression achieved 67% agreement, 
two out of the six raters questioned the position of the item within the QOL-CCS rather 
than the items themselves. As discussed in the clarity rating section, questions 21 and 
22 have been changed following the expert panels comments to reflect language more 
commonly acceptable to the Australian population. 
All three rating tools provided opportunity for comments. These included the 
suggestion for additional individual questions in the physical domain about diarrhoea 
and vomiting, as some patients will experience one symptom without the other. It was 
also recommended that menstrual changes and fertility should be separated and written 
as individual items, these suggestions have all been adopted in the revised instrument 
(Figure 4). There was a query as to whether people would understand the word 
“fatigue”; this was replaced with “fatigue (tiredness)”. It is the opinion of the researcher 
that changes in language and chemotherapy agents in the past 15 years since the 
instruments were developed may account for the suggested changes. The new domain of 
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items related to “information needs” generated from interview findings from this study 
were rated consistently at 100% across all three psychometric assessments, in addition, 
no comments were provided by raters to change these items. The QOL-CCS tool with 
amendments based on the above analysis is displayed below in Figure 4 with the 
changes highlighted in Blue for ease of recognition. 
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Quality of Life Chemotherapy Cancer Survivor Version 
 
 
Directions: we are interested in knowing how your experience of completing 
chemotherapy affects your quality of life. Please answer all of the following questions 
based on your life at this time. 
 
 
Please circle the number from 0-10 that best describes your experiences: 
 
Physical Well Being 
 
To what extent are the following a problem for you: 
 
1. Fatigue (Tiredness) 
 
no problem 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
severe 
problem 
 
2. Appetite changes 
 
no problem 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
severe 
problem 
 
3. Aches or pain 
 
no problem 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
severe 
problem 
 
4. Sleep Changes 
 
no problem 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
severe 
problem 
 
5. Constipation 
 
no problem 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
severe 
problem 
 
6. Diarrohea 
 
no problem 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
severe 
problem 
 
7. Nausea 
 
no problem 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
severe 
problem 
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8. Vomiting 
 
no problem 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
severe 
problem 
 
9. Menstrual Changes 
 
no problem 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
severe 
problem 
 
10. Fertility 
 
no problem 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
severe 
problem 
 
11. Rate your overall physical health 
 
no problem 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
severe 
problem 
 
 
Psychological Well Being Items 
 
 
12. How difficult is it for you to cope today as a result of your disease and treatment? 
 
not at all 
difficult 
 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
very difficult 
 
13. How good is your quality of life? 
 
extremely 
poor 
 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
excellent 
 
14. How much happiness do you feel? 
 
none at all 
 
 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
a great deal 
 
15. Do you feel like you are in control of things in your life? 
 
not at all 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
completely 
 
16. How satisfying is your life? 
 
not at all 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
completely 
 
17. How is your present ability to concentrate or to remember things? 
 
extremely 
poor 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
excellent 
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18. How useful do you feel? 
 
not at all 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
Extremely 
 
19. Has your illness or treatment caused changes in your appearance? 
 
not at all 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
extremely 
 
20. Has your illness or treatment caused changes in your self concept (the way you see yourself) ? 
 
not at all 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
extremely 
 
 
 
 
How distressing were the following aspects of your illness and treatment? 
 
21. Initial diagnosis 
 
not at all 
distressing 
 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
very 
distressing 
 
22. Cancer treatments (i.e. Chemotherapy, radiation or surgery) 
 
not at all 
distressing 
 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
very 
distressing  
 
23. Time since my treatment was completed 
 
not at all 
distressing 
 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
very 
distressing 
 
24. How much anxiety do you have? 
 
not at all 
 
 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
a great deal  
 
25. How much emotional distress do you have? 
 
not at all 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
a great deal  
 
To what extent are you fearful of: 
 
26. Future diagnostic tests 
 
no fear 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
extreme fear 
 
27. A second cancer 
 
no fear 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
extreme fear 
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28. Recurrence of your cancer 
 
no fear 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
extreme fear 
 
29. Spreading (metastasis) of your cancer 
 
no fear 
 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
extreme fear 
 
 
Social Concerns 
 
30. How distressing has the illness been for your family? 
 
not at all 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
a great deal 
 
31. Is the amount of support you receive from others sufficient to meet your needs? 
 
not at all 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
a great deal 
 
32. Is your continuing health interfering with your personal relationships? 
 
not at all 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
a great deal 
 
33. Is your sexuality impacted by your illness? 
 
not at all 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
a great deal 
 
34. To what degree has your illness and treatment interfered with your employment? 
 
no problem 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
severe 
problem 
 
35. To what degree has your illness and treatment interfered with your activities at home? 
 
no problem 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
severe 
problem 
 
36. How much isolation do you feel is caused by your illness or treatment? 
 
none 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
a great deal 
 
37. How much financial burden have you incurred as a result of your illness and treatment? 
 
none 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
a great deal 
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Spiritual Well Being 
 
38. How important to you is your participation in religious activities such as praying, going to 
church? 
 
not at all 
important 
 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
very 
important 
39. How important to you are other spiritual activities such as meditation? 
 
not at all 
important 
 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
very 
important 
 
40. How much has your spiritual life changed as a result of cancer diagnosis? 
 
less 
important 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
more 
important 
 
41. How much uncertainty do you feel about your future? 
 
not at all 
uncertain 
 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
very uncertain 
 
42. To what extent has your illness made positive changes in your life? 
 
not at all 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
a great deal 
 
43. Do you sense a purpose/ mission for your life or a reason for being alive? 
 
none at all 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
a great deal 
 
44. How hopeful do you feel? 
 
not at all 
hopeful 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
a great deal 
 
 
 
Information needs at the end of Chemotherapy treatment. 
 
45. Did you receive enough information about physical changes at the end of chemotherapy 
treatment? 
 
not at all  
 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
a great deal 
 
46. Do you understand everything that happened to you during treatment? 
 
not at all 
 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
a great deal 
 
47. Do you understand your plan of care from now on, including timeframes? 
 
not at all 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
a great deal 
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48. Have you tried to find information from other places? (i.e. cancer council, internet, friends) 
 
not at all  
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
a great deal 
 
49. Were you provided with any written information about life after chemotherapy? 
 
not at all 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
a great deal 
 
50. If you were provided with information, was it useful? 
 
not at all  
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
extremely 
 
51. Have you been able to make any plans for your future? 
 
not  at all 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
a great deal 
 
 
Figure 4.  Quality of Life – Chemotherapy Cancer Survivor Tool (changes to the 
original tool have been highlighted in blue). 
 
 
Summary 
Only preliminary assessment of clarity, content validity and apparent internal 
consistency was possible in this study due to the scope of the Master’s study. The 
researcher plans to conduct a comprehensive psychometric assessment of the QOL-CCS 
following completion of this Masters thesis. This will include three further measures of 
validity: stepwise multiple regression to determine factors most predictive of overall 
quality of life in chemotherapy treatment; Pearson's correlations to estimate 
relationships between the subscales of QOL-CCS and the subscales of an established 
tool such as the FACT-G. Further measures of validity will be undertaken including: 
correlations of individual items of the QOL-CCS tool, factor analysis, and construct 
validity discriminating known groups of cancer survivors. Once the QOL-CCS has been 
validated it is anticipated the QOL-CCS will be used by clinicians to measure quality of 
life in a large cohort of survivors who have completed chemotherapy within a three-
month period to determine the needs as they transition to life immediately following 
chemotherapy. This information will be utilised to plan approaches to assist in the 
transition period for chemotherapy survivors. 
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Chapter Six 
Discussion and Conclusions 
 
Introduction   
This chapter will present and discuss the major findings of this two-phase study 
in association with current knowledge about methodological, theoretical and clinical 
domains in cancer survivorship. Following this discussion, the strengths and limitations 
of the study will be explored. This final chapter will then present both the conclusions 
of the study and the recommendations for future research, education, and clinical 
practice. 
The purpose of Phase One was to identify, explore and describe the experience 
of cancer survivorship transition from chemotherapy patient to life after cancer 
treatment as a cancer survivor. During this process, factors which improved or 
exacerbated this transition were identified for consideration. Following this, the main 
themes identified in Phase One were utilised during Phase Two to modify an existing 
Quality of Life – Cancer Survivors tool (Ferrell et al., 1995) in order to later explore 
quantitatively the experiences of a larger number of patients. For the purposes of this 
study an expert panel reviewed the modified tool to ensure that it was clear, confirmed 
internal consistency and confirmed content validity.   The experiences of people with 
cancer as they transition from the completion of chemotherapy to life after cancer is an 
under researched area, the findings of this study will therefore contribute to the 
understanding of this part of the cancer continuum from both an Australian and a time 
perspective. The study findings represent the experiences of 14 cancer survivors from a 
tertiary cancer centre in Western Australia. 
This study was initiated following the researcher’s search for information about 
this subject whilst preparing patient information plans in the clinical environment; the 
lack of available information and research findings were the impetus for this study. 
Findings from this study will add to the current knowledge deficit and provide a 
platform for a myriad of future research and clinical information developments.  
This chapter is organised into two sections. Part one presents a discussion of the 
key findings in relation to the following themes identified in Phase One: the experience 
of loss; the experience of changing emotions; the experience of resilience and the 
experiences relating to empowerment. Part two presents a discussion in relation to 
Phase Two of this study which includes the adaptation and testing of the existing 
Quality of Life– Cancer Survivors tool based on the findings from Phase One. 
80 
Following this, strengths and limitations of the study will be considered, prior to the 
conclusions and recommendations that have been drawn from this research study. 
 
Part one: qualitative phase (interviews) 
 Experiences on completion of chemotherapy 
The experience of loss 
The findings of this study indicated that participants were experiencing a range 
of losses including the: loss of the treatment experience; loss of identity; loss of 
treatment community and loss of the perceived planned future. The experience of loss in 
relation to cancer is not a new concept. There is detailed literature about loss when an 
individual is diagnosed with cancer and throughout the subsequent continuum 
including: loss of disease monitoring and loss of an action plan against cancer (Allen, et 
al., 2009; Shaha, Cox, Belcher, & Cohen, 2011); loss of a safety net and loss of contact 
and support with other cancer patients (Allen, et al., 2009; Doyle, 2008; Jefford, et al., 
2008; Jefford, et al., 2011; Shaha, et al., 2011). There is also detailed discussion in the 
literature relating to the physical, psychosocial and spiritual losses that cancer 
survivors’ experience. This literature  acknowledges that facing a cancer diagnosis and 
the stress associated with medical choices and treatment side effects is a traumatic event 
for any individual to face (Alfano & Rowland, 2006; Allen, et al., 2009; Costanzo et al., 
2007; Doyle, 2008; Pinquart, Silbereisen, & Frohlich, 2009; Shaha, et al., 2011). 
Participants in this study found the time immediately following completion of 
chemotherapy, to be a time of change. During this time they moved from the structure 
and culture of being a chemotherapy patient in a community that supported and shared 
their experience, to an individual who was still dealing with the burden of treatment side 
effects without the supports they valued. The loss of identity from the status as a patient 
was a concept they clearly struggled with, alongside the awareness they had changed in 
the process of the cancer care to date. One survivor described the feeling of not 
belonging and not understanding her position in society now that she is no longer 
receiving treatment. This sentiment is certainly reflected in the literature with 
descriptors such as “warriors without a war” (Morgan, 2009). Despite the planned 
nature of chemotherapy, all participants expressed their shock at the abruptness of 
treatment ending, this was coupled with the vulnerability of not having ready access to 
health care professionals and fellow patients for support and information. The final and 
largest loss in terms of impact on the participants was the loss of their perceived 
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planned future and the vulnerability this brought with the lack of ability to plan for the 
future in case treatment had not been successful. 
A small number of research studies that capture some of the domains of the 
current study have been identified in the literature. A quantitative study from the USA 
which addressed breast cancer survivors’ adjustment to life after treatment by Costanzo, 
et al. (2007) identified that of the 89 participants in this study, 71.6% had received 
chemotherapy as a part of their cancer treatment. The survivors were surveyed during 
treatment, three weeks following the end of treatment and three months post treatment. 
Costanzo’s (2007) study identified that fear of recurrence and side effects or physical 
problems were the greatest sources of stress at three weeks and three months post 
treatment. The sources of post treatment stress all reduced between the three-week and 
three month survey milestones (Costanzo, et al., 2007). Research identified that women 
who had received chemotherapy reported more worry about recurrence and cancer 
related intrusion than women who had received radiation therapy. This was attributed to 
the longer length of treatment and the severity of side effects experienced. Overall the 
post treatment period was identified as a distressing time when women not only dealt 
with physical side effects of treatment, including fatigue and lymphoedma, but also the 
distress of the unanticipated longevity of these treatment effects (Costanzo, et al., 2007). 
It was suggested the psychological struggle may be come to the fore, when survivors no 
longer had the treatment routines to distract from reflecting on the impact of a cancer 
diagnosis (Costanzo, et al., 2007; Karahalios, et al., 2007). 
Another USA study of breast cancer patients as they transitioned from patient to 
survivor was undertaken  (Allen, et al., 2009). This qualitative study used focus groups 
to capture the experiences of 47 women in this transition phase; the cohort’s average 
time from completion of treatment was four months with the range between 1-14 
months. It was not evident how many participants had received chemotherapy as a 
treatment. Overall the descriptors used to describe the findings of this study were 
congruent with the psychological experiences expressed by participants in the current 
study. The element that was not discussed in Allen et al’s (2009) findings was that of 
physical impact, or the management of post treatment symptoms. Further, there was no 
discussion relating to fatigue or it’s impact on psychological adaption, which was a key 
factor for participants in the current study.   
An Australian study addressing survivorship issues following completion of 
treatment also used the focus group approach with 22 participants. Of these six had 
completed treatment within the previous year although the type of treatment received by 
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participants was not stated (Jefford, et al., 2008). Findings from this study were 
congruent with findings from the current study. Of the 12 key themes identified in that 
study the only disparity noted was in the descriptors relating to positive experiences of 
having a cancer diagnosis, which perhaps is attributable to the length of time in 
survivorship. The findings in relation to information needs were consistent with the 
findings in the current research, survivors wanted to know: What were signs that their 
cancer was returning? What they should do now treatment was over? How to improve 
their health and reduce their risk of a cancer recurrence? Who to contact for practical 
advice and support including resources?  Finally if how they felt was normal? The 
Jefford team [Peter Mac Cancer Centre, Melbourne]  has continued to build on these 
initial findings, testing new interventions such as written information (Jefford, et al., 
2007) and nurse-led packages (Jefford, et al., 2011). 
Lethborg, Kissane, Ivon Burns & Snyder (2000) interviewed eight women with 
early stage breast cancer who had completed adjuvant chemotherapy two to four weeks 
previously at a cancer centre in Victoria, Australia. The intention of the study was to 
identify issues, which arise as medical support becomes less intensive. This study 
identified three distinct time points for the women, firstly at the time of diagnosis when 
crisis, shock and bewilderment were the key experiences described. During treatment 
when trauma was identified as a key domain this encompassed confrontation with 
diagnosis, and physical and psychological impacts of cancer. Attempts to regain control 
and the importance of social support were also important during this treatment time. 
The final time point highlighted three main themes, recovery, ambivalence and fear; and 
processing the experience. The findings and discussion of this study are highly 
congruent with the findings from the current research study.  
Overall the participants of Lethborg et al., (2000) study had a need to tell their 
story from diagnosis onwards. Once the trauma of treatment was completed the women 
began to process the impact of this journey and the spiritual issues that it had created. 
The survivors in the current study all had a story to tell and shared their experience 
willingly. In hindsight the interview itself provided an opportunity for survivors to 
reflect on their recent experience; like the Lethborg study, they were able to recall the 
exact diagnosis conversation as if it was yesterday.  
Finally, a quantitative study assessing the unmet needs of Western Australian 
patients with haematological malignancies surveyed 66 participants who had completed 
treatment an average of eight months earlier.  Again, it was not evident how many 
participants of this cohort had received chemotherapy.  On the whole the top ten 
83 
identified needs were consistent with the views expressed by participants in the current 
study, although the language was different as it reflected the items in the quantitative 
surveys. For example, 33% of respondents identified the “need for an ongoing case 
manager to whom I can go and find out about services whenever they are needed” 
(Lobb et al., 2009). 
The vast majority of literature focuses on survivors who are much further into 
their survivorship journey than those survivors in the current study. The main point of 
difference in findings between this study and the wider literature is the perceived 
positive impact of a diagnosis of cancer. A number of papers discuss cancer as a life 
changing experience with positive outcomes, recognizing that as humans go through life 
gains and losses are a normal part of life’s trajectory. Further, whilst a cancer diagnosis 
may begin with negative associations, the longer the person lives past their diagnosis, 
the more likely positive associations and actions will be when  survivors are reassessing 
their life to determine what is important in life and establish new priorities (Breaden, 
1997; DeMarco, Picard, & Agretelis, 2004; Doyle, 2008; Leigh & Logan, 1991; 
Meraviglia, 2006; Pelusi, 1997; Pinquart, et al., 2009; Shaha, et al., 2011; Thornton, 
2002; Vachon, 2001; Wallwork & Richardson, 1994). It has been suggested that 
survivors who report higher levels of stress early in the transition period tend to have a 
diminished longer term adjustment (Allen, et al., 2009). Therefore in identifying and 
reporting the true experiences in the early post treatment period, this study can 
contribute to the understanding of survivors as they begin their transition journey to life 
after cancer. 
Apart from the current study, no other study has focused solely on the 
immediate transition time following the completion of chemotherapy. It may well be 
implied that survivors need time to recover and adjust from their diagnosis and 
treatment side effects before recognition of positive outcomes begin; as displayed in the 
longer-term survivorship research.  
The literature supports the physical side effects identified by the participants in 
this study, in particular fatigue and it’s impact on daily living (Alfano & Rowland, 
2006; Broeckel, et al., 2000). Other previously reported outcomes such as goal setting 
and mixed emotional reactions were all congruent with the experiences of the survivors 
in this study (Cheung, Thompson, Ling, & Chan, 2005; Deimling, Sterns, Bowman, & 
Kahana, 2005; Dow, 2003; Dow, Ferrell, Haberman, & Eaton, 1999; Doyle, 2008; 
Ferrell, 1996; Lancee et al., 1994; Pinquart, et al., 2009; Vachon, 2001). 
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 The positive emotion of elation related to treatment completion is often marred 
by negative emotions. The anxiety associated with the loss of contact with the treating 
hospital, grief and uncertainty about the future is well described in the literature and is 
consistent with the findings from this study (Auchincloss, 1995; Diamond, 1998; Dow, 
et al., 1999; Doyle, 2008; MacBride & Whyte, 1998; Mellon, Northouse, & Weiss, 
2006; Mullen, 1985; Pelusi, 1997; Wallwork & Richardson, 1994).  
 
Loss of a perceived planned future 
Cancer survivors differ from other survivors because they live with a fear of 
cancer recurrence in addition to the physical, psychosocial and spiritual impacts related 
to their diagnosis and treatment (Breaden, 1997; Welch-McCaffrey, Hoffman, Leigh, 
Loescher, & Meyskens, 1989).  Alfano & Rowland (2006) described the fear of 
recurrence as one of the most universal and durable legacies of surviving cancer; its 
prevalence is said to range between 5-89% of cancer survivors (Alfano & Rowland, 
2006; Allen, et al., 2009; Costanzo, et al., 2007). The participants in the current study 
all expressed their inability or unwillingness to plan too far into the future, in case the 
treatment had not been effective or in case the cancer recurred.  Uncertainty is a 
common element of discussion in cancer survivorship literature and a given part of a 
survivor’s existence (Morgan, 2009). Uncertainty ranks in the top 10 of the 50 most 
distressing unmet needs (Lobb, et al., 2009; Moore, 2011; Schlairet, et al., 2010). Lobb 
et al. (2009) confirmed that 73% (n=66) of survivors identified their need for help to 
manage fears about cancer recurrence and 43% considered that this need remained 
unmet.   
Many authors discussed the Damocles syndrome in association with cancer 
survivors, inferring there is an inability to enjoy living in the present due to the fear of 
cancer recurrence having recognised their own invulnerability and mortality 
(Auchincloss, 1995; Breaden, 1997; Doyle, 2008; Fritz, 2001; Koocher & O'Malley, 
1981; Moore, 2011). The link between surviving cancer, fear of cancer recurrence and 
fear of death are said to be omnipresent (Cheung, et al., 2005; DeMarco, et al., 2004; 
Doyle, 2008; Koocher & O'Malley, 1981; Mellon, et al., 2006; Mullen, 1985; Pelusi, 
1997; Vachon, 2001; Wallwork & Richardson, 1994), although this is disputed in one 
study of long term survivors who described that participants found the experience 
largely unremarkable (Killoran, Schiltz, & Lewis, 2002).  
Conversely, Dizon (2009) identified that up to 40% (n=153) of women treated 
with chemotherapy experienced a degree of distress which persisted for up to 20 years 
85 
for some.  Uncertainty has a huge impact on survivors spiritual well-being with frequent 
descriptions of survivors searching for the meaning of illness and the meaning of life; 
highlighting a sense of both mortality and vulnerability (Breaden, 1997; Doyle, 2008; 
Hassey Dow, 2003; Morgan, 2009; Shaha, et al., 2011; Shanfield, 1980).  The days 
prior to a routine follow up appointment bring an experience of heightened anxiety with 
an increased fear that they may be informed that their cancer has returned, many 
survivors often have a scan or blood tests prior to the specialist appointment as a routine 
part of monitoring. The time between this procedure and the actual follow up 
appointment when they will get results is particularly traumatic (Jefford, et al., 2008). 
Coping strategies related to dealing with uncertainty may be positive or negative 
(Morgan, 2009).  Rowland & Baker (2005) discussed the belief that people are 
essentially goal orientated and for those people diagnosed with cancer there is a 
disruption in working towards personal goals whilst going through cancer treatments. 
The goals that people strive to achieve are what provide both meaning and quality of 
life; therefore a disruption to this process can in turn affect one’s perceived quality of 
life. This belief is supported elsewhere (Breaden, 1997; Pinquart, et al., 2009). 
The cancer survivors in this study were very aware of their vulnerability and 
uncertainty about the future, to the extent their ability to plan was virtually stifled in the 
early days following completion of treatment. Shaha et al. (2011) acknowledged these 
experiences related to anxiety, vulnerability, fear and loss of control all impair the 
individuals inability to cope. The literature discusses steps that survivors take to 
reassess values and embrace changes as they progress through the survivorship journey. 
Again, the disparity between the participants in this study and the wider literature 
appears to be time since treatment completion (Shaha, et al., 2011).  As Doyle (2008) 
confirmed a researched model to find a new normal life after cancer is yet to be 
identified. 
 
The Experience of Changed Emotions 
There is overlap between the experience of loss and emotional change; it is not 
possible to feel a loss without feeling an emotional response. Findings from both this 
study and that of Costanzo et al. (2007), identified that cancer survivors in the early 
days following the completion of chemotherapy experienced a myriad of emotional 
changes, many of which were unexpected. Participants who were excited about the 
prospect of completing chemotherapy were caught unawares with emotional mood 
swings in the time period immediately following chemotherapy completion, recounting 
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how low in mood they felt. There is evidence in the literature that going through the 
experience of being diagnosed and treated for cancer changes a person’s outlook, 
perceptions and expectations even though they hope to return to their usual normal pre 
cancer state (Doyle, 2008; Schlairet, et al., 2010). Fear of isolation and changes in 
existing relationships can impact on the survivor’s positive responses to these changes. 
The participants in the current study not only identified the physical isolation 
from their treatment community of health professionals and fellow patients, but also 
their emotional isolation from their own social community of family and friends. Upon 
removal from the treatment community the survivors expressed anxiety about needing 
to take responsibility for themselves, including their own self monitoring. In the 
literature this theme has been identified as “losing the safety net” (Allen, et al., 2009; 
Squiers, Finney Rutten, Treiman, Bright, and Hesse, 2005). The emotional isolation 
theme links with the previously identified experience of loss of identity, where 
survivors have recognised they are not the same person as they were pre diagnosis. The 
participants in this study identified some changes in the behaviour of friends and family 
on completion of treatment, for example  loved ones no longer phoned to see how they 
were or  else they avoided contact with the survivor all together.  Others expected the 
survivor to “be back to normal” and therefore they no longer treated them like a patient 
experiencing limitations due to treatment side effects; these  changes in behaviour 
occurred before the survivor was ready. The immediate post treatment period has been 
identified as a time when friends and family celebrate the survival from the cancer 
treatment and remind the survivor that they are  “lucky to be alive”.  This makes  it 
difficult for the person to express any fears or needs they may have at this time, 
particularly if they are feeling ambiguous about their cancer survival due to fears of 
recurrence or physical and psychological compromises (Itano & Taoko, 2005; Morgan, 
2009).  
In addition, one study found that survivors perceived that maintaining a positive 
outlook and getting on with life was the approach most respected by health 
professionals, family and friends (Leydon et al., 2000). It is acknowledged that people 
are comfortable talking about strokes or heart attacks, but that discussions about cancer 
remain difficult due to a general lack of understanding about the effects of the disease, 
treatment and the societal stigma attached to cancer (Carlisle, 2011). Additionally, 
following treatment completion survivors now have limited contact with health care 
professional further highlighting their isolation. Authors have suggested that more 
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rehabilitation assistance may therefore be required in this period (Breaden, 1997; 
MacBride & Whyte, 1998; Mah, Bezjak, Loblaw, Gotowiec, & Devins, 2010). 
In a review of literature undertaken by Holland & Reznik (2005), it was 
determined that up to 45% of patients in ambulatory cancer centres may have significant 
levels of distress whilst only 10% are referred on to appropriate supportive care.  This 
may well be an indication of the reluctance that cancer patients may have about asking 
for help with psychosocial concerns due to the stigma attached to issues related to 
mental health concerns (Earle, 2006). If Holland & Reznik’s (2005) claims are correct, 
then as many as 35% of patients may complete cancer treatment with some level of 
unidentified emotional distress before they commence their transition journey.  All the 
participants in this study experienced a tumultuous array of emotions in the immediate 
post treatment period, which was compounded by the social isolation due to the 
inability of non-cancer survivors to truly understand the experience.  
The participant’s experiences in the immediate post treatment period do not 
wholly correlate to the findings in the wider literature currently available. The negative 
experiences detailed are certainly congruent and mainly link to physical and 
psychological issues associated with treatment side effects and the meaning of illness 
(Doyle, 2008), however the positive life changing experiences illustrated in many long 
term studies are not evident at this period in time. Researchers have suggested the 
positive aspects of cancer survival are linked to experiences of personal growth, self 
improvement and appreciating life more (Doyle, 2008). This sentiment is supported 
suggesting that when people have confronted their own mortality and re evaluated their 
life goals and priorities a more positive outlook is achieved (Andrykowski & Hunt, 
1993; Cordova, Cunningham and Carlson, 2001; Davies, 2009; Pemberger, Jagsch and 
Frey, 2005). Finding meaning in becoming a cancer survivor is clearly a process, which 
is either helped or hindered by all of the points discussed above. Survivors each bring 
pre existing experiences, ideas and assumptions that have evolved since early 
childhood. These assumptions shape how survivors view the world and their role within 
it (Lethborg, Aranda, Bloch and Kissane, 2006). A diagnosis of cancer and surviving 
the experience forces a shift in beliefs which the survivor has essentially held since 
childhood. 
Perhaps time is of the essence in this transition period; fatigue described as a 
persistent lack of energy, is certainly the dominant all encompassing symptom 
described by all but one of the participants at this time. Several authors have identified 
the difficulty in achieving any goals towards personal growth when fatigue is present, 
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given the omnipresent and unrelenting nature of post treatment fatigue and the 
associated distress it causes. Fatigue is described as almost ubiquitous amongst cancer 
survivors disrupting routine activities and causing a negative impact on quality of life 
that is more alarming than pain or nausea as it cannot be relieved (Ahlberg, Ekman and 
Gaston-Johansson, 2005; Dizon, 2009; Donovan & Ward, 2005; Hjorleifsdottir, 
Halberg, Gunnarsdottir, & Bolmsjo, 2008; Karahalios, et al., 2007; Morgan, 2009; 
Pinquart, et al., 2009; Prue, Allen, Gracey, Rankin, and Cramp, 2010). Ahlberg (2005) 
stated that cancer-related fatigue is the most frequently reported unmanaged symptom 
that affects 70-100% of all cancer patients for months or years after treatment. Several 
studies have demonstrated that fatigue is a major obstacle to patients normal functioning 
and to their ability to achieve a good quality of life (Ahlberg, et al., 2005; Broeckel, et 
al., 2000; Loge, Abrahamsen, Ekeberg and Kaasa, 2000). This is disconcerting given 
the importance that quality of life holds for cancer survivors and their families (Ahlberg, 
et al., 2005;  Ferrell, Dow, et al., 1995; Morgan, 2009).  
There was certainly a notable change in the experiences described by 
participants in the current study. Fatigue was the most monitored of symptoms and as 
fatigue levels began to improve, there was a constantly identified awareness of new 
goals reached and improvement in mood levels. This became a recognizable next step in 
the participants’ transition to life after cancer with some participants already able to 
identify that for them the “new normal” may have some physical limitations that were 
not present in the pre cancer days.  
 
Experiences in transition 
This part of the transition journey has been defined as the process or period in 
which the person with a cancer diagnosis undergoes a change and passes from one stage 
to another. For participants in this study this stage involved dealing with highlighted 
personal challenges whilst finding a new balance, working towards future goals and 
achieving a normal life. The discussion in this section has been divided into two 
sections: experiences in resilience and experiences in empowerment. 
 
Experiences in resilience 
Resilience has been described as the ability to bounce back or cope successfully 
after substantial adversity (Earvolino-Ramirez, 2007; Herrman, Stewart, Diaz-
Granados, Berger, and Jackson, 2011). Resilience is depicted as having four 
characteristics to achieve this positive adaption: 
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1. Hardiness: - a dispositional characteristic that includes a sense of control over one’s 
life. 
2. Benefit finding: – the ability to make sense of adversity by focusing on positive 
changes and personal growth. 
3. Thriving: – which occurs when the person not only returns to a pre stress level of 
functioning but attains a higher level of functioning with acquired skills knowledge, 
confidence or improved social relationships. 
4. Post traumatic stress growth:- described as a stage beyond thriving and resilience 
which includes an increased appreciation of life, closer intimate relationships and a 
greater sense of personal strength (Earvolino-Ramirez, 2007; Herrman, et al., 2011). All 
of the above four characteristics rely on finding meaning in the experience of cancer and 
reprioritizing for the individual their own unique life goals. Resilience is the personal 
characteristic that enables the cancer survivor to cope and re frame meaning in the face 
of adversity. This does not occur in isolation and is intricately connected with the 
process of empowerment in order to achieve resilience.   
As participants’ energy levels returned, so do did their resilience. This was 
characterised by language which became much more focused on positive outlooks, 
fighting spirit and normalizing of experiences. Some participants accepted their cancer 
diagnosis as a personal challenge; this has been described in the literature as 
inevitability (Mok, 2001). In this study participants often referred to their coping skills 
or ability to cope, which is considered to represent the ability to deal successfully with a 
difficult problem or situation. Participants discussed their surprise at the inner strength 
they found to deal with their situation for some this was attributed to God and 
strengthened their spiritual beliefs. There were a variety of emotional resilience 
approaches displayed along a continuum, that ranged from choosing not to believe in 
depression and therefore not experiencing it, to acknowledging depression as a potential 
problem and seeking professional help early as a preventative measure. From the 
experiences shared by the survivors in this study it is clear that resilience is a complex 
web of personal values that is unique to each survivor. 
The literature confirms the positive link between developing survivorship skills 
and coping mechanisms. Failure to cope has been identified as increasing the risk of 
more negative outcomes for the survivor (Hewitt, et al., 2006; Jefford, et al., 2011; 
Rendle, 1997). Studies with longer term cancer survivors have shown that coping 
mechanisms change over time for almost half of all survivors; the dominant coping 
styles that have been successfully adopted include optimism, supportive, confrontational 
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and self reliance (Rendle, 1997). Survivors in the current study were using optimism as 
their dominant coping style in partnership with maintenance of hope and avoidance of 
negative information. Hope has been closely associated with ability to cope and a 
perception of a positive quality of life and adjustment to illness amongst patients with 
cancer (Benzein, Norberg and Saveman, 2001; Herth, 1989; Hjorleifsdottir, et al., 2008; 
Vellone, Rega, Galletti and Cohen, 2006). Hope is represented in the literature as being 
present from the beginning of the cancer journey, even when initial descriptions about 
the shock of diagnosis are listed they are closely followed with actions towards a 
positive outcome such as maintaining normality, faith, hope and a belief that the 
treatment will be effective  (Benzein, et al., 2001; Herth, 1989; Hjorleifsdottir, et al., 
2008; Vellone, et al., 2006). 
Hope has also been described as a universal human phenomenon essential for 
the overcoming of adversity and the fostering of resilience. It correlates strongly with 
health, wellness, strength of will and determination to endure rigorous medical 
treatments and strive towards a successful outcome (Hjorleifsdottir, et al., 2008; Leung, 
Silvius, Pimlott, Dalziel, and Drummond, 2009; Mattioli, Repinski and Chappy, 2008). 
Health professionals need to maintain a delicate balance between encouraging 
reasonable hope and creating unrealistic expectations. If health professionals fail to 
display a minimal sense of hope there is a risk that patients may become anxious and 
distressed, however, if patients’ expectations about the normative experiences of cancer 
and it’s treatment side effects are not adequately addressed then patients experience 
decreased satisfaction and increased distrust (Leung, et al., 2009; Saegrov and 
Lorensen, 2006). Survivors in this study provided examples of positive and negative 
experiences when the balance of information was correct, and this assisted them in 
managing their physical symptom at that time, or, when it was absent or diminished in 
importance to the point where it caused the participant an additional anxiety. 
Hope and fear are interwoven and survivors are caught between their desire for 
more information and the avoidance of new information which may challenge their 
optimistic stance (Leydon, et al., 2000). In a qualitative study with 17 cancer survivors 
the narratives displayed a sense of hope yet were closely linked with fear. The survivors 
were described to be  creating a façade of  hopefulness which was indispensible to 
survival and interacted with information seeking in a complex way (Leydon, et al., 
2000).  In keeping with Leydon et al.’s (2000) findings, the participants in this research 
maintained hope on occasions by using periods of self censorship, searching by proxy 
(usually through other friends who had already successfully gone through cancer 
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treatment) or actively not seeking information. These actions prevent opportunities to 
experience negative information, which may have threatened their hopes. Hopes are 
beliefs concerning future outcomes in this study hope  maintained the illusion of a 
positive outcome that the participants were seeking. These illusions of a positive nature 
can be powerful coping strategies in a time of immense stress (Houldin and Lewis, 
2006). 
 The experience of resilience for participants in this study appeared to be a  “light 
bulb” moment or an awakening from one stage to another that was embroiled in 
structure, treatment burden, treatment routine and passive acceptance and a transition to 
the next stage of life. To move into the new stage, participants were carefully and 
intuitively selecting information and support that met their criteria to maintain a realistic 
but positive future. The participants in this study were within the first three months of 
completion of chemotherapy but were already displaying some characteristics of 
hardiness and benefit finding. 
 
The experience of empowerment 
Traditionally when diagnosed with cancer and becoming a cancer patient an 
individual takes on a passive role as a recipient of health care from experts. Kvale and 
Bondevik (2008) found that whilst some patients had a strong desire for information and 
involvement in decision making other patients wanted to be informed about their 
disease and treatment but preferred the doctor to make the decisions.  Salmon and Hall, 
(2004) postulated that information giving was a strategy to build relationships and 
maintain hope rather than as a basis for decision making about treatment.  At the time of 
diagnosis there is often an inequality in the relationship between patients and health 
professionals, patients self determination at this stage can be enhanced or impeded by 
the professionals who are involved in their care. Empowerment is defined as a process 
that promotes individual mastery and control over one’s life and decisions that affect his 
or her life, information is essential for patients to feel empowered and gain control  
(Anderson and Funnell, 2010; Buffum, 2004; Bulsara, Ward and Joske, 2004;  Kvale 
and Bondevik, 2008; Mok, 2001). These sentiments appear to be a sensible and 
reasonable approach to promoting patient empowerment, however in the discussion to 
follow the complexity related to information sharing will be discussed further.  
  The participants in this study identified several stages that occurred in their 
empowerment journey which included: self awareness; seeking support; self protection; 
self informing; and self management.  Self awareness appears to emerge as energy 
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levels begin to return; the person begins to reflect on the more passive role they have 
taken as a patient when going through treatment and their expectation that it is now their 
responsibility to become more pro active. Self awareness therefore for these participants 
appeared to represent their understanding and expectations of actions and 
responsibilities as the person with cancer. Participants were able to identify and enjoy 
positive outcomes such as improved self care in the form of assertiveness or health 
awareness. 
 In the early stages some participants did seek support from others, however they 
were very careful who they chose to gain support from. This action was very much 
about self protection; the participants were conscious of the consequences of sharing 
their feelings with others, health care professionals or someone not too closely 
connected were the favoured resource at this time. This behaviour has been described in 
other studies. Byrne, Ellershaw,  Holcombe and Salmon (2002) found in their 
qualitative study that nearly all patients (n=28) interviewed described the importance of 
concealing distress and unhappiness from others. Patients in this study anticipated that 
the displaying of emotion would be catastrophic, the main reason patients had for this 
concealment was to protect other people, or to avoiding upsetting, displeasing or 
embarrassing others. 
 Whilst the participants in the current study did not wish to upset their friends 
and family, there was a strong self protective method in their approach as they were 
indirectly protecting themselves from exposure to more negative emotions.   The self 
protecting strategies that participants intuitively adopted and described in their 
interviews were very much aimed at maintaining their hope and therefore positive 
outlook. Any potential for negative feedback was avoided whether that was support 
groups, individuals or written information. This behaviour was consistent with findings 
by Leydon et al. (2000), who described how patients often stopped information seeking 
at different times in their cancer journey because they were fearful of contradictory 
information. This self censorship functioned to preserve hope and avoid negative 
information thus helping to manage their fears.  The participants were adept at hiding 
their feelings to maintain this façade of positive emotion, often using humour or 
storytelling to cover distress for others behaviours of avoidance and distraction helped 
to maintain the approach. 
Patients recognised empowerment being displayed when they were respected, 
listened to, valued and given honest information. These actions not only increased their 
self worth, they also gave participants a sense of control (Kvale and Bondevik, 2008). 
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Encouraging self management and patient autonomy have been identified as important 
aspects of patient care (Jefford, et al., 2011; Karahalios, et al., 2007). Self management 
and self monitoring enabled the participants to assess their progress and set new goals, 
this positive and forward looking process strives towards improvement and maintains 
the positive approach. The constant evaluation and resetting of goals was discussed 
particularly in relation to fatigue-related limitations; this appeared to be the most 
frustrating symptom to monitor and assess because the participants had no prior 
knowledge of the recovery trajectory, but had expectations based on prior experiences 
of fatigue with flu related illnesses for example.  
The study participants were very clear that this knowledge deficit affected their 
ability to cope and also highlighted their need for honest information, so that they could 
set realistic goals. At this stage participants were keen to learn from and listen to other 
survivors who understood their journey and needs. As the participants travelled further 
along the transition continuum their information needs changed and focused much more 
on the future, such as understanding the future management plan or planning future 
lifestyle goals and less on the individual treatment side effects. The participants in this 
study displayed an array of self informing skills that were delicately interlinked with 
their self protection and self management needs for the longer term. This enabled the 
survivors to continue towards their new normal with appropriate knowledge which 
didn’t threaten their coping skills and facilitated the maintenance of a positive outlook. 
There is evidence to suggest that self management strategies are beneficial for patients 
as they transition from primary treatment to life after cancer, understand the signs and 
symptoms of disease recurrence, manage long term side effects of cancer and its 
treatments and re establish normal routines. 
The experiences and wishes of the survivors in this study appeared consistent 
with other studies. Hindle (2010) stated that survivors wanted; support and information, 
to be empowered to take as much control as they wished, to be able to cope with life 
after cancer and to get their relationships back on track.  Information needs have been 
constantly highlighted in the literature; the demand for better information in the post 
treatment phase includes subjects such as post treatment care, physical activity, help 
with everyday problems, and what measure to take to help them function better 
physically and emotionally  (Karahalios, et al., 2007; Saegrov and Lorensen, 2006; 
Sanson-Fisher et al., 2000). 
In summary, the major themes identified and described by survivors at this time 
of transition were: the experience of loss, the experience of changing emotions, the 
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experience of resilience and the experiences relating to empowerment. These themes 
have been discussed in relation to current available literature and identified congruence 
between the current study and available knowledge as well as gaps that this study 
begins to address. The factors which were identified as having improved or exacerbated 
the transition experience were intricately interwoven throughout this phase. Hope was 
the overarching positive determinant which improved the survivors’ transition through 
this time, whilst an information limitation was identified as the overarching 
exacerbating factor. However, as discussed in the discussion, achieving stability 
between hope and information is a complex challenge that must be survivor-led, 
accessible, negotiable and achievable. 
 
Phase Two: quantitative phase (Instrument development and testing) 
Introduction 
As previously discussed the aim of this phase of the research was to develop an 
instrument which could be used to explore the needs of a large population of cancer 
survivors as they transitioned from chemotherapy treatment to life after cancer. Rather 
than develop a new instrument, the decision was made to adapt the Quality of Life-
Cancer Survivor (QOL-CS) tool as it comprises many items that were consistent with 
the key descriptors identified from the qualitative interviews conducted in this study. 
Given the universal acceptance and current use of this tool, as well as the relevance of 
many of the items to the population of interest in this study, the researcher opted to 
make a minor adaptation to this instrument by adding seven additional items designed to 
capture the full scope of key descriptors (needs) identified from the qualitative phase of 
this study.  
The main identifiable distinctions between the items in the QOL-CS and the 
findings in Phase One of this study were in relation to information needs. Therefore the 
original questions in the instrument remained relevant and were not modified in any 
way. Seven additional items were added to reflect the key areas identified in relation to 
information seeking and deficits. These items were added to a new section titled, 
Information needs at the end of chemotherapy treatment. 
The additional questions were: 
• Did you receive enough information about physical changes at the end of 
chemotherapy treatment? 
• Do you understand everything that happened to you during treatment? 
• Do you understand your plan of care from now on, including timeframes? 
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• Have you tried to find information from other places? (i.e. cancer council, 
internet, friends) 
• Were you provided with any written information about life after chemotherapy? 
• If you were provided with information, was it useful? 
• Have you been able to make any plans for your future? 
 
The title of the original instrument was changed from the Quality of Life- 
Cancer Survivors (QOL-CS) to the Quality of Life- Chemotherapy Cancer Survivors 
(QOL-CCS).  
The QOL-CCS was then tested by an expert panel of six chemotherapy nurses 
for clarity, apparent internal consistency and content validity. Expert panel members 
were recruited from the same tertiary centre as the participants in Phase One. Each 
panel member met the criteria that had previously been considered to ensure their 
expertise and therefore suitability to undertake the psychometric testing of the adapted 
instrument QOL-CCS. This process resulted in tiredness being added after the word 
fatigue in question one, diarrhoea, vomiting, menstrual changes and fertility all being 
developed into individual questions within the physical well being section. Question 25 
changed from depression to emotional distress in an attempt to remove a medical 
diagnostic term and a word which carries a stigma in wider society. 
The changes and suggestions identified by the expert panel are in part due to 
language changes or the awareness of language. It is now 17 years since the original 
tool was devised and during this time there has been a rapid rise in awareness of 
information provision in language that is acceptable to patients (Jefford, et al., 2007). 
Furthermore, there have been rapid advances in chemotherapy treatments in the past 17 
years; physical side effect profiles have changed considerably, anticipatory nausea and 
vomiting once a constant research and publication topic is now minimal due to the 
introduction of highly effective anti-emetics changing the emesis profile of 
chemotherapy side effects (Sharma, Tobin, and Clarke, 2005). Likewise, diarrhoea is 
now recognised much more commonly as a chemotherapy side effect with the 
introduction of new chemotherapy agents (Richardson and Dobish, 2007). The changes 
that were recommended are therefore much more a reflection of physical changes 
related to treatment. The domains of psychological, social and spiritual apart from a 
slight language change as discussed appear to remain as relevant today as they were 17 
years ago. In addition the newly added items based on feedback from in Phase One 
received no comments or scores less than 100%. 
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Summary 
Overall the preliminary assessment of clarity, content validity and internal 
consistency was successfully achieved in keeping with the original purpose of this 
Master’s study. The researcher plans a more comprehensive psychometric assessment of 
the QOL-CCS in future phases, as detailed in the summary of Chapter Five. Once the 
QOL-CCS has been validated it is anticipated it will be used for a much larger scale 
study with survivors in the first three months as they transition from chemotherapy to 
life after cancer. The findings of this larger population of survivors will then contribute 
to the care planning and information sharing that is currently delivered with a limited 
evidence base. 
 
Limitations and Strengths 
Limitations 
The researcher acknowledges a number of limitations to this study. The first is 
the extent to which the findings of Phase One can be generalised to the wider 
survivorship community with any degree of certainty. Results from a population of 14 
participants from one tertiary treatment centre cannot represent the many thousands of 
cancer survivors currently living in Australia. 
Second, one third of the participants had the same haematological diagnosis of 
myeloma. The potential differences in needs between haematology and medical 
oncology patients were considered and discussed with the Director of Haematology 
prior to commencing the study. As the focus of the research was on patient needs in the 
immediate post chemotherapy treatment period it was considered appropriate to include 
both groups of patients to provide a baseline of information related to the immediate 
impact of chemotherapy treatment. 
Third, the expert panel currently work in the same cancer centre and whilst this provides 
congruence to this study, it is not possible to be reflective of the many thousands of 
cancer health professionals practicing in Australia. In addition the panel were all from 
the same discipline of nursing. This may have been strengthened by the addition of a 
medical oncologist and haematologist. Finally, the scope ofthis study  was limited by 
the time available for completion of a Master’s research project. 
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Strengths 
All the interviews and analysis were undertaken by the same researcher who was 
able to reflect not only the words, but the passions and inferences which were applied to 
the conversations. This ensured that a consistent approach of interpretation occurred 
across all 14 interviews. There is a high level of academic and clinical interest in the 
field of cancer survivorship, particularly within Australia. This study has provided a 
strong basis for a future program of research with an instrument that is ready to be 
utilised immediately. This will provide opportunities for study findings to be useful and 
clinically relevant in the very near future. 
 
 
 
Conclusion 
This study intended to explore and describe the experiences in transition from 
the completion of chemotherapy to life as a cancer survivor. The aims for Phase One 
and Phase Two of this study were achieved. Specifically, the experiences following the 
completion of chemotherapy have been themed following analysis using Grounded 
Theory to a descriptive level. These identified themes have been the key to  adaptating 
and testing  an instrument which is now considered ready for piloting in a large 
population of cancer survivors. The identified themes have been explored in the wider 
literature and whilst elements have demonstrated synergy, there has also been a 
demonstrated lack of research related to this cohort of cancer survivors at this particular 
time of transition. The development of the adapted instrument QOL-CCS will add to the 
current body of research evidence and provide a basis for a larger population study and 
the shaping of future cancer survivorship care delivery based upon its findings. The 
findings from Phase One provide a strong base on which chemotherapy nurses can 
begin to question the role that they play in preparing cancer patients for life after 
chemotherapy, particularly regarding the provision of information and resources which 
assist self-management. 
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Recommendations 
Research 
• The key recommendation from this study is build on this work by conducting a 
follow-up study to explore the psychometric properties of the revised QOL-CCS 
tool, followed by implementation of the tool in a large scale study of this 
population across all tertiary chemotherapy  services in Western Australia.  
• Once there is a more comprehensive understanding of this populations’ needs at 
this particular time, then further research and developments would be warranted. 
• The development and testing of delivery methods to facilitate self management 
of survivorship issues is also recommended. 
Education 
• The development of appropriate information materials such as pamphlets, DVD’s 
web resources and methods of dissemination to reach all survivors in a timely 
manner. 
• The introduction of transition education sessions to patients during the last two 
weeks of chemotherapy treatments and to chemotherapy nurses to further reinforce 
the information. 
Clinical 
• The development of peer led survivorship clinics, 
• The introduction of psychosocial ‘drop in’ clinics where survivors could seek 
council from allied health, social work and legal teams regarding financial, social or 
psychological issues, 
• The development of nurse-led clinics for patients post chemotherapy across a 
continuum from tertiary centres to practice nurses in primary care, 
• The development of shared cared models immediately post chemotherapy between 
specialists and primary care. 
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9th April 2010 
Dear Participants name 
 
We are writing to ask if you would be willing to be contacted about a project 
 “Issues and concerns after completing chemotherapy” for which we hope to recruit 
suitable patients from this hospital. From our records you would appear to be a potential 
participant for this study. 
 
We would like to improve the amount and type of information that we provide to people 
when they complete chemotherapy treatment. In order to understand how we can make 
these improvements we are conducting a research study which involves an interview by 
telephone. We would like to interview people who have completed chemotherapy 
within the last 1-4 months. 
 
If you do not wish to hear more about this study, or be contacted further, could you 
please complete the attached slip and return in the envelope provided. If we do not hear 
from you within 3 weeks we will assume that you are willing to be contacted and Violet 
Platt will contact you shortly after this to give you more information regarding the 
study. 
 
We have included an information sheet which provides further information about this 
study. If you are happy to be included or wish to discuss this further you do not need to 
do anything. You will be contacted during the week beginning 3rd May 2010 to discuss 
this further. 
 
Whether or not you participate in this project, any future care you receive at this 
hospital will not be affected in any way. 
 
This study has been approved by Sir Charles Gairdner Hospital and Edith Cowan 
University Ethics Committees and the confidentiality of all participants is assured. 
 
Thanks for considering this request 
 
Yours Sincerely 
 
Violet Platt                                               Tina Crosbie 
Director of Nursing                                  Haematology CNS 
WACPCN                                                 SCGH 
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PLEASE TICK THE BOX, THEN SIGN, DATE AND RETURN THE SLIP IN 
THE ENVELOPE PROVIDED. 
 
 
  Please do not contact me regarding my participation in the Study “Issues and 
concerns after completing chemotherapy treatment” 
 
 
 
 
Name:  Participants name 
 
 
 
 
 
 
Signature:………………………………………. 
 
 
Date :…………………………………………… 
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Sir Charles Gairdner Hospital 
 
PARTICIPANT INFORMATION SHEET  
 
Lay Title  
What are the needs of people in the first 3 months following the completion of 
chemotherapy?  
 
Title of Study 
Survivorship issues following completion of chemotherapy.  
 
Investigator’s Names 
Mrs Violet Platt 
A/Professor Leanne Monterosso 
Ms Christina Crosbie 
 
Please take time to read the following information carefully and discuss it with your 
friends, family and general practitioner if you wish.  Ask us any question if some part of 
the information is not clear to you or if you would like more information. Please do this 
before you sign this consent form.   
 
Who is funding this study? 
This is a study for a Master in Research Nursing at Edith Cowan University. The study 
is funded by the student Mrs Violet Platt undertaking the research, and the School of 
Nursing, Midwifery and Postgraduate Medicine. 
 
Contact persons: 
Should you have questions about the study you may contact: 
 
Mrs Violet Platt Phone No     0439 512 903     (after hours)      0439 512 903 
 
All study participants will be provided with a copy of the Information Sheet and Consent 
Form for their personal records. 
 
You may decide to be in the study or not take part at all. If you do decide to take part in 
this study, you may stop at any time.  However, before you decide, it is important that 
you understand why this research is being done and what it will involve.  
 
Whatever your decision, this decision will not lead to any penalty or affect your regular 
medical care or any benefit to which you are otherwise entitled.  
 
The following information sheet will explain the study and will include details such 
as: 
o Why this study might be suitable for you; 
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o The nature of your participation including how many visits you will make to the 
hospital 
o Your rights and responsibilities 
 
What is the purpose of the study? 
This study will identify if there are common issues experienced by people when they 
complete chemotherapy treatment following a diagnosis of cancer, and whether the 
hospital team have provided appropriate information to deal with any issues that may 
arise. The study will take place at Sir Charles Gairdner Hospital in the medical 
oncology department. We will be inviting up to 24 people who are completing a 
minimum of four cycles of chemotherapy and have no further cancer treatment planned.  
 
Why is this study suitable to me? 
This study is suitable for patients with cancer who have completed chemotherapy and 
have no further cancer treatments planned.  
 
How long will I be in this study? 
This study will run over three months following the completion of your chemotherapy. 
 
What will happen if I decide to be in this study? 
If you decide to participate in this study, you will be given a small diary in which you 
can jot down issues as they occur to help your remember them. This is not compulsory. 
 
You will also be asked to complete a brief interview with the researcher (Violet Platt) 
12 weeks after your last chemotherapy treatment and no more than 16 weeks after this 
date. This will last no longer than 30-60 minutes and will take place by telephone at a 
time convenient to you. This interview will be audio taped and transcribed (typed into a 
written document) which will not contain any personal identifying information. The 
recording will then be destroyed. 
 
The interviewer will ask questions about: 
• Your overall quality of life in the weeks since completion of treatment, if any issues 
or side effects caused you trouble and if any further information could have been 
provided to support you during this time. 
 
Personal details such as your age, gender, type of cancer, type of cancer treatment and 
when you commenced treatment will have been recorded at the time you agreed to be a 
part of the trial. 
 
Your involvement in the study will cease following the telephone interview. 
 
Are there any reasons I should not be in this study? 
No 
 
What are the costs to me?  
No personal costs will be incurred. 
 
What are the possible benefits of taking part?  
We wish to discover if we are preparing people properly for moving back into life after 
cancer treatment. We hope to discover the issues that affect the quality of life in people 
who have received cancer chemotherapy in order to improve the way we care for, and 
prepare individuals more appropriately in the future.  
115 
 
How will my safety be ensured? 
Taking part in this study will not affect your personal safety. 
 
What alternatives do I have to going on this study? 
You may choose not to be a part of this study. This will not affect the current care you 
are receiving. 
What are the possible side effects, risks and discomforts of taking part? 
None.  
 
What if new information comes along during the study? 
Sometimes new information about treatments becomes available as a study progresses. 
You will be told about any information that could be important to your decision to 
continue in the study. If you then want to continue in the study, you may be asked to 
sign a revised consent form.  
 
Stopping study treatment early: 
Sometimes a study needs to be stopped early due to unforeseen circumstances. If this 
occurs the reasons will be explained to you. 
 
What happens if I change my mind after I have done the interview and wish to 
withdraw from the study? 
If you decide to withdraw from the study after your interview, then simply inform the 
researcher and your interview will be deleted and all related information will be 
destroyed, none of your information will be used in the study. 
 
What happens at the end of the study? 
At the end of the study you will continue with your cancer care follow up plan as per 
normal department follow up. 
 
What if something goes wrong? 
In the unlikely event you experience any emotional distress during the interview, it will 
be stopped immediately. If you need to be referred to a health professional for 
emotional support, the research assistant will ensure this occurs as soon as possible.  
 
This treatment will be provided at no cost to you. 
 
Your participation in this study does not prejudice any right to compensation which you 
may have under statute or common law. 
 
Will my taking part in this study be kept confidential? 
The researchers will need to collect personal data about you, which may be sensitive 
(e.g. date of birth and relevant health information). The researchers may also need to get 
some of your health information form your medical records. 
 
Any personal or health information will be kept private and confidential. It will be 
stored securely and only authorised persons, who understand it must be kept 
confidential, will have access to it. Your study details will be given a number so that 
your identity will not be apparent. The study records will be kept in a locked filing 
cabinet in the office of the Research supervisor at Edith Cowan University during the 
study and in a locked archive for at least 5 years from the time the study is closed, and 
will be destroyed at any time thereafter.  
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Authorised representatives of the study funders, the investigators, the Hospital Human 
Research Ethics and Research Governance Committees may require access to your 
study records to verify study procedures and/or data. In all cases when dealing with 
your information, these people are required to comply with privacy laws that protect 
you. 
 
Will I find out the results of the study? 
You will be sent a summary of the findings from this study. The result of the research 
will be made available to health professionals through medical journals or meetings, but 
you will not be identifiable in these communications. By taking part in this study you 
agree not to restrict the use of any data even if you withdraw. Your rights under any 
applicable data protection laws are not affected. 
 
Who has reviewed the study? 
The Human Research Ethics Committee of Sir Charles Gairdner Hospital has reviewed 
this study and given approval for the conduct of this research trial. If you have any 
ethical concerns regarding the study you can contact the secretary of the Sir Charles 
Gairdner Hospital Human Research Ethics Committee on telephone number (08) 
93462999. The study is also approved by the Curtin University of Technology Human 
Research Ethics Committee (Approval Number HR 73/2008). If needed, verification of 
approval can be obtained from either by writing to the Curtin University Human Ethics 
Committee, c/o Office of Research and Development, Curtin University of Technology, 
GPO Box U1987, Perth, 6845 or by telephoning 9266 2784 or by emailing 
hrec@curtin.edu.au. This study is also approved by Edith Cowan University Human 
research Ethics Committee c/o Research Ethics Office, Edith Cowan University, 270 
Joondalup Drive, Joondalup, WA 6027 or by telephoning 6304 2170 or by emailing 
research.ethics@ecu.edu.au  
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                                  CONSENT FORM 
 
Survivorship issues following completion of chemotherapy  
 
Investigators:  
Mrs Violet Platt,  
Ms Christine Crosbie,  
A/Professor Leanne Monterosso 
  
Participant Name:_________________________________________ 
 
Date of Birth: _______________ 
 
1. I have been given clear information (verbal and written) about this study and have 
been given time to consider whether I want to take part. 
 
2. I have been told about the possible advantages and risks of taking part in the study 
and I understand what I am being asked to do. 
 
3. I have been able to have a member of my family or a friend with me while I was 
told about the study.  I have been able to ask questions and all questions have been 
answered satisfactorily. 
 
4. I know that I do not have to take part in the study and that I can withdraw at any 
time during the study without affecting my future medical care.  My participation in 
the study does not affect any right to compensation, which I may have under statute 
or common law. 
 
5. I agree to take part in this research study and for the data obtained to be published 
provided my name or other identifying information is not used. 
 
If you are unclear about anything you have read in the Participant Information 
Sheet or this Consent Form, please speak to your doctor before signing this 
Consent Form. 
 
 
Name of Participant    Signature of Participant                                
Date 
 
 
Name of Investigator   Signature of Investigator           
Date 
 
The Sir Charles Gairdner Hospital Human Research Ethics Committee has given ethics 
approval for the conduct of this project.  If you have any ethical concerns regarding the 
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study you can contact the secretary of the Sir Charles Gairdner Hospital Human 
Research Ethics Committee on telephone number (08) 93462999 
 
All study participants will be provided with a copy of the Information Sheet and 
Consent Form for their personal records. 
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                 Welcome 
• Ensure interviewee is comfortable, needs are met, drinks etc. 
• Confirm interviewee is comfortable with the purpose and process around the 
interview and happy for this to be recorded. 
 
                  Opening Question 
How have the last 3 months been for you since completing treatment? 
• Opening, question to set the scene and relax the person 
 
                  Main questioning 
1. Can you tell me about any side effects that you may have experienced? 
Prompts: 
Nausea & Vomiting 
Sore mouth – eating & drinking 
Constipation or diarrhoea 
Fatigue / tiredness 
Altered sleep patterns 
Pain 
Any other symptoms 
 
2. How has it been for you in settling back into your life as it was before your cancer 
treatment? 
Prompts: 
Has anything been difficult? 
Work 
Family expectations 
Friends 
 
3. How have you been feeling in the last (12) weeks? 
Prompts: 
Tearful 
Glad to be alive 
Anxiety about treatment success 
 
4. Can you tell me about the information & support that you received? 
Prompts 
What else would you have liked to know? 
How and when would you like to know this? 
 
5. Would you like to tell me about any support from GPs or hospital staff that you may 
have received? 
 
6. Is there anything else that you would like to tell me about this time? 
 
Finish with another thank you 
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(ECU Letterhead) 
 
Transcriber Confidentiality Agreement Form 
 
Applicants name: 
 
 
As an employee of the research title … 
I certify that I have read the sections of this document regarding the legislation and 
policies of the National Health & Medical Research council (NHMRC) and Edith 
Cowan University (“the University”) that govern access to and use of participant and 
employee personal information. 
 
I acknowledge that I have been instructed regarding the confidentiality of the project’s 
activity and records, and except as required by law in the course of my duties or where 
instructed in writing by management, I am aware that all project raw data records, files 
and memoranda are to be treated in strict confidence. 
 
I agree to keep project information confidential by observing the following: 
• I will comply with the legislation, the policies of the NHMRC and the 
University that govern access to and use of information contained in employee 
and participant records and raw data and other university documents or systems. 
 
• I will make a reasonable effort to access only the information/ data that is 
relevant and necessary for me to perform my duties for the project. 
 
• I will be a responsible user of the information/data, whether it relates to my own 
project or other projects, by adhering to the University’s rule of conduct 
whenever I use E-mails, handle files, and answer, telephone or fax queries. 
 
• I will restrict access by others to any confidential information and/or data that I 
obtain, by following the University and the NHMRC policies regarding the 
storage of information and data under secure conditions. 
 
• Before sharing information/data with others, electronically or otherwise, I will 
exercise reasonable care to ensure that the recipient is authorized to receive that 
information/ and understands his/her responsibilities as a receiver of this 
information/data. 
 
• When sharing information with appropriately authorized personnel, I will ensure 
that I am in a private setting where others cannot hear, see or otherwise unduly 
access the confidential information. 
 
• I will make every reasonable effort to interpret the information/data I obtain in 
an accurate, accountable, ethical and professional manner. 
 
• I will use information/data that I obtain only for tasks specifically related to the 
project I have been employed under. 
 
• I will log-off or secure any computer system that contains participant and/or 
employee information/data when I am not actively using it. (Securing the 
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information/data is considered to occur through the use of     password-protected 
screen saver) 
 
• I will keep any password(s) issued to me, ore devised by myself, confidential 
and will not disclose them to others unless my immediate supervisor authorizes 
such disclosure in writing. 
 
• When working on my home computer, I will password protect any project 
information/data to ensure that there is no inappropriate access. 
 
• I will not disseminate project information/data from my home computer without 
appropriate authorization from my supervisor for the release. 
 
• I will dispose of confidential information/data when I have finished using them 
in a manner that will preserve the documents confidentiality (e.g. in accordance 
with ethics form requirements (where applicable) or NHMRC and/or University 
policies, which ever is the most stringent.) 
 
• I understand that audits might be conducted on the project, such as financial 
telephone or E-mail usage, records, etc. and I acknowledge that I am required to 
ensure compliance with these audits. 
 
• I understand that this confidentially agreement will remain in force until my 
employment on this project is terminated (either voluntary or involuntary) 
 
• I understand that my employer has the right to take disciplinary action up to and 
including my termination of my employment for breaches of confidentiality. 
 
 
 
Signature ---------------------------------------------------------------------------------- 
 
Date ------------------------------------ 
 
Witness ------------------------------------------------------------------------------------ 
 
Date ------------------------------------ 
 
 
 
 
 
 
 
 
 
 
124 
 
 
 
 
 
 
 
 
 
Appendix D: Open and axial codes identified.  
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 Level 1 Codes Level 2 
1.Different phases 
2 Looking ahead to the future 
3 Positive approach to finishing chemotherapy 
4 Planning for the future 
 
Planning 
5 During chemotherapy / thinking time 
6 Rewards at the end of treatment 
7 Lots of support whilst on chemotherapy 
 
chemotherapy 
8 Transition to non treatment 
9 On a journey 
10 Changes to work status 
11 Need to change from being a patient 
12 ‘new life’ 
13 Transition behavior 
 
 
Transition 
 
14 Unexpected feelings 
15 Depression 
16 Emotional feeling deflated 
17 Glad its over – relief 
18 Enjoying all the little things 
19 Wants to celebrate 
20 Pressure to be different and happy 
21 Afterwards need emotional support – feel 
vulnerable 
22 Detox after chemotherapy 
23 Psychological – residual chemotherapy 
24 Enjoys meeting/ talking to others 
25 Get energy back and boost mood 
26 Exciting to get energy back 
27 Unforeseen upsetting moments 
28 Disruption to life after treatment 
29 Surprising – a challenge 
 
 
 
 
 
Emotion 
 
30 Time after treatment 
31 Later months physically stronger 
32 Four months, physically well, look normal 
33 On treatment no energy and lots of time 
34 After treatment lots of time, not well enough 
35 Physically weak in the first few weeks 
 
Time 
 
36 During treatment – don’t feel like a victim Patient role / time 
37 Lack of structure not in a cycle 
38 Not having treatment, loss of identity 
39 After chemotherapy, isolation, not being cared for 
40 Loss of friendships 
41 Not belonging 
42 Out patient and the system has finished with you 
 
Loss of patient structure 
Loss of patient identity 
Loss 
Role change and loss 
43 Finances Finances 
 
44 Tired 
45 Hair growth, eyebrows and alopecia 
46 Constipation 
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47 Nausea 
48 Mouth care 
49 Too tired to work 
50 Body stiffness / moving pains 
Physical 
 
51 Don’t look different/ what others think 
52 Treated normally by others 
53 People are kind during treatment 
54 Miss the amazing conversations 
55 Key people ie psychologist 
People and others 
expectations 
  
56 Can’t avoid the feelings 
57 Everyone goes through a crisis 
Normalizing 
 
58 In a different place, not identifying with other 
survivors 
59 Sense of community- ‘looking for belonging’ 
60 Tolerance 
61 Altered expectations 
62 Cant return to normal/ feel different after treatment 
 
 
Different 
 
63 Wants to meet other survivors without recurrence 
64 Worry about recurrence 
Recurrence/ avoidance 
Recurrence 
65 Wishful use of skills 
66 Reality of finances/ part time to exist 
67 Opportunities based on importance/ community 
benefit 
68 Wishful thoughts versus reality 
69 Need to find balance between stress, energy and 
priorities 
70 Questioning future directions and work role 
71 Making a commitment & ‘re-engaging’ 
 
 
 
 
Re evaluate 
 
72 Getting on with it / keeping active 
73 Attitude/ approach important 
74 Assist ‘ long term benefit 
 
Values and attitude 
 
75 Feeling a bit lost, where to from here? 
76 Information timing and booklets 
77 Identify community support 
78 Doesn’t know what’s normal follow up 
 
Information 
79 Started smoking – rebelling 
80 Feeling virtuous – making health choices 
81 Coping mechanism – old behaviour 
82 Feelings about self 
 
Taking control, making 
choices 
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Appendix E: How the codes developed to themes 
 
 
 
128 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
129 
 
 
 
 
 
 
 
 
Appendix F: Example of memo showing trail from codes to the themes 
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Example of a memo showing open data exploration from which open codes were 
identified.  
Date:  June 17th 2011 
 
Properties and dimensions of the survivorship experience relating to feeling different. 
 
“Initially I was quite excited to finish chemo and really looking forward to that, wishful 
thinking. You know, all the things that you are going to do. So I suppose having had 
chemo I spent a lot of time thinking of the resolutions if you like of things I was going 
to do. But I was actually quite surprised I went to see a psychologist at the same time to 
kind of pre-empt the transition back into non treatment and  I was really surprised how 
depressed I got and how emotional I became probably about a month after treatment 
[stopped]. Talking to the psychologist, she said its actually quite common and was quite 
relieved to see me upset, its quite common because people don’t have a structure 
anymore. And I think I felt like I had landed back on earth but in a foreign country, if 
that makes sense, just the sense that I cant just re join the flock again and carry on as 
before.”  
 
Quote from interview with survivor (S04) 
 
 
Memo 
 
This women is describing her experiences of how different or changed she feels 
following her diagnosis and treatment for cancer. The description is from her 
perspective, in the description she describes the properties of anticipation, planning, 
expectation, excitement, distraction, rewarding, surprise, low mood, mixed emotions, 
unexpected emotions, normalising, validation from others, not belonging. 
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Appendix G : Permission to utitlise Quality of Life – Cancer Survivor Tool 
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From: BFerrell  
> To: violet platt 
> Date: Fri, 23 Mar 2012 06:38:08 -0700 
> Subject: Re: Quality of life patient/ cancer survivor version 
>  
> You are welcome to use and adapt any of our instruments. All are on our website 
http://prc.coh.org.  
>  
> Good luck with your research.  
> Betty Ferrell  
>  
> ----- Original Message ----- 
> From: violet platt  
> Sent: Friday, March 23, 2012 06:30 AM 
> To: Ferrell, Betty 
> Subject: Quality of life patient/ cancer survivor version 
>  
> Dear Dr Ferrell 
 
> > I understand that you and Marcia Grant have been very generous in allowing duplication of 
the Quality of Life cancer survivor version tool. I would like to request permission to add some 
questions (7 in total to the tool) regarding information needs in this phase? 
> > I have recently been under taking a Masters degree in nursing research, I am especially 
interested in survivors as they transition from chemotherapy treatment to life after cancer. As 
an oncology nurse I have found that myself and my team all have a different set of, end of 
treatment 'pep' talks based on our different experiences. Therefore my research set out to 
understand the patients experiences. I performed 14 interviews and identified a range of 
themes all of which harmonise very well with your tool. 
> > As my interest is in ensuring that as chemotherapy nurses we prepare people in the most 
effective way, I would like to use your tool and add some information questions which will go 
through all the required psychometric testing before utilising with a larger population. I will fully 
acknowledge all of the great work that has been happening in City of Hope over the years 
which has been highly inspirational to me and I am more than happy to share my thesis (once 
marked) with your team, as a small contribution to your vast works. 
> > Many Thanks for your consideration of this request 
> Kindest Regards 
>  Violet Platt 
> > Director of Nursing  > WA Cancer and Palliative Care Network,  Western Australia 
> 
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Appendix H  Tools utilised by the expert panel to assess clarity, internal consistency, 
content validity. 
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CLARITY 
 
Instructions 
 
This survey is based on a previous work by Ferrell et al. (1995). The original survey 
was designed to find out more about the long term quality of life issues of cancer 
survivors. I am interested in the issues for cancer survivors in the short term period up 
to 6 months after they complete chemotherapy. I have modified this survey to ensure 
that questions are relevant to cancer survivors as they transition from completion of 
chemotherapy. These modifications have been made based on the findings of qualitative 
interviews with cancer survivors who had recently completed chemotherapy. You are 
being asked to rate: (a) the instructions in the survey, and (b) each question in the 
survey on it’s clarity since you are familiar with this content. 
 
(a) Are the survey instructions clear? Circle either yes or no on the next line.  
     YES  NO 
 
(b) Read each question in the survey separately and respond to the same number on the 
response sheet. Beside each question number on the response sheet circle C (clear)  
 or  U (unclear) to indicate whether the question is clear or unclear to you. 
 
After you finish you may wish discuss your comments with the researcher. 
 
Thankyou for your assistance. 
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Code ____ 
RESPONSE SHEET: CLARITY 
 
Please indicate whether each question is C (clear)  or  U (unclear) to you. 
 
 
Circle One   Comments 
 
 
Physical Well Being 
 
1. C U 
 ________________________________________________________ 
2. C U 
 ________________________________________________________ 
3. C U 
 ________________________________________________________ 
4. C U 
 ________________________________________________________ 
5. C U 
 ________________________________________________________ 
6. C U 
 ________________________________________________________ 
7. C U 
 ________________________________________________________ 
8. C U 
 ________________________________________________________ 
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Psychological Well Being 
9. C U 
 ________________________________________________________ 
10. C U 
 ________________________________________________________ 
11. C U 
 ________________________________________________________ 
12 C U 
 ________________________________________________________ 
13. C U 
 ________________________________________________________ 
14. C U 
 ________________________________________________________ 
15. C U 
 ________________________________________________________ 
16. C U 
 ________________________________________________________ 
17. C U 
 ________________________________________________________ 
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How distressing were the following aspects of your illness and treatment? 
18 C U 
 ________________________________________________________ 
19. C U 
 ________________________________________________________ 
20. C U 
 ________________________________________________________ 
21. C U 
 ______________________________________________________ 
 
 
22. C U 
 ________________________________________________________ 
To what extend are you fearful of: 
23. C U 
 ________________________________________________________ 
24. C U 
 ________________________________________________________ 
25. C U 
 ________________________________________________________ 
26. C U 
 ________________________________________________________ 
Social Concerns 
27. C U 
 ________________________________________________________ 
28. C U 
 ________________________________________________________ 
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29. C U 
 ________________________________________________________ 
30. C U 
 ________________________________________________________ 
31. C U 
 ________________________________________________________ 
32. C U 
 ________________________________________________________ 
33 C U 
 ________________________________________________________ 
34. C U 
 ________________________________________________________ 
Spiritual Well Being 
35. C U 
 ________________________________________________________ 
36. C U 
 ________________________________________________________ 
37. C U 
 ________________________________________________________ 
38. C U 
 ________________________________________________________ 
39 C U 
 ________________________________________________________ 
40. C U 
 ________________________________________________________ 
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41. C U 
 ________________________________________________________ 
42. C U 
 ______________________________________________________ 
 
Information needs at the end of chemotherapy treatment 
 
43. C U 
 ________________________________________________________ 
44. C U 
 ________________________________________________________ 
45. C U 
 ________________________________________________________ 
46. C U 
 ________________________________________________________ 
47. C U 
 ________________________________________________________ 
48. C U 
 ________________________________________________________ 
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CONSISTENCY 
 
Instructions 
 
In this section, you are being asked to look at the questions in the survey and decide if 
you think they seem to belong together. 
 
Read the entire survey first. After you finish reading the survey, answer question (a) at 
the top of the Response Sheet, then answer the following question (b) for each question 
in the survey. Answer by circling the response you choose under question (b). Add any 
comments you wish to explain your answers. 
 
Thankyou for your assistance.  
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Code ____ 
RESPONSE SHEET: CONSISTENCY 
 
(a) Do these questions generally belong together? 
YES  NO 
 
(b) Does each question belong in the survey? 
  
 Please circle   Comments 
1. Y N  _____________________________________________ 
2. Y N  _____________________________________________ 
3. Y N  _____________________________________________ 
4. Y N  _____________________________________________ 
5. Y N  _____________________________________________ 
6. Y N  _____________________________________________ 
7. Y N  _____________________________________________ 
8. Y N  _____________________________________________ 
9. Y N  _____________________________________________ 
10. Y N  _____________________________________________ 
11. Y N  _____________________________________________ 
12. Y N  _____________________________________________ 
13. Y N  _____________________________________________ 
14. Y N  _____________________________________________ 
15. Y N  _____________________________________________ 
16. Y N  _____________________________________________ 
17. Y N  _____________________________________________ 
18. Y N  _____________________________________________ 
19. Y N  _____________________________________________ 
20. Y N  _____________________________________________ 
21. Y N  _____________________________________________ 
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22. Y N  _____________________________________________ 
23. Y N  _____________________________________________ 
24. Y N  _____________________________________________ 
25. Y N  _____________________________________________ 
26. Y N  _____________________________________________ 
27. Y N  _____________________________________________ 
28. Y N  _____________________________________________ 
29. Y N  _____________________________________________ 
30. Y N  _____________________________________________ 
31. Y N  _____________________________________________ 
32. Y N  _____________________________________________ 
33. Y N  _____________________________________________ 
34. Y N  _____________________________________________ 
35. Y N  _____________________________________________ 
36. Y N  _____________________________________________ 
37. Y N  _____________________________________________ 
38. Y N  _____________________________________________ 
39. Y N  _____________________________________________ 
40. Y N  _____________________________________________ 
41. Y N  _____________________________________________ 
42. Y N  _____________________________________________ 
43. Y N  _____________________________________________ 
44. Y N  _____________________________________________ 
45. Y N  _____________________________________________ 
46. Y N  _____________________________________________ 
47. Y N  _____________________________________________ 
48. Y N  _____________________________________________ 
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CONTENT VALIDITY 
 
Instructions 
 
In this section, you are asked to look at the questions in the survey and decide if you 
think they seem to belong together. 
 
Read the entire survey first. After you finish reading the survey, answer question (a) at 
the top of the response sheet – either YES  or  NO. Then answer question (b) for each 
question in the survey. Answer by circling the response you choose under question (b) – 
either Y (YES)  or  N (NO). Please add any relevant comments you wish to explain 
your answers.   
 
Thankyou for your assistance. 
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Code ____ 
RESPONSE SHEET:  CONTENT VALIDITY 
Label: Quality of Life Chemotherapy Cancer Survivor Version 
 
Definition: The survey is intended to measure the quality of life of cancer survivors as 
they transition from completion of chemotherapy to life after cancer. 
 
(a) In general, do the label and definition fit the whole set of questions in the survey? 
Answer once for the whole survey by circling either YES or NO on next line. 
 
YES            NO 
 
(b) Does each question fit the label and definition? Please circle Y (YES) or N (NO). 
 
      
 Circle One  Comments 
 
1. Y N 
 ________________________________________________________ 
2. Y N 
 ________________________________________________________ 
3. Y N 
 ________________________________________________________ 
4. Y N 
 ________________________________________________________ 
5. Y N 
 ________________________________________________________ 
6. Y N 
 ________________________________________________________ 
7. Y N 
 ________________________________________________________ 
8. Y N 
 ________________________________________________________ 
9. Y N 
 ________________________________________________________ 
10. Y N 
 ________________________________________________________ 
11. Y N 
 ________________________________________________________ 
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12 Y N 
 ________________________________________________________ 
13. Y N 
 ________________________________________________________ 
14. Y N 
 ________________________________________________________ 
15. Y N 
 ________________________________________________________ 
16. Y N 
 ________________________________________________________ 
17. Y N 
 ________________________________________________________ 
18 Y N 
 ________________________________________________________ 
19. Y N 
 ________________________________________________________ 
20. Y N 
 ________________________________________________________ 
21. Y N 
 ________________________________________________________ 
22. Y N 
 ________________________________________________________ 
23. Y N 
 ________________________________________________________ 
24. Y N 
 ________________________________________________________ 
25. Y N 
 ________________________________________________________ 
26. Y N 
 ________________________________________________________ 
27. Y N 
 ________________________________________________________ 
28. Y N 
 ________________________________________________________ 
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29. Y N 
 ________________________________________________________ 
30. Y N 
 ________________________________________________________ 
31. Y N 
 ________________________________________________________ 
32. Y N 
 ________________________________________________________ 
33 Y N 
 ________________________________________________________ 
34. Y N 
 ________________________________________________________ 
35. Y N 
 ________________________________________________________ 
36. Y N 
 ________________________________________________________ 
37. Y N 
 ________________________________________________________ 
38. Y N 
 ________________________________________________________ 
39 Y N 
 ________________________________________________________ 
40. Y N 
 ________________________________________________________ 
41. Y N 
 ________________________________________________________ 
42. Y N 
 ________________________________________________________ 
 
43. Y N 
 ________________________________________________________ 
44. Y N 
 ________________________________________________________ 
45. Y N 
 ________________________________________________________ 
147 
46. Y N 
 ________________________________________________________ 
47. Y N 
 ________________________________________________________ 
48. Y N 
 ________________________________________________________ 
 
 
 
 
Code ____ 
 
(c) Is the question unique, i.e. not repetitious? Please circle Y (YES) or N (NO). 
 
      
 Circle One  Comments 
 
1. Y N 
 ________________________________________________________ 
2. Y N 
 ________________________________________________________ 
3. Y N 
 ________________________________________________________ 
4. Y N 
 ________________________________________________________ 
5. Y N 
 ________________________________________________________ 
6. Y N 
 ________________________________________________________ 
7. Y N 
 ________________________________________________________ 
8. Y N 
 ________________________________________________________ 
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9. Y N 
 ________________________________________________________ 
10. Y N 
 ________________________________________________________ 
11. Y N 
 ________________________________________________________ 
12 Y N 
 ________________________________________________________ 
13. Y N 
 ________________________________________________________ 
14. Y N 
 ________________________________________________________ 
15. Y N 
 ________________________________________________________ 
16. Y N 
 ________________________________________________________ 
17. Y N 
 ________________________________________________________ 
18 Y N 
 ________________________________________________________ 
19. Y N 
 ________________________________________________________ 
20. Y N 
 ________________________________________________________ 
21. Y N 
 ________________________________________________________ 
149 
22. Y N 
 ________________________________________________________ 
23. Y N 
 ________________________________________________________ 
24. Y N 
 ________________________________________________________ 
25. Y N 
 ________________________________________________________ 
26. Y N 
 ________________________________________________________ 
27. Y N 
 ________________________________________________________ 
28. Y N 
 ________________________________________________________ 
29. Y N 
 ________________________________________________________ 
30. Y N 
 ________________________________________________________ 
31. Y N 
 ________________________________________________________ 
32. Y N 
 ________________________________________________________ 
33 Y N 
 ________________________________________________________ 
34. Y N 
 ________________________________________________________ 
35. Y N 
 ________________________________________________________ 
36. Y N 
 ________________________________________________________ 
37. Y N 
 ________________________________________________________ 
38. Y N 
 ________________________________________________________ 
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39 Y N 
 ________________________________________________________ 
40. Y N 
 ________________________________________________________ 
41. Y N 
 ________________________________________________________ 
42. Y N 
 ________________________________________________________ 
 
43. Y N 
 ________________________________________________________ 
44. Y N 
 ________________________________________________________ 
45. Y N 
 ________________________________________________________ 
46. Y N 
 ________________________________________________________ 
47. Y N 
 ________________________________________________________ 
48. Y N 
 ________________________________________________________ 
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Code ____ 
 
(d) Are there any questions you think should be added to the survey? 
 
______________________________________________________________________
______________________________________________________________________
_________ 
______________________________________________________________________
______________________________________________________________________
__________ 
______________________________________________________________________
______________________________________________________________________
__________ 
______________________________________________________________________
______________________________________________________________________
__________ 
______________________________________________________________________
______________________________________________________________________
__________ 
______________________________________________________________________
______________________________________________________________________
__________ 
______________________________________________________________________
______________________________________________________________________
__________ 
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Appendix I : Invitation letter to expert panel 
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189 Royal Street 
East Perth 
WA 6004 
23 -09-2011 
 
Dear  
 
I am writing to ask for your assistance with my Masters Research study. As an expert in 
the field of cancer nursing and chemotherapy I would be grateful if you could review 
the adapted survey Quality of Life Chemotherapy Cancer Survivor Version for 
content validity, internal consistency and clarity the tools for this review are included. 
 
The tool has been adapted from Ferrell et al (1995) Quality of Life cancer Survivor 
Version which was developed for long term cancer survivors, the adaption’s that have 
been made are as a result of findings from recent qualitative interviews that I have 
undertaken with individuals who have completed chemotherapy within the previous 6 
months. 
 
The review should take approx 30 mins, I would be grateful if you could return your 
reviews by Monday 3rd October 2011. If you would like a paper copy of this review 
please let me know and I will arrange this 
 
Thank you in anticipation 
 
Kindest regards 
 
Violet Platt 
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Appendix J: Original Quality of Life Cancer survivor tool 
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